INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137497, 18342, 1.95, 1.95, 'g', NULL, 1, 'Pediatric', X'789cf3cb2f5128c95748ad484e4d4d5130d4b3345548574849cccca9040072f7086a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137498, 25907, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73cacf292d56d0f04dac54284a2d484d2c512834cecdcc53282d5028c957c84dac5048c92f4e553034c84dd7040055f20ed5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137499, 25907, 2.0, 2.0, 'mg', 'IV', NULL, 'Adult', X'789c732cc84bcd4c56c82f52c84b4d2cd24d847075158c72d3153cc300a23b09e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137500, 25907, 0.4, 0.4, 'mg', 'IV', NULL, 'Adult', X'789cf32fc8cccf4cd1cd4bcc2c4b5528cf2cc950c8cdcccbcc4dcc51284a2d2ec82c4a2cc92faa5448492d00728b33f3f31474150cf44c72d3153cc3009dfc155a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137501, 25907, 0.05, 0.05, 'mg', 'IV', NULL, 'Adult', X'789cf32fc8cccf4cd14d492d48cd4b49cd2b5128cf2cc950c8cdcccbcc4dcc51284a2d2ec82c4a2cc92faa54002a01728b33f3f31474150cf40c4c73d3153cc3001815172f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137502, 25907, 8.0, 8.0, 'mg', 'IN', NULL, 'Adult', X'789c25cacb0980400c45d156de5241053f0bb107c1160246093899311941bb57707bcf5d8ceb2037af50723ae0c9e899d05743856818117614ed9f4b88222a43a36793a3c14c0f8c1353c689aeee1144afcc0ed9bee9234f519d5f965a21be', X'789ced576d4fdc4610fe2ba3932a81c4716f212fd74f242429524828d0f4438c4e833de7db62ef3abbeb70d788fef63e63df01476940a452bf4442c6dedd997d66e69997fbdac97c9d4f2c97d21953e73d176eeeac74b6a853fb429766315661dceb5d987329b79dcff5cdf46e9e0ca9e74ab209471518f6874fbbfd4177d03fe93f1befe0eff976ffc5d3c1f3517356d2689c0d38f9b5f356ac782e9af728f346fc6451c938b11f2ae34c9658b69173674d8861abf932998b92d83d1738177ae37c1970fc952b4b67e9c47326f41ed68431fef9946d73697d76f3de4b2c453e2b44bf3e9de2ab30f6bcf9b8c6d102b8df11cb73d0792dbb8279bff4eeeae4e5a9a2dacdea224e609bb1f99a57eeb062897012dddca4262ed6cebf74451d68e38017e4a5128ef479541a4b7545d151c973ca5c101af4cb7c33b1bb95159392f364857d97dbcf2e0dcb9cf63fae82d1b56cbe085d983823e8322517501e2ae3393abfa04c2a7c06e083687ffbc9ba3076c56662e38315f477961af6edb4d655e8b2c582724561a61467421547a33a558d83fa4ccdd38db3c6016c336c7dae8d976ce508cef4ee107169a3f3384a458331ed49148f2d69e493ce059f4b17fe5247251d754eabf34a1f6ed2332d8eb854341cd35bc537ec8dc84def565589a799ff193e9813623278477b3bbfab99c064397091d8432f5d6ce396668142e57931a6d1d6932d45f29ce09a8d41bbbca94a908a641dac32c536dd0c3b0dbb23f5761d25a8d7ac5b3a0b50ecfe470a304a1d31a6e152299ec2e96ca58e6a65232144a5f9533ce8f26970da594fa1cb6fa45443ec1f5cfdc1d5ff93ab0fef000d5d0f25330c85e95db5f84d5d2817be88576b371c5e1a82c256631b8637d1da54c8bdfd0f63d04381f6ce8158d9acd837b7e9a8355af52cb086085ddbce01ec165024b12746a30fe7a6cefbd6040dd6bf7071ea5da981d4860c57214f967d54a11cf48e7f7bf9abe2e9f777f442bc0c5a6070eeb781e87226a1215326b9176951b45e78848b8f2b490d17934357d5055f77b59597c1aa1cfd3e5dd011766d9e20eaaf12fb8ed3c82d078c0df5748a7aa2499571e4c41e894548da986100706de5e0ec8f3ac412c712fb8b681aa6df38f3d881e136e0fb9bff9e8e5eede130317672a561390dbc729a65c6664b46ad3b68b728c4e70b0d4c5a70083d9de41e1188dd4c6328932324d23f6f692b62530733cf179aefef9deda6ec33e372b1264d2c0288e18bc11e30a544183e0d4f5162c41b871a94bab22a5616107b218fc7f78d6537f03c74429bdc10591bd66ea1bf5fdfe14a60d20ab4c13a9cb12f397585cbd7dbdb81c0285798508e69d6b22fb1afe7a99796c65e399bd80349678c5a5f6a5eeda6ed5e9bbd743d04d386ba533435a7a837650df154aaa8155f8982e2170c76b72833a12a38d59556cba6b6a42051f5b79146e71a748748758cd375db62d63687fdee8bbe76e28dc49628d36742084e407d61ab8fb8ea1ab84482d6a855b5c15d98ccb167b4077180ba92ed82660e552b2245b9c89d47404af083514ed598bf46d8af7d50adaff7c8811cfe4b8baa02957c53824c809b7c8e7e70ec4aa150aa74887566e09219a39ba93e40518d99a47abbfaa081120d44a61e3f0f54d7a0b98eceead8544c69b8e9a6512caa4193135a136d0cdab3187ecdad41b9413080c755ceaf1c06e970d5de31c9687f53480b0a3377a1b5537d35d8f9490f5f1d9b7176fb9e50a3952d4b6e6340a8abaa10ad4af0999b2f72c506841e2d2e4a5969e9b8f609e92d8d51daf846c8c1edc7146691c96e11dc5d656035bfad26a55b79f81d097d35193e349daf04d692f9bf290f98672fff061ff63b86', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137503, 25907, 2.0, 2.0, 'mg', 'IV', NULL, 'Adult', X'789cf30c5328cecf292dc9cccfb3523052c84d57d0300491a989c9190a79f9c5254599390aa5c59979e90a8925f9b99955a9459a00ca9e1200', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137504, 25907, 0.1, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf30cd3f7f4b75230d03354c84dd7cf4e57d0c84dac5030027234f51482520b52134b1452cb528b2a816225f90ac60ab99979a525a9c50a89c50a79a9a929a929007dea1482', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137505, 25907, 0.005, 0.01, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c15cbb10a80200045d15f795f9056b434b6393444e42ef812290dd482febedc2e07aed242cd62dda665846ca41c50ae1a6d70e270501a7c985e74d57b041fefc20c9311494b5bd932fbf4a7a54b24ae1da94ed99c1f1e311e2b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137506, 7051, 30.0, 45.0, 'mg', 'PO', 3, 'Adult', X'789c3336d03531cd4d5708f05708f17451c82f520884501ac60606b93e0a99790ae60606c9c90a1e46fe0a45a925a9792599f9790aa979a9b9890a15c606b999799a0083741405', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137507, 216, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'789cbd56df4f1b3910fe5746794e48082dbd86a788b602e9e050c2e91e6eab95634f762dbce3957f04f62afef71befd2409a482108f529d9f1f89bcfdf8c67fca3a75c2c721215f626d0fbeba1a93088ffacd184bd3ef4a233c95e8650fbc97078afefb03ab2ae48fff470cbdd4b276a54b90869d778343e1d8c8e07c7a3dbd1a7c9c7cf93d1f8e88fcf1f4e3f9db4be2883b6e4d9f3476faa2a4dda072792ad35057c68516e9b1a27197d4169a9401f04858cce60aa1c12ba424b981636ede55fa470069795564f9c40a1d32bc65c2123582f0a846fd6557e02736b628a7506d7c20b03be76a2c9686663400f76099b94267049fc97926f46e7b6aa2cc1ad130a797f850c783c1e5cd8e89ee0666834ae10e609b60fd3a5d3d487ab2899d5431fbeb4c06cb9463bf00d615dba9f1ac6c54b691ed914c4c260fafaf73b7ff1c1eeda8f678d5e8ab33f6d1bde8fdf5384a98a26e4ac90a66243fd4bf2411b03e3c149279187a57580429640960fa18d8770af256b2db469dad52c8ec7a71f4ed8d2f8c38ed492b941a50523cb5d84ce4b6d52eabb201f4fa141e17c4acfef273aaf516a61f21b5b47239eabf927d71b870509920dcc78958a8ccb682e96181a5091f35d40bdf62885679e0116c867f3212a8dea28a33f850c2d3238edef12c0353b89151f2111db41ba3743624e3ba46b93dc0110a24295d15aea97e6dee6b1d3492fb066163b13f256d45715f6af0abea2b8533feb9c7dae295f23f438e033f0a6aefb61d7fe79f2cfa5085858a7997c7781de45f45f33f97b557fcf441f7891ce6d6aae9a94963baed1d4186ef40d040bd208ef876966bd21ca3fc2512a8b21d78414713bd0df1ee15e87129e564113243978acf86ea1e461e40292e7d53e94dc7a022cf92e4687c0fd445a6749b806d88efca3b447e179f6ec4766211798464f85c6e810fd6b367574cac659cda1aad76c5920e9828d8e7b62ca748751b3ae5abc41d3a95aa1f398cfb8d16e0bbaaba8e73c926ddcf49be1c24652d08e57789a4e897e251ab052f2586dc9b33b129718448f8756f67bc63d74a095c255425a638b6623fe8530cb81d14b9cb4bd7fddd633bae277d582df30beda5afafa201d766f12da330bf611bb42590a7ee454b95de653b9f5f69a075da5c9c66599c5d1c9e278209e9f5d7c89b0e6324f35d6d6bbb6a67b3a75725651f28bab9f4a4d451ebb2be12d4b9c467117e940be8f8fff03fcd9aa66', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137508, 17397, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137509, 8238, 15.0, 45.0, 'mg', 'PO', NULL, 'Adult', X'789c3334d53531cd4d5708f057c8cb4ccf28c9a904002e3705af', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137510, 6681, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65270760cb0523054c84dd751300293a660d2d0004801000ed70bb0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137511, 6681, 1.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d4353450c84d5708f05728cc280600190f03df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137512, 6681, 1.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c33d4353450c84d5708f05728cc280600190f03df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137513, 6681, 2.0, 5.0, 'mg', 'PO', NULL, 'Adult', X'789cf34f4bd3cd494c4acdb15230d23555c84d5708f05728cc2806005cdc0756', X'789cdd576d6fdb3610fe2b07030352c08e2d27293af79397b448813531120fc35007c2993a49ac295223a9244e91ffbea3fc9228719ad94387615f6c933ede3df7f0def8ad95d82a8b3516d41a406b4c16ef8c93bad586566555d8cbbd2fdda0dbbd91332af68dcdc22fd96d883a61b1a424461f4ef47bfdb79d5ed4897ae3debb41ef6010bddb3fea45fdde412d4bc24ba31d4b7e6b0d93426ae9bcc5b0576f79baadb58ce7250d6052f50ea65167aa8c98919de813e33023f8686ce106703c1c0d2082226b43bffe3caa3fa31e7f4df485a93c39302934cd0ce0dca29ae863531446c3d8624270c614b0c6d3b9b74b9faae963a8f7bce571aa28acbe5cf14a493d5b2cc27fc3a4523e3e098c640d3f36e86afd425a663a2ead719e21893867676da9d0496c1c0e24b22f303a873f73d76a6208664fc3414fda3da5efd593bf59a3a4cf25db748d93e769da51382535807ee7e8651daf31f20f9c7ccad77fd8cb2da03df5ea8763dbc9c096713fa24422e78cd814fb9798929f77294da54031076d3c900beaa4cb29d9c1dc654942a28a47a6ac143e70b9b238b29469d46ceb82ffd55c05b84aecc30dc92c072bddac3b254da9f490549ce81994ab03ef191de455811a12f408788d52052413fd2b0a5fdbaa3504959f748adad74b10a8835f53025b294a80abcefb4d066f72a908a696d0f9949836266b43545c9066ff3690595798019c19c0e46be57c41da6faa0854d6d9b6a386ef5cc0cb2cbfde2e4e429b5908bb58ea78ada1c5061f1437997e5ded5a3e0ef2b1404f99b192c1dfd7646c4de6b3caf3c3d8dcf5b2b64c9863a3b9ed499d70063e4f97a15264b33978036110e80aaecebb548161724dd6517c41289e5bd944ec255969aaa61cd752b32ca5137d39d7c2949c7d232bb194aed810eb8b0ede2c6dd6e7cb8603f9637d27f2ee4e6a726ea24f09131439ebfe9d70b6d83bc3ca11866f870a98b58c0b55a8e9bbe5c703e4ef07f05a7211afbbb1f294dbff1d2dff9243dbb6be1c6d81c22893cd9b37868afbab4c797e8dfa9de81072cb963f132be386ec0a6e497f8c0e8f7a13fde156585acca41f49f0b0baf7b6f7d31b409d800da50bf60e79bd03b6cf2472e491b7884d1a0fc5b3e97a39574743b6e53133613ae661bb1ffddc075718e373282a27b861595278bba8c952c354619290054d62d686e56c476da8d88ddce24a85d422f439ee86a1cb12a4cadc004fdf047b97c4f731c6c2552a14bd897ec3cb9c4ce041a0527360a71cb8d0e8796c80d4d8b555ec448c4750e98d75354b3eaf1ce4c80bc8b9e3b24cdd93c321f352847cd22c1deaada28ee0aaca873e5496b38a5bffc5f1b80d7ef5b681bd6b077e8d952fa6642936cdf592fb3dd74ac3d38867376f78ce7a842178caef0e372f186a51437811ce97e86a89a9e008e9205ffb9c073648ad2978f3380fd14c0c0a8b3614cc13702c7ce558703517f23a8c312f43a65b1e502569c12893556ed4dc3551f4afb60bb3472fb5b5b5bff16c7c905d553c8a87ca99276da9cc11968f3ef7385c76c5d8d4f83ace5a3e5ecb378694ddfdbdbfff0bcdeb367b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137514, 24646, 20.0, 40.0, 'mg', 'PO', NULL, 'Adult', X'789c0bf0b7523032d03531c84d5728b4c828d251c82f523036d035030968a45694a4e6a5a4a62814a5e6a42616a76a2a141a1a65140100946a100c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137515, 24646, 5.0, 5.0, 'mg', 'IV', NULL, 'Adult', X'789c25cc4d0e40301086e1ab7c4b123f45ba710317b02f292631d38411dc5eb17ef2be5ddfc2f25c2e1b861bfb1a4e904cc74e419058c36b943483926e4e3d3480dd457c30c284c67c65e4c54b0412f5e264f42fd685418eca16fffe013ff12244', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137516, 24646, 2.0, 2.0, 'mg', 'IV', NULL, 'Adult', X'789c458dc10d80200c0057e900bedcc205fc23166802ada145e3f6a23c7cdf5d6e596193dc1476510409309738812564f0c246dca443e2d09484c1f94478a282ba829f5125bf59ba0fac863caccecdd55ec73fbdc892341bbb073bbd2cd8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137517, 24646, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c0b2e492c2a51482c5130cd4dd7cf2802002a780536', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137518, 24646, 2.5, 2.5, 'mg', NULL, NULL, 'Adult', X'789c05c1c90d80300c04c056b6021e4829823272ac124b39c07690e89e996b666534e2094326d287f308a3624f970e6f8447ad74a4be56c1ad34db4a8821e6267c597e2297182b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137519, 24646, 3.0, 3.0, 'mg', NULL, NULL, 'Adult', X'789c0dc6c10980301004c056b600c187add8403017b3e0ed41722276aff39abd9b16d0dd2a4bdaf52299e31f6a3c4206bc50692a3a0c54bb27438886cdcfb58f0f098517bb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137520, 24646, 20.0, 40.0, 'mg', 'PO', NULL, 'Adult', X'789c3332d03531c84d5708f05728b4c82802001d9f042a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137521, 24646, 0.5, 3.0, 'mcg/kg', 'IV', NULL, 'Pediatric', X'789c33d033d53556c84d4ed7cf4ed7cfcdcc53f00c03003240057e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137522, 11749, 100.0, 300.0, 'mg', 'IN', 1, 'Adult', X'789c3335d0353430d0353630c84d574849cccca9d451c8cc5330d4355648c92f4e2d060085e908fd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137523, 11749, 10.0, 10.0, 'mg', NULL, 3, 'Pediatric', X'789cb33334aaccb7523034c84d5708f1745148cc4b513002710a3d82016fe007ef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137524, 8463, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137525, 8738, 2.0, 10.0, 'mg', 'PO', 1, 'Adult', X'789c0bf0b7523052d055303450c84d5730d2355128c9cc4d2d564849cccca9040068060816', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137526, 8738, 2.0, 10.0, 'mg', 'PO', 1, 'Adult', X'789c0bf0b7523052d055303450c84d5730d2355128c9cc4d2d564849cccca9040068060816', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137527, 8738, 5.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c2dca4d0a80201006d0ab7c072833a416de20a86d7bc9c1249a017f826e9f8bd6ef2dbbc52ace470ef092c962428f51e30e1d3617b9103b3ee847adb469aed5d8c27005d043e985693f722d945104334ea9297fe6521bf7', X'789cbd55db4e1b3110fd95519e73d9245cd47d0ba10524a0285c5eba281aecc9c6c26baf6c6f9380f8f78e37a19094968268dfd69ef19c33b7b3f70de9aa7c6cb0a0460a8d7d85775462d16842a3723a5e4d43287ddae9ccd42d156debf2f8a53acf3dbd7058921c63880f7a496fa795745bdde422d94db7bbe976d24eb63e6dedf66b5f124159e3d9f3be7140861ceafa3bd0bc7e7eb12829cdcc1e993b2b6b1065c86766df7acc09be585778b60f6d515803170e25c129d3f7295ca156d5925175f31ce881af02de688aa76fd77cd2cadcd68727e00dc4d74bb0f9e0e13ae20c64a5c398d92a93af2536307345619199b3af29f4a005dd048a1c7aad2d088af98344a5d97c5279a1097c89be78d5f99c24c6344119381a5e66e6e82a85638b92d1415a4f296c3fbe6ec2092a13c8a011b432726bfa6c4fda5d76e8dce640dfc92da0cffeca54818182851d98dacaf9b715b62ec6794942a11e9fd9b2d2f8d4f8c79a9c39ca239d058cd86af2cca4b09f996314a1f6e6d36ace008d848218cc6a1579a123281d793221267fe3087d60d6fa363323ce51c3b20799a93b9299531b40d2845b25b9acc48d0b4e898dfb43c60a4afce16d132a4f3053610a02ab48b2c9b504c31e6c906079a0a1ae49f091988f152598ae02aba244e50a66fd3b121f06f0de45d86cca5f8841d490a5b31f2b33fe1961b513436b82e3d9934abc300403adc9e58b386942a3f79d284999f9a0bc564bc9b13c8d4784e257022f046c9c9353b65af71b912f95c360dda2333c3de786c501f4fc860767515a5eade5a14496253be76c354447cf3bbb9affc63ad36575a294ad214967673e8a0a0b9f54fc3555372ad4b131e05ce166985717f11fa6b359baff91cf7b31de3837675374050aab6dbe58033b443d6969356109ed27ad9d64a9902cde2b85f205cbb0e2a1cbcce7b970b414b34bc7fca29398a2611fb0131888a5ed60b03700cc2ddfbf67c24734e16d61615feff1a37cb290f252b15c4cf8ff5977ae0d97e585ddc7406d98cd66edaa0c56c693b0459b5971a4a83683d2290dbd26f492eea7f65b893d3cfc001883dc3d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137528, 9026, 100.0, 300.0, 'mg', 'PO', 1, 'Adult', X'789cd351c84b2dc828cacfc92cc9c84c2cce2cb652303430d0353630c84d5708f05730d4355228c9cc4d2d564849cccca904006db50f06', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137529, 9026, 200.0, 800.0, 'mg', 'IN', 1, 'Adult', X'789cd3cfa82c482d2a2dca4c4ecdcd4c54c8cc53c8c92c2ccd4c51c84dccc94ccf4bcc4bce4c2db652303230d0b5303050c84d5708f057c82f52f00c534849cccca90400e93c15a8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137530, 9026, 150.0, 150.0, 'mg', 'PO', 1, 'Pediatric', X'789cb331abccb75230343550c84d5708f0574849cccca95448cb2f52305228c95730060a5416eb289464a4e62924a66495169728a4e417a78255e42666e695a4e625e625a702001253178c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137531, 9026, 300.0, 300.0, 'mg', 'PO', 1, 'Pediatric', X'789cb333abccb75230363050c84d5708f0574849cccca95448cb2f52305228c95730060a5416eb289464a4e62924a66495169728a4e417a78255e42666e695a4e625e625a702001223178b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137532, 9026, 200.0, 200.0, 'mg', 'IV', NULL, 'Pediatric', X'789c33323050c84dd7cfd530d2d44f49ac54f00c03002b0604d2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137533, 9026, 200.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c732e72ce513034d03532b05230323050c84d5708f057c82f52f00c534849cccca904008c980907', X'789ced565d6fdb3614fd2b177e6a01bb969d36698d6280e1766b86350d9ca00f9d068191ae2d3614a9915412adc87fdf21e57c28f19025c3860dd89b4d5d1ede7beeb91fdf06856dd69916150f6634982b65eac64a6dd4604883c6aa705a7a5fbbd9787c2e4fb97a61ec3afc92e33bc62eb7a2e622133edc9926d3dd5132194d92e3646ff6726f3679f32279f9fad5ee5eb4e5dc4ba31d2cbf0de64525b574de8a70168f3c5f4494e3b6e6195d08ed4ba999cc852c846392ba9427d21b9bea77c68935d3f7c6566e465e9c28f643aacd79c19656c6c2f66bf758aa97a6f1ecc8aca8ffe48cf63f0fe9f053aa17a6aa8ca6632b0aa6039002cc2f2dc2b4b21ad2bcfb1103684e6ec77089a3f876f8f7f32ff8a7a43eedfe846ff3a2513e83af52af7b01fe0097523d24cd75698d928853388957274932da49926a0dbf68329a9297f0860a21559beae3a64268aa8529b95617d6549cea7109ba2c32927325052227257f6d6441955072ad85ce6508680ae8d749421d3670f63f77b88f0bac1fc4c3728956c0bb95dd2d513c8c136f65f156767deb32d27cc885141ef16fa3faed6e6bc0ebababc063c8512220d7d00e0e5a37245fb226517c6d9ca7c2406cc1a212527b0e0c82e6ef22d04ef29781a611625c3d9b3e1fe30ef2f004691dd59c4ba1b243d4a21237557515f6a1e598fa9696f8aad729e4be48f54f22f7d19aac74a7e1705faf5067f12f85ea8068b6b83358c27bb58ddf855d28c876344da2c4eecb0be5154c76d0136620e262435ce466d2bfb0317dbb130be13692f0940ef022eb820b0a64da33a15c3a18f4790ad47ce01a216e15c381d9a4a662edef5efd53a2bfcbebc3c27d173a6d67ec32a9b36b847e55f433f330ecb57d16ecb35c785e1b8b4adf14c5bf396177c5f53764ecd14a7864fd2d8cc61891ba90f996eac38c64bb6e435fc895706e1cc66d98333a3795f4a1e01ab0798ec64f05869b0e0ef29326cc195bc7d992457edf8d6d5c1fb195a6e9db2d844507cd4958cb0e73f40c9ca09da2b16098ca132b55d7628654b2b09e56104463d1ca8e7e3c1a1fbf3f48f57c6d856e94c95b8f50d006ab9695714d5d03d1c5aba20613c806091de654e894e8e127f14acd3a9c70a0c1d4a5545260c6efa3614519df3cb864574b8c6f6321c830c9819eea9867e3b127e4d2b743da3853e1b071f039a8c04b181e796b4e79488ee56fc0dbd23cba55a02f15815cc1bbb390bad84a97c295d836c2ccf5a0f291aafc3f03fd0cdc55e83f9082273ef1c8e23c2c85ad446e9459b7bdb73e08b51a29b9c2921b76bcd23416d47c6480611974d58c369d2bd5ef2f72cbddb61a13f104373e725e0aacbd556656d93cbfb76def776bb5bbbf703fcb8d467fc127ac98e6eaf3f8da0eed2dac9d2472593c1f92625180b9705c30dc064471634000cb83acbb7dff092b0f733657ce6cd9a4ff68a5fcefaeb59797bf03ffada339', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137534, 9026, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c732e72ce5130d63534b052c84dac504849cccca95448c92f4e5530343050c84d5708f057c82f52f00c0300fbec0c08', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137535, 9026, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c732e72ce51b031b652303430c84d5708f057c82f52f00c53482c51504aad2849cd4b494d51c8cc2b492d2a4bcc2956020045120ed4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137536, 2446, 20.0, 70.0, 'mcg', 'IV', NULL, 'Adult', X'789c732caecc2d28c9cf4d2cc94c56c82f5240e6e6a426a62814e46716e7e765e6a5eb00f965a9390a4606bae6060ab9c9e9fa293e560a860606404eba7eae8691a67e4a62a5826798427e596a918285aea151060034bd1eb9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137537, 2446, 70.0, 70.0, 'mcg', NULL, NULL, 'Adult', X'789ccb4c53c8492d4bcd51b0333750c84d4ed74ff151c82f5228aecc2d28c9cf4d2cc94c0600c4b40bde', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137538, 15480, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c333230c84dd737caf551d0300433737d340135fd053f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137539, 15480, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789c333530c84dd737cdf551d0300433737d340136630545', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137540, 15480, 16.0, 16.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c2d8cc10dc23010045bd90a00f3a0071ae06fec8d7370dc45be24b41f23f19b9995f6fec0d3750b88bd5856711b346dc10adfd9912e0816b71ad825a3d0d69e15deb1b0cb32f3672a467c659d916ef8b4f3bb0d5345e7b8082223c49a12e974fdefd547f7e90060fd2c95', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137541, 15480, 4.0, 4.0, 'mg/kg', NULL, NULL, 'Adult', X'789c15cb410e80200c04c0afec0788173f446481c658485bf5fbca7592d971b5ed6c908a9943a8819e1d3a10afc4d161f439d4e988df2c8ba651531db7216b012f5a5bcbf8d09c9095034a16960f3d2c2240', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137542, 15480, 2.0, 2.0, 'mg/kg', NULL, NULL, 'Adult', X'789c15cbd10980300c05c055de06821b85f6b50d6a2269d4f5d5efe3d6a32f5b87369c924a4b0c99104c16b78a7c34cb80b4642043d4e00dcdaf807c6c0e1e8cfebfe0cd98b243278cacac2ff1fc2145', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137543, 15480, 16.0, 16.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c333453c84dd7cf4e5748cb2f5228484dc94c2c29ca4c5628482cc94ccd2b2956484c4f4d513052a84c4d2c0272f25214f27352528b00fc1b12f1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137544, 565, 25.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789cf32f4accb1523032d53535c84d572834d1b5c8d051c84dac503036000ae8a724560200a6b709ce', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137545, 565, 10.0, 50.0, 'mg', 'IM', NULL, 'Adult', X'789cf3f4d5f70cb3523034d03535c84dd74fc92f4e050030600560', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137546, 565, 25.0, 50.0, 'mg', NULL, 3, 'Adult', X'789cf32f4accb1523032d53535c84d5728c94cd10df474010043ba0622', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137547, 565, 10.0, 50.0, 'mg', 'IM', NULL, 'Adult', X'789cf3f4d5f70cb3523034d03535c84dd74fc92f4e050030600560', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137548, 565, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789cb3523035c84d5708f05728cc280600171403bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137549, 565, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c358c310ac3301004bfb24dc0ae1c3f23904faca5c55290ce46ba04fc7bab4931cd30cccb3e0acead08eb03319f4996aed858b309d3fa44dd97fa9e1168d8846f57043b88720416d0d43d0d72008bab193dff043f30a4da324651ff6c54fd06dddf28c3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137550, 565, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c0ba92cc84c4ecc5128cb041299c50aa6060ab9e9fab93e3a0ac5f90a25f90ab989d9a90a8650412b0066460e86', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137551, 565, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c734c4951303450c8f551c84f53300532d2f581ec94cc828cd4bc8cca94a2c4dcccbc5485927c05139822bf6000a1cd1029', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137552, 565, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789cf32f4accd1f7f4d5f70cb35230cd4dd7cf4ed74f49ac5448c92ccb4c494d512834d3b5c850d030d43332d535d4333387aac82f4ed504000965115f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137553, 565, 6.25, 6.25, 'mg', NULL, NULL, 'Pediatric', X'789c33d23553a8ccb75230d33332cd4d572834d135cb000033c80527', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137554, 565, 12.0, 25.0, 'mg', NULL, NULL, 'Pediatric', X'789c33d3353452a8ccb7523034d23532cd4d572834d135cb00003c420584', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137555, 651, 12.0, 12.0, 'g', 'IV', 1, 'Adult', X'789c158b310e84300c04bfb2255742c11fee03f4511c728bc0162406f1fb4bba9166669c902181fb8b219a56aa9b177c1750572f34855d8d31239d1ef6d6096f4a1288959053f974dbd6cd35d6de3fac3fe4a4351c8cd43fa1ae2376', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137556, 651, 2.0, 2.0, 'g', NULL, NULL, 'Adult', X'789c1dcbd10980300c45d155de00fe282ee1182d4d3590369aa64ab75784fb75e06e959d8360c18ea48d101cce85a01912a21abeac9fdeedb742255aa8d4266415d18712e2c0fcedd77a5843afce8244c237d9780138ab21bc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137557, 651, 150.0, 200.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c333435d0353230c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d510834cbc82f2d2a56d0c84dac5048c92f4eb55230495728482d52002ad404000ae01264', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137558, 651, 100.0, 400.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c333430d0353130c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d13534f3c82f2d2a56d0c84dac5048c92f4e5530344252aa09008e5f13d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137559, 651, 100.0, 400.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c333430d0353130c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d13534f3c82f2d2a56d0c84dac5048c92f4e5530344252aa09008e5f13d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137560, 5386, 1.0, 1.0, 'g', 'IN', NULL, 'Adult', X'789c33d033565528cecf292dc9cccfd3513054482f2951c8cc5348ad4c552834ca50282d5028c957b0a8d04f49ac5400614385c4bc1405231d85928cd43c85404f17850a0553904c310071801715', X'789ced586d6f1b3712fe2b0301055254966c27695a7f3840969dc448ece8ac24c85d15181497da65cd25b77c71bc57e4bfdfc35d49966d399bb0771fae572046a4dd998733c3996766f47b2fb321bfd0ac14bd03eabd605e2e94b9665cea5e9f7ac1aaf8b8f0be7207c3e1277929ca81b179fc248777a51db7ac12d905f351697f77ffc79dddbd9dbdddb7bbcf0e9e3ec6bfc1cf3fef3fdbffa99115dc4ba31d247fefbd105a58a69acf5e5c37ea6feb4a1cd0135f50fb364acff473158c35bf05a98d325ab8993e328ee5829e1b5bba037a5315be60aa949c9c51a1551a9bb2349ade5a96093a83ab10fc675d32db6ffebb96596351986f1af5198f3c9b2b11bffdf211df94d497cd971b23ef9ad31db37b1a9f3fc693465950fe02be489ddf0ac3eee0f1776b57fab447b9f72435895ad06ffb05858abca19fae8719ab29feed11d319edf7c91742d3df4f8ee89a9ec63788d5eee0e9d7832da4753e2a2ea1e632db69e17e6ce0be2d668d97139149e6ade4db3cfd1beca987265af92772795a092e99ba98982a287693f22baf2756e49a695ed339deea7ca60f683cd3af19f78df4014dd942f89adee94b6d3e219bcf85668ada00ce74933833bd8eec4cbf141534f98312a9b97ed7d2ee5c3f8ad4d20abb0ba92fd608cba41f1bed2d933a937c4b64464a099bd7f17ab862ce0d235325dcc028bb12d6898b73c1f8fd53b600f6a6c24a136ecbc1d65f8386d015825f88d2585b8077667a1a2a88eb450b80f083b7709c7612b212176797e7f66edbd9062012d3c3e7486ba55f32df1b8efcb1b71e1dd52e17c149b67e5b219ae0bb689f93911c6d1d33ddad0532e978c16c34fc50890a1f61a68b49c332c60b3c7e2f5dc0d18c87683c8475def2daa6ed9d59ff5f8be0ddbbfad386f07fcab16fed03c02e194707cceb5b1ebe646ab1a3e4029d9fce86237af46c67ef09152658470b63c9d5ce8bd8dc2b0b966b8702f7fd4c9f0a1c679474e5019d4a2d4ba666faf89a5bd172680b169065a203273a0518320b1af156f910d98704e53263aa8fde51c8b9f48e8ece4694d79639d1b41f6f2a239d2945f3e4e47d0a53690f6803f2be98aed35f8a6ec27a256e87713ad32e382e2ae029315cd5924008e205aa1aae9eccb4d4f0ab6cfa025e5de1be615c4d9baa5620573cd31e1ae733bdfe4a8f10456d3c894553b7c0e6700644dea24f7f800935e6b61cf288f32789418e0ba5e8132410b095a7c8af77105d5b186fe7dddb13321a963cd218dbd677b5a608e07fd89b696dd0943d12fcc3fe4cb3d6087476c4cc9a3ecd836f0c0c4e641bb641faf117a46f04373c8b36bdb006a3c2889c47c6502c8e5ae7b13e082fd79639ca82881deb78400b2600140be8c393941397276911c003927d993fd0a71b0b9b21deb29226a60d68547b63f326a99bd488a883953b7d3aecd3b84f2f7a0d69af29b791ece1880dd80790262b034502c67b695155085be36cba1120220cd4485cca53508e6321186e3807c2eadefe133832945b604e3a604ea7d351c2e9a7e75bd5ba4e1b8f761235a79e55c5808e2b998147649614b3f1807e15981bb787eac35e87faeb0121fb0cafbdc9c57203ebb0a0a98f3391b3581fee2ee0d9807200623831626b4e77450500a500b74676480bc9a9b1ec1a5cc90873318b63525a3abe1c44665241e87f255527480c3d5a2668be5262ee6474c125d5637bf0f006868ea787af7f4881ba87f46a32de0674fe55b53d6f660157f569545663d2224fa6893b509549b9620cda717a490bf34a994a66b940d3d7db4ce82cc1295328c1e4cb9e16324f569e58e331e652292d9bcbb43259615c059563064a84b802096aacfae4aa415acde34b93a06900e33856b439450b2b02b6ea94cadd84c964dc9c4312ab6fc0a4f933428920ad18668394c41871ccfafecb267431f9c489902d8d60c28666c660094087c15e1646a14b223f305b332eb7c17451d0d40b4c8cd654c5d228ac39583b0ae47d8a55ffc0e562f6642496638b8232df86d415ece79621f55d93bd3eee92513d894b0e6de05f2882ee7140e4d2fc91329a306c1bc13608654078e3da97d27b19f6ec783521ee045844eb6dd5d8e9cf7b39b7d2446ad27221f9d65abc07728a45fe5e41168a9575d698c4d24aeab4e6a6024f97374b49ca54712ef9a5f0dec907cce88c49b4a3ad6bcc8cc4aebe72721c6916bbeefd892feef9da9435ffaae9f15ec6369618b03f467ecbf2079a5027d758718536d4a49d5078ace33c9b568e6365b04f61f8447832b940de48b5eda6baf86613e751dc55d760dfa79044701bd7a6056f88cca68dfd135179d32c8d7eb56f3d58ef1fefffd2f2d70f26ff1f3f987ccb0f709f3fff1b3a88a77b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137561, 5386, 1.0, 1.0, 'g', 'IN', NULL, 'Adult', X'789c33d033555528cecf292dc9cccfd3513054482f2951c8cc5348ad4c552834ca50282d5028c957b0a8d04f49ac5448cb2c2a2e5100b274144a3252f31492325374033d5d142a14cc40a2c500bc4218c6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137562, 5386, 1.0, 1.0, 'g', 'IN', NULL, 'Pediatric', X'789c33d033565528cecf292dc9cccfd3513054482f2951c8cc5348ad4c552834ca50282d5028c957b0a8d04f49ac5400614385c4bc1405231d85928cd43c85404f17850a0553904c310071801715', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137563, 5386, 1.0, 1.0, 'g', 'IN', NULL, 'Pediatric', X'789c33d033555528cecf292dc9cccfd3513054482f2951c8cc5348ad4c552834ca50282d5028c957b0a8d04f49ac5448cb2c2a2e5100b274144a3252f31492325374033d5d142a14cc40a2c500bc4218c6', X'789ced586d6f1b3712fe2b0301055254966c27695a7f3840969dc448ece8ac24c85d15181497da65cd25b77c71bc57e4bfdfc35d49966d399bb0771fae572046a4dd998733c3996766f47b2fb321bfd0ac14bd03eabd605e2e94b9665cea5e9f7ac1aaf8b8f0be7207c3e1277929ca81b179fc248777a51db7ac12d905f351697f77ffc79dddbd9dbdddb7bbcf0e9e3ec6bfc1cf3fef3fdbffa99115dc4ba31d247fefbd105a58a69acf5e5c37ea6feb4a1cd0135f50fb364acff473158c35bf05a98d325ab8993e328ee5829e1b5bba037a5315be60aa949c9c51a1551a9bb2349ade5a96093a83ab10fc675d32db6ffebb96596351986f1af5198f3c9b2b11bffdf211df94d497cd971b23ef9ad31db37b1a9f3fc693465950fe02be489ddf0ac3eee0f1776b57fab447b9f72435895ad06ffb05858abca19fae8719ab29feed11d319edf7c91742d3df4f8ee89a9ec63788d5eee0e9d7832da4753e2a2ea1e632db69e17e6ce0be2d668d97139149e6ade4db3cfd1beca987265af92772795a092e99ba98982a287693f22baf2756e49a695ed339deea7ca60f683cd3af19f78df4014dd942f89adee94b6d3e219bcf85668ada00ce74933833bd8eec4cbf141534f98312a9b97ed7d2ee5c3f8ad4d20abb0ba92fd608cba41f1bed2d933a937c4b64464a099bd7f17ab862ce0d235325dcc028bb12d6898b73c1f8fd53b600f6a6c24a136ecbc1d65f8386d015825f88d2585b8077667a1a2a88eb450b80f083b7709c7612b212176797e7f66edbd9062012d3c3e7486ba55f32df1b8efcb1b71e1dd52e17c149b67e5b219ae0bb689f93911c6d1d33ddad0532e978c16c34fc50890a1f61a68b49c332c60b3c7e2f5dc0d18c87683c8475def2daa6ed9d59ff5f8be0ddbbfad386f07fcab16fed03c02e194707cceb5b1ebe646ab1a3e4029d9fce86237af46c67ef09152658470b63c9d5ce8bd8dc2b0b966b8702f7fd4c9f0a1c679474e5019d4a2d4ba666faf89a5bd172680b169065a203273a0518320b1af156f910d98704e53263aa8fde51c8b9f48e8ece4694d79639d1b41f6f2a239d2945f3e4e47d0a53690f6803f2be98aed35f8a6ec27a256e87713ad32e382e2ae029315cd5924008e205aa1aae9eccb4d4f0ab6cfa025e5de1be615c4d9baa5620573cd31e1ae733bdfe4a8f10456d3c894553b7c0e6700644dea24f7f800935e6b61cf288f32789418e0ba5e8132410b095a7c8af77105d5b186fe7dddb13321a963cd218dbd677b5a608e07fd89b696dd0943d12fcc3fe4cb3d6087476c4cc9a3ecd836f0c0c4e641bb641faf117a46f04373c8b36bdb006a3c2889c47c6502c8e5ae7b13e082fd79639ca82881deb78400b2600140be8c393941397276911c003927d993fd0a71b0b9b21deb29226a60d68547b63f326a99bd488a883953b7d3aecd3b84f2f7a0d69af29b791ece1880dd80790262b034502c67b695155085be36cba1120220cd4485cca53508e6321186e3807c2eadefe133832945b604e3a604ea7d351c2e9a7e75bd5ba4e1b8f761235a79e55c5808e2b998147649614b3f1807e15981bb787eac35e87faeb0121fb0cafbdc9c57203ebb0a0a98f3391b3581fee2ee0d9807200623831626b4e77450500a500b74676480bc9a9b1ec1a5cc90873318b63525a3abe1c44665241e87f255527480c3d5a2668be5262ee6474c125d5637bf0f006868ea787af7f4881ba87f46a32de0674fe55b53d6f660157f569545663d2224fa6893b509549b9620cda717a490bf34a994a66b940d3d7db4ce82cc1295328c1e4cb9e16324f569e58e331e652292d9bcbb43259615c059563064a84b802096aacfae4aa415acde34b93a06900e33856b439450b2b02b6ea94cadd84c964dc9c4312ab6fc0a4f933428920ad18668394c41871ccfafecb267431f9c489902d8d60c28666c660094087c15e1646a14b223f305b332eb7c17451d0d40b4c8cd654c5d228ac39583b0ae47d8a55ffc0e562f6642496638b8232df86d415ece79621f55d93bd3eee92513d894b0e6de05f2882ee7140e4d2fc91329a306c1bc13608654078e3da97d27b19f6ec783521ee045844eb6dd5d8e9cf7b39b7d2446ad27221f9d65abc07728a45fe5e41168a9575d698c4d24aeab4e6a6024f97374b49ca54712ef9a5f0dec907cce88c49b4a3ad6bcc8cc4aebe72721c6916bbeefd892feef9da9435ffaae9f15ec6369618b03f467ecbf2079a5027d758718536d4a49d5078ace33c9b568e6365b04f61f8447832b940de48b5eda6baf86613e751dc55d760dfa79044701bd7a6056f88cca68dfd135179d32c8d7eb56f3d58ef1fefffd2f2d70f26ff1f3f987ccb0f709f3fff1b3a88a77b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137564, 13950, 8.0, 8.0, 'mcg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65270760c50b0c84d4ed75130320152008eff0921', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137565, 13950, 24.0, 24.0, 'mcg', 'PO', 2, 'Adult', X'789c3332c94d4e5708f05770f274010015fc034c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137566, 13950, 8.0, 8.0, 'mcg', 'PO', 2, 'Adult', X'789cb3c84d4e5708f05770f274010013cf031e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137567, 13950, 24.0, 24.0, 'mcg', 'PO', 2, 'Adult', X'789c3332c94d4e5708f05770f274010015fc034c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137568, 13950, 8.0, 8.0, 'mcg', NULL, 1, 'Pediatric', X'789c73cec8cc49d10d284dcf5070ce492c2e5670b652b0c84d4e57284c01007f1c08dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137569, 13950, 8.0, 8.0, 'mcg', NULL, 1, 'Pediatric', X'789c73cec8cc49d10d284dcf5070ce492c2e5670b652b0c84d4e57284c01007f1c08dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137570, 3988, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137571, 14053, 250.0, 250.0, 'mg', 'PO', NULL, 'Adult', X'789c333235c84d5708f0572834cb282a5648cb2f5230d73534514849ac2c060074ed0860', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137572, 14053, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f0572834cb282a5648cb2f52282d5028c9573032544849ac2c06009e680a00', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137573, 14053, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c25c7d10980300c05c055de080551c7d01582265a681b4c52c1ed15fcbb1b53aa07d605d7749a43d43063a7c7f1a9b7c805c37f9260036d3d18b949a15a29b23618bb969bfd05a6d61a53', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137574, 14053, 50.0, 100.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cb3b33554a82c5228c95730b400328aad144c0d740d0d0c72d3f5b3d3f553122b15f28b1273722a155232cb325352531452cb528b2a15cc14328a8a75147c132b1452f28b53154cc06a01995318a0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137575, 14053, 50.0, 100.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cb3b33554a82c5228c95730b400328aad144c0d740d0d0c72d3f5b3d3f553122b15f28b1273722a155232cb325352531452cb528b2a15cc14328a8a75147c132b1452f28b53154cc06a01995318a0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137576, 1162, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c33333050c84d5708f0d7f70c53083434f250a8503034d135b2504849ac2c0600714907b9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137577, 1162, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c33333050c84d5708f0d7f70c53083434f250a85030554849ac2c0600570306f2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137578, 1162, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c33333050c84d5708f0d7f70c53083434f250a85030554849ac2c0600570306f2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137579, 1162, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c33313050c84d5708f057083434f250a8503034d03534514849ac2c06005a0106e0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137580, 1162, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c33333050c84d5708f0d7f70c53083434f250a8503034d03534514849ac2c0600710607b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137581, 1162, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c33333050c84d5708f0d7f70c53083434f250a8503053284f4dcd2e06005e920761', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137582, 1162, 600.0, 600.0, 'mg', 'IV', NULL, 'Pediatric', X'789cb3333452a84c4d2c2a56c8cf49b152303330c84d57f00cd30ff057283434ca000091a908f2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137583, 1162, 10.0, 10.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cb3313452a84c4d2c2ab6523034c84dd7cf4e57f00cd30ff05728b4d03534ca00008eb308c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137584, 2745, 80.0, 80.0, 'mcg', NULL, NULL, 'Adult', X'789c7dccc10d80200c40d1553a8046623c18bcba811334d800095043cbfe128e1e3cff977fb2a027b8b452f11ac402574c104bc0841ab9005265e164613313ec263bbfa0d336e20199942addf3cd42204d1e2ad243d7ebafe4d474b8cff105bdaa345e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137585, 2745, 40.0, 320.0, 'mcg', NULL, 2, 'Adult', X'789c732c2ec9c84db45230315028c95730363250c84d4e5748aa54c82f4acc51c8cccb48cc492cc9cccf5370f274010035560e2b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137586, 2745, 80.0, 80.0, 'mcg', 'IN', 1, 'Adult', X'789c0bcac8cccb2cc92cb6523052282e284aac2c56d0b03050c84d4ed70773351532f3145213933314f2f28b4b8a327314f2f3925315521233732a0171e014f2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137587, 2745, 40.0, 80.0, 'mcg', NULL, 2, 'Pediatric', X'789c732c2ec9c84dd45130d3353454a8ccb7523031d0b53050c84d4e5748aa54c82f4acc51c8cccb48cc492cc9cccf5370f2740100691f0f21', X'789cbd576d73e23610fe2b3b7c69326303360488fb890bcd5b21a121d79b4e7dc3085bd8ead9924792c9d1cefdf7eeda8400492fcdcdb55f122caf56cfee3e7a76fd5723d66532972ce78d001aef7894a99cdb94192579c38146a9337a915a5b98a0d57a109f78de543aa15fa2f5dcde449a153c9e334bdbfcb6df73db9eebb5efdbfda03b08ba5eb3db6bf74efb952d8fac50d2a0e55f8d619c0b298cd58cd6aa25cb3f575eeed7050f4279255396f1188ce55a89d884d209e599d256446ab316ca91322ce170ae746e02509a6520685fe515185a1995398098b9e6b11b2bc341328366a6d06c0da6340597068dbf66a4b292fc6d8f9b59cd6562d37f3e32806edb81413b8f92168b6c59bdfc71ff88a7b3d1daffaae5064070e8319477aab4dc805ac27e46831d500efec6e59d902891798e70ef358b39dc201f30965f564c3bd55fb8e3b1b8c4f4e333165de1560ec35ff0e5cd7036ae8a592e76ebf905972c5b649c9e7eff884f99909faa87a7c21e56f475c26d76ccb73bf09c277ffb6478dddb81fd978f847a1897999d6361854cf668383436cd191512ac828edf064c3d2cd6cf4afeee6a84754831f9566016fd3ac5068e06d59656f5788c3b80b328058900b4c840c98843cc44b67e5b3e2bd453ac0f4337d13f2377a0e77a1eac1585e00efe1d7c07ba8f9bbc0dfb8fbaff5d18b382478265f3a92aca1a8ed98b64aa7922998cd670876f651222afcf4239c60b5083d7c27ca2c52bb964d2568f40d720671906c525861a57090a1030b0f88fd2d89c4b1bca4b5ea08be8e5d7dfcaf043bcaf7372447a5c1b9bb990f3ad877daaef47fcbadbadfd9cece711b33c515a20f89af5678a1441c858442fa47d98e1cd4fd6c4fb2863c6b4a86b84f246595a5a70280d5e6366a0d098698d869ab32a71b0541a58849a84af8985c03fb388eb452df36f67c8305e716df8fc0e49f71ce80b0e1b33ae852af7ed66a46131214dd7858a4807505385c9510899651a7d3b9064ac8c54ce42f94e23ab53650a66f2c63ec03a79a49d7b075c7216e3ade087d6af5e80ef0ff6301fdf11ed2baedeaa6129d3398b54a692f5be4f962ddd4c2c7900ed66c7eda4a19c70f454252180c79bbb120cce7e9b7686dd50fef439d2bcee7b1314a66c0d4b1eb1ec1b504d789432eca3f95c2de7c3e8d974b2df441cc0265d46d881855c662ccfbf95e733cee7c3cca8af9c851350adecdfaa4e07eededa300fbaef1396af3bd9d8d5ba73c79738d660cb38109cb3db0b2076096b39c79e0253a2b9c0d6f2ae4431427934eeed028150cfc32e15d65b9e59617bc0c051d43298e0c093f04a942e4a11735cc732913e6d1d0926dd8bb5e415077174327053e60baee11487b773bed025dd42bfdd1e04508741ed6f2bd14ed8d8f8828d17a73276c0f3bc231fa616bce3a07bd2777bdd26fc3e2d1713944d6fe07706a783c147bcbaec532a345f3118df3870ad08e0cf6307664841fb274c1c40d70cbd86a5dff6a20d0474b2516d788f63d92e22603246e016c3bfd0eac1a64eb533866b78d474ca0f5ce5792937704f086eefa8731c9cb43beee90ed09e7772daf37a08f41c9b2b5eb6cb260c2b6ddf15f56af864dbec309aa7700cbac40f850a8e5a2ea942f9b61c4d9822a5e0fe03861737e17d71af46d89f9af08165f869913b301906db656ced513394442ee2d6c343b32cac8a6903ea5f280912d2891ad2b6627d0acc3bc56d17995a6032ae68b841b42b5e116093c8a38bab9be17113e81fdee302d9eec066c78ce6688ef9dab1df61140586595fe16f4cc13ebe44c83a1d740708e0fb82e0c68469b003f736b28ac8e6779cfad516eedee136e530122cc1818be6b32710ce010aaac3598add00b59168a9cba88a785a66a8da949791301c27f9808eebe28c4f1137e1e51cbde4695ccae4d1093cf085115436a40b0a735a07d8fd7fa3187caf28b6154c541647aa886b012b5cecc51691b5ca22532c362d3cb4dff2bcd6c5ed78e4120277d56bb6dd73e4d0d8c528d06f8cebee8d5acd3f4c66cd225e1207f692b4cb826b262bce7afe130b148fb9b6707dedc0af022f337ee03a3066a5a68e77200a7734f29ea30c2a5dabdb194d6c9502fecc0accf60f06664cd3acf0240637cc6670868a81f4bb92c6564280004ebb47be7f1c787dcf77073b4ae077bb5ec7efa3128c5599a41cd7262384c4731196ed361f684ec0463cc3b28f0e10e2390cbf56f06333c56f8f08ab315391e076fdc2bda2b954c8b2ccc1a56cb469c1e0477289419479356bd66515598c7d0466e233fcc699aebf80935a716e57f4dd4abfaa8f3bf318370241ba984268b8ae928d2aeff58f50a3bd13d7df9168aa43afd3eb7f7c6b23fff2e56f4116dc3c', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137588, 2745, 40.0, 40.0, 'mcg', 'IN', 1, 'Pediatric', X'789c0bcac8cccb2cc92cd65130d1353454a8ccb7523054282e284aac54d0303150c84d4ed707f3341532f3145213933314f2f28b4b8a327314f2f3925315521233732a01e8501691', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137589, 8949, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494c523034c84dd75130029200872108c3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137590, 8949, 20.0, 20.0, 'mg', 'PO', 1, 'Adult', X'789c333250c84d5708f0574849cccca904001bfc0449', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137591, 8949, 10.0, 10.0, 'mg', 'PO', 1, 'Adult', X'789c333450c84d5708f0574849cccca954a83051c8cdcf2bc928060057c607cd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137592, 8949, 20.0, 20.0, 'mg', 'PO', 1, 'Pediatric', X'789c333250c84d5708f0574849cccca904001bfc0449', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137593, 2009, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b6523034d233d55130026253031d05430383dc7400df650a6b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137594, 2009, 6.25, 150.0, 'mg', 'PO', NULL, 'Adult', X'789c33d33332d5353435c84d5708f05728c9284a4d5528c9cc4d2d5628482d524849ac04009d930a61', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137595, 20440, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137596, 3423, 125.0, 125.0, 'mg', 'IV', NULL, 'Adult', X'789c333432cd4d57f00c03000931022c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137597, 3423, 2.0, 2.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c33ca4dd7cf4e070006b90208', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137598, 20209, 648.0, 648.0, 'mg', 'PO', NULL, 'Adult', X'789c3333b1c84d5708f05708b4c850a85030574849ac2c06003de40607', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137599, 20209, 648.0, 648.0, 'mg', 'PO', NULL, 'Adult', X'789c3333b1c84d5708f0572834d3b5c850a830d73534504849ac2c0600563406f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137600, 20209, 30.0, 30.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336c84dd7cf4ed74f49ac5408f05728b4c850a85030d63557000a140300821108b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137601, 20209, 648.0, 648.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523033b1c84dd74fc92f4e0500243804d1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137602, 20209, 8.0, 8.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cb3c84dd7cf4e5708f05728b4c850a85030d73534504849ac2c06005e8b074c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137603, 20209, 648.0, 648.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523033b1c84dd74fc92f4e0500243804d1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137604, 1892, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137605, 9475, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303435d0313630d0313330c84db756300651faa60ab93e00e5ba0abf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137606, 9475, 600.0, 600.0, 'mg', 'PO', 2, 'Adult', X'789c4b4cc92acd4b2e5128294a4d2cc94dcd2bb15270c92f4eb552303330c84d5708f05748ca4cb156082e492c024a192309ea2864e625037515a72a24552a94162894e44334e9a724562a1496675b2bf8265658291899c004ad01b75422ed', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137607, 9475, 1200.0, 1200.0, 'mg', 'PO', 2, 'Adult', X'789c4d8e4d0ac2301085aff20ea058ad74916edd8a82279826a106db4c4d26d5dcde64217431f07ee09ba7d9af3644c71ec298d9b33c6da0252b5c385a85e3a969e611f71b06677a3c848228b49b7007e775b0142d868cb4545057fb83a18cf7e7d5e34a5f85d3f91ff6302e6af6e27cb22842f3ec84bca09c2b7e4d532c3282cb38b4fbae428496624c5985319049344db9fedab07e4a9047cf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137608, 9475, 600.0, 600.0, 'mg', 'PO', 2, 'Adult', X'789ccbcccb2cc94ccc51c8cdcfcb2fc9482d4a2ca8b45270c92f4eb552303330c84d5708f05748ca4cb156082e492c2ab152304612d451c8cc4b2e4a4d2c4e5548aa84c8e8a724562a141a2b00a9626b05dfc40a2b052313980400a42b22ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137609, 9475, 450.0, 1200.0, 'mg', 'PO', 2, 'Adult', X'789c333135d035343230c84d5708f05748ca4c01002314046c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137610, 9475, 300.0, 300.0, 'mg', 'PO', 2, 'Adult', X'789c0b2e492c2ab152303630c84d5708f05748ca4cd151c84dac54c8cc4b2e4a4d2c4e5548aa543003c9eaa700450bcbb30194dd1040', X'789ced5a6d6fdb3812fe2b448002dd8355bf271ba758c04df6d01edadb20ed7d389c17062d8d259e29524b52499c45fffb3ea4ec4472dca46eb1b797c01f8258d4705e9f190e45fe7e9098329d2a9ed3c1881dfc721d7333e337540845072d76501ae9c733e70a3b6ab7afc482f257daa4fe9768df23b7b1e1052553eefcac5ea7771875ba51b7f3a973341a1e8f3abd5787bd6e777018682976422b0bcadf0fc6492e94b0ce703f16861c5d072e9f96058d266aac9c801c498513b19da8336d794aecefdae476c4bac34eabdfe9b40e3b9d3c3d617dffaf3d64f9fb89bad0a523cbf49c35858cd8f92f1375aaf35c2bf6c9f084d83fe10630fb6482182e839ae5acaee9670c393e93e49ffef32b9ea4508bf070a77253d7c7fdb841fff9572f659c94d24d61a65069c3215bb43a38e7c6092ea796c44d69c83626f0e4bfa58a1d7386b8cb49b911035b1ab1e02db881cd4472c23e3a301955be5b0db6985031665962b3252b0be67435a99df025fbed6a71c23ef0eb11eb0dd6832713156b7549c642374f0eef6a971170b15c8bedf6fe04b92c1116929d502531fc88752e1c578ee14f78954a69f113408072ac1f1d7a260e68352c81562c05024a2ee5d2cbaaf19a2860c6fb769b253b3ab07f67429fe19fbd67c641135e1e0740634a002ea2aba8345ca68237c23b1876a2864b276aab2639e4d6b56938748be037a2d0929b299ca14d42a6211493bf4ae883e6336d1e55e481840b5aee91ff7c90bf59d5f6d07f10faff3bf76c06e669f8e7afd3f2eb9b86aa865122b83322fedae57e55d7a6aba46cd0f7a23e5bead020853c85668b4a399894884b9150d2c8da1fd1a06d257af3ee6cb302d5fc116a472829bd68705b976af226cae3ca7a21ac7b18f5be2c442856a027235fa45ef73a6c914ed420ea1ec28e16eb75a2de71187aa0f27ca30d18c6fc945cdd9aab454dfa4ffdbaece33f5ff6966a542bbfcdf4aebb68505313388d90fb3ba87a0feac33bb235d6c59c6d5910562950d959e78e54f053beb82642d99dd7ad3a2c8651bf6eb3af75bb41e3e9d9dc1f46834d9b8f9e799c07b07923fd9fbdcd08eb70d3e6dd4acfd3b3f910e9bb6973b7f3cc03fdd351a766f2d1f0b99afcbd9bba696fdf12ed5ba27d4bb46f89f62dd1be25dab744cfd8e87d4bb4bd25fa5850ec5ba2735d9492dff53deb95efdc50aab88a97ec026f153c3862a713f59ec72e503323ecc20f5a3e27072bd542e92bb5ad95ba20ff4971cba7a8702405b6e654b2d7fdce68ddc984f884e0bc3d6b9f9f8d98d2cc964521c97f733f61efd45c8f9813fee46dd52559a9afa4d7c209c9d0e115104e1375fb25ac2e25a155302b7161feb0f3c27fb7bcae8f559fe77a83ec7bf5d8d270bc25df8e6dfd40b7f24a2e6412e53a61222fb830d5690314f08da975950296107fdaa080f634178a9286f9dfcf6e07847d19468f1f5e9ef903e48ad84e859ade723880c03bc64d203ecef6967eeae9a73122966a23687d3cba07e996cc7dde287dca89b8e389c0291613c3854a44bca5d68fa5249386f3ba58726bdbfe12c744bd7d3f8edefc0d40ef310e0a49ece5edc167a4b8b8a4db3de50f13c52fb548189f99b270ec4ab82c31fc8acb898a7919f2142b5eb62cb0e091b2af822c7fd9235f5df7a8d1294632210384aed9375e16eb82b0c95a2bb89872c11b2f8c4fec9a2b1b2f1302371b96602cd699b04e9b6d47878ff9779cf8959ca617c4e3fbfedd965a1fc9085d36e99a3670c58b6c29f9b5b0fe21159a12caf1c2470766559282ab1979f4ea22135270340909b34bebc02666f6da1f44014fca46ffd099b2986297e0a173f8dce96bd02000f0770e3729541d2d97d68b24b3443f927396230dc45c1b3f81c725aa484a78cba5b8417f44d7e8443c9d8339ac00864ba903035b8a582420730895a472a10b52de329741fa4cc74bb71e297c3c6f9f786ab802173f1438f102b04496c2b4ca379ede43113d175edfa18dadbff0f8e0aeb07877041da0df245fe685d3f903e45bd6eeea8e4f237289b8b901882d94c988273ccee02bc54b4bbc7de99bb7d041599d2b2d49c578998842eac2db32e312d6105b1f2b4ed41c92d392dab0395b790c98d078d344c8a5b0258cc044572295025f85c0f3342fbdd71cb0e3dd39533a4437e5c2f9c74487535ea497803b92a52da8b09e32854453f914f5ca18d8126e21c0f7c5ca79b14e7da78bdcc7bcb9ff441686abfc021c7cb74a6a75272a4c9e9736fcfcd7c5bb8046c36d063dc95c023095cf44704dd035f6a5a0c834220fc87a4980cfcecded3eb99e4c726d16c67d76fdbf67d73e427f458476bd039271d81c6ba9d3e627edb75cce2329e63462bd8cbd2c381a242426cade0f2d761475bbcdc116fbf982f9fa84b7c7789513a46a941d42cff761f560f31193f0893961a7ff3e1f0cb17fe99d768fd1ad656226d0539db0fe78d01e622029634f56ed4a7c958527ef784ed4cfd7a83dd57ddad20052ec78f882bd7cdd7d81ed4a9ca15253024de614a30cbd1ebcf806cf7c20cf073a4ff57c3a8eef5d109ea1362e2cbbd41240a2681d067f9d97f9998aa46df92dd84cf8226d5975590a56e4339456b2adb5dd160b4941ae9a3d173007eef40bc87a7367fd6ac1fd2d5ddfa096127bb3c2e882a75faa8e8f2f7c341d4bab1b067d5c95edead273edf3d1b7de475e337c7cd77d4bd9d8bb6f51e3f10bcdf509eb2dfb1cbb24a45b73a1a742c77eafbba379a87b9fff008fe62fee', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137611, 9475, 600.0, 1200.0, 'mg', 'PO', 2, 'Adult', X'789c333330d035343230c84d5708f05748ca4c010022e60469', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137612, 9475, 300.0, 300.0, 'mg', 'PO', 2, 'Adult', X'789c0b2e492c2ab152303630c84d5708f05748ca4cd151c8cc4b2e4a4d2c4e5548aa84c8e8a724562a141a2b00a96285fc2290b81942bc3c1b000fbf165e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137613, 9475, 60.0, 60.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c73c92f4eb5523033c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4cb156082e492c2ab152b0d035c4aec8c9d345a1b440a1241f680a4805505a4721332fb92835b13855210568be427e596a918291ae4979b6b5826f62058a7d007b46295b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137614, 9475, 16.0, 20.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789ccb4dac54282e492c2a513034d33532c84dd7cf4ed74f010a06f82ba4649665a6a4a6283879ba2864e62914249664a6e695142bd818192864a703002f4112c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137615, 9475, 600.0, 600.0, 'mg', 'PO', 2, 'Pediatric', X'789c73c92f4eb552303330c84d5708f05748ca4cb156082e492c2ab152b0d035048aea67a7eba7245682245332cb32535253149c3c5d144a0b144af221fa40d23a0a9979c945a989c5a92061a0fef4d4128514a0d90af965a9450a46e5d900bb2f21ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137616, 9475, 900.0, 900.0, 'mg', 'PO', 2, 'Pediatric', X'789c158c410e40301405aff20e409485503bb1b1227182f27f9a46a8b445dc5ebb9dc9cc603d4bb4421c1af384d55087252817249abc8cb4d87541ea4b92cc638809fd38e0be102cead4259dc19c9b63e539e1d86b0ea0f8867dd8a17af71fbc5821ed', X'789ced5a6d6fdb3812fe2b448002dd8355bf271ba758c04df6d01edadb20ed7d389c17062d8d259e29524b52499c45fffb3ea4ec4472dca46eb1b797c01f8258d4705e9f190e45fe7e9098329d2a9ed3c1881dfc721d7333e337540845072d76501ae9c733e70a3b6ab7afc482f257daa4fe9768df23b7b1e1052553eefcac5ea7771875ba51b7f3a973341a1e8f3abd5787bd6e777018682976422b0bcadf0fc6492e94b0ce703f16861c5d072e9f96058d266aac9c801c498513b19da8336d794aecefdae476c4bac34eabdfe9b40e3b9d3c3d617dffaf3d64f9fb89bad0a523cbf49c35858cd8f92f1375aaf35c2bf6c9f084d83fe10630fb6482182e839ae5acaee9670c393e93e49ffef32b9ea4508bf070a77253d7c7fdb841fff9572f659c94d24d61a65069c3215bb43a38e7c6092ea796c44d69c83626f0e4bfa58a1d7386b8cb49b911035b1ab1e02db881cd4472c23e3a301955be5b0db6985031665962b3252b0be67435a99df025fbed6a71c23ef0eb11eb0dd6832713156b7549c642374f0eef6a971170b15c8bedf6fe04b92c1116929d502531fc88752e1c578ee14f78954a69f113408072ac1f1d7a260e68352c81562c05024a2ee5d2cbaaf19a2860c6fb769b253b3ab07f67429fe19fbd67c641135e1e0740634a002ea2aba8345ca68237c23b1876a2864b276aab2639e4d6b56938748be037a2d0929b299ca14d42a6211493bf4ae883e6336d1e55e481840b5aee91ff7c90bf59d5f6d07f10faff3bf76c06e669f8e7afd3f2eb9b86aa865122b83322fedae57e55d7a6aba46cd0f7a23e5bead020853c85668b4a399894884b9150d2c8da1fd1a06d257af3ee6cb302d5fc116a472829bd68705b976af226cae3ca7a21ac7b18f5be2c442856a027235fa45ef73a6c914ed420ea1ec28e16eb75a2de71187aa0f27ca30d18c6fc945cdd9aab454dfa4ffdbaece33f5ff6966a542bbfcdf4aebb68505313388d90fb3ba87a0feac33bb235d6c59c6d5910562950d959e78e54f053beb82642d99dd7ad3a2c8651bf6eb3af75bb41e3e9d9dc1f46834d9b8f9e799c07b07923fd9fbdcd08eb70d3e6dd4acfd3b3f910e9bb6973b7f3cc03fdd351a766f2d1f0b99afcbd9bba696fdf12ed5ba27d4bb46f89f62dd1be25dab744cfd8e87d4bb4bd25fa5850ec5ba2735d9492dff53deb95efdc50aab88a97ec026f153c3862a713f59ec72e503323ecc20f5a3e27072bd542e92bb5ad95ba20ff4971cba7a8702405b6e654b2d7fdce68ddc984f884e0bc3d6b9f9f8d98d2cc964521c97f733f61efd45c8f9813fee46dd52559a9afa4d7c209c9d0e115104e1375fb25ac2e25a155302b7161feb0f3c27fb7bcae8f559fe77a83ec7bf5d8d270bc25df8e6dfd40b7f24a2e6412e53a61222fb830d5690314f08da975950296107fdaa080f634178a9286f9dfcf6e07847d19468f1f5e9ef903e48ad84e859ade723880c03bc64d203ecef6967eeae9a73122966a23687d3cba07e996cc7dde287dca89b8e389c0291613c3854a44bca5d68fa5249386f3ba58726bdbfe12c744bd7d3f8edefc0d40ef310e0a49ece5edc167a4b8b8a4db3de50f13c52fb548189f99b270ec4ab82c31fc8acb898a7919f2142b5eb62cb0e091b2af822c7fd9235f5df7a8d1294632210384aed9375e16eb82b0c95a2bb89872c11b2f8c4fec9a2b1b2f1302371b96602cd699b04e9b6d47878ff9779cf8959ca617c4e3fbfedd965a1fc9085d36e99a3670c58b6c29f9b5b0fe21159a12caf1c2470766559282ab1979f4ea22135270340909b34bebc02666f6da1f44014fca46ffd099b2986297e0a173f8dce96bd02000f0770e3729541d2d97d68b24b3443f927396230dc45c1b3f81c725aa484a78cba5b8417f44d7e8443c9d8339ac00864ba903035b8a582420730895a472a10b52de329741fa4cc74bb71e297c3c6f9f786ab802173f1438f102b04496c2b4ca379ede43113d175edfa18dadbff0f8e0aeb07877041da0df245fe685d3f903e45bd6eeea8e4f237289b8b901882d94c988273ccee02bc54b4bbc7de99bb7d041599d2b2d49c578998842eac2db32e312d6105b1f2b4ed41c92d392dab0395b790c98d078d344c8a5b0258cc044572295025f85c0f3342fbdd71cb0e3dd39533a4437e5c2f9c74487535ea497803b92a52da8b09e32854453f914f5ca18d8126e21c0f7c5ca79b14e7da78bdcc7bcb9ff441686abfc021c7cb74a6a75272a4c9e9736fcfcd7c5bb8046c36d063dc95c023095cf44704dd035f6a5a0c834220fc87a4980cfcecded3eb99e4c726d16c67d76fdbf67d73e427f458476bd039271d81c6ba9d3e627edb75cce2329e63462bd8cbd2c381a242426cade0f2d761475bbcdc116fbf982f9fa84b7c7789513a46a941d42cff761f560f31193f0893961a7ff3e1f0cb17fe99d768fd1ad656226d0539db0fe78d01e622029634f56ed4a7c958527ef784ed4cfd7a83dd57ddad20052ec78f882bd7cdd7d81ed4a9ca15253024de614a30cbd1ebcf806cf7c20cf073a4ff57c3a8eef5d109ea1362e2cbbd41240a2681d067f9d97f9998aa46df92dd84cf8226d5975590a56e4339456b2adb5dd160b4941ae9a3d173007eef40bc87a7367fd6ac1fd2d5ddfa096127bb3c2e882a75faa8e8f2f7c341d4bab1b067d5c95edead273edf3d1b7de475e337c7cd77d4bd9d8bb6f51e3f10bcdf509eb2dfb1cbb24a45b73a1a742c77eafbba379a87b9fff008fe62fee', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137617, 9475, 300.0, 450.0, 'mg', 'PO', 2, 'Pediatric', X'789c4dcc410e82301005d0abfc0348a84112835bf79a7882818e38413ad0564c6f6fbb92d524ffbf3f570ddca131a63ab5661e71bfa1177bc123928f1dced531a7f534d6965229ad6c62d9167480b8c13305469fd0fed9da209f0079662151e88d599dc6177b5a12d417ff591015fbefeb772a9341ddc63e88ba0276c31f691d39e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137618, 9475, 450.0, 600.0, 'mg', 'PO', 2, 'Pediatric', X'789c4dcc410e82301005d0abfc0348a8518cc1ad7b4d3c4161469c201d682ba6b7b75dc96a92ffdf9fab066e716c4c7532661a70bfa113bae011ad8f2dced53ea7f538d4645329495621a6827610d77bb681d125347fb61c904f803cb39028f68d499dc6177b3b27a82ffe33232ab6df97ef5826bdba957d1075056c863f6b1839ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137619, 9475, 450.0, 750.0, 'mg', 'PO', 2, 'Pediatric', X'789c4dcc410e82301005d0abfc0348c068a3c1ad7b4d3c41a1234e900e4c2ba6b7b75dc96a92ffdf9fab046a71344d7532cd34e07e43c7ee8247b41a5b9cab7d4eeb71a89d4da574bcb22357d00eec7b251b085d82f9b3e5807c02f8990547b66f4ce225be48ed9c205afc6746146cbf2fdfb14c7af12b6960f1056c863f6ed939f0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137620, 9475, 600.0, 750.0, 'mg', 'PO', 2, 'Pediatric', X'789c4dcc410e82301005d0abfc0348a831a8c1ad7b4d3c4161469c201d682ba6b7b75dc96a92ffdf9fab066e7134a63a35661a70bfa113bae011ad8f2dced53ea7f538d4645329495621a6827610d77bb681d125347fb61c904f803cb39028f68d499dc6177b3b27a82ffe33232ab6df97ef5826bdba957d1075056c863f6cef39ed', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137621, 9475, 600.0, 900.0, 'mg', 'PO', 2, 'Pediatric', X'789c4dcc410e82301005d0abfc0348a8311ac5ad7b493cc140479c201d682ba6b7b75dc96a92ffdf9f9b066e7032a6ba18330d68efe8c45ef188e4638373b5cf693d0eb5a5544a2bab58b605ed20aef74c81d1251cff6c39209f0079662151e88d499dc6177b9a13d417ff991115dbefcb772c935eddca3e88ba0236c31f6b1139ea', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137622, 9475, 600.0, 1050.0, 'mg', 'PO', 2, 'Pediatric', X'789c4dcc410ec2201005d0abfc03688a3135a66edd6be20968197152615ac01a6e5f58b5ab49fe7f7fee12a9c345a9e349b5ca593c1fe8d9dcf04a3aa40ed7923bdb8cb6313ad7d2f0c2864c4507b01f02e948e833da8dcd679413c1ef2238b1fec28997f4a1a0a70c09d5ff2624c1fefbfc1feb6410bf50882cbe82dd70058a333a17', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137623, 9475, 750.0, 1050.0, 'mg', 'PO', 2, 'Pediatric', X'789c4dcc410ec2201005d0abfc03688a314453b7ee35f104b48c38a9302d600db717567635c9ffefcf5512f53869b53f28adbcc3fd8681ed058f6c62ee71aeb977dde43a6b4a2b2daf6cc936b4038731924984a140ffd972443d09fcac82339b37bc04c92f8a662e90d8fc6746166cbf2fdfa94d46092bc5c4121ad80c7f8e123a1d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137624, 9475, 150.0, 150.0, 'mg', NULL, 2, 'Adult', X'789c05c1310e83300c05d0abfc1b1484ba0416448676eb15403128926347b1a38adbf3de9a3a7bc0d636c6320d01e67b738cefa15c38729af189af5f0c1085f55a990a89cff8caa9019ebded4e486a0463fdf38d2e9e198dacaa183dd50620d5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137625, 9475, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789c4dcbbb0ac2401046e157f91b3b218bd166639714dae51596eca80bb317662668de3e828ddde18333534cc1242d1ea38c8c6bef3c222d4241096a410cb17ef3e20e47e4f0f9b7deb9fcec4ee7d780dbd4cd9347a9d0b535a64cc506dccba37a58320946bf47b9be79c35a2c3184b4d5a2b403985f2d97', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137626, 516, 10.0, 15.0, 'mg', 'PO', NULL, 'Adult', X'789c73ce28cacfcb4c5628aecc2d28c9cf2db6523034d03534cd4d5708f0d7f7f4d5f70c53284c4c5648cc4b5128cc2806006bfe0efb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137627, 516, 20.0, 20.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dacb052a830342acfb656c8cc2b492dcacd2c2949cd2b5128aecc2d28c9cf2db652282d5028c9573032c84d5708f0d7f7f4d5f70c53a8503054484a4dcb2f4a852b0400bd53197e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137628, 516, 10.0, 10.0, 'mg', 'PO', NULL, 'Adult', X'789c3334c84d5708f0d7f7f4d5f70c53284c4c5648cc4b5128cc2806005bbd079c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137629, 516, 1.0, 2.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c33d435ca4dd7cf4e57f00c532834d235ce000029e804b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137630, 516, 10.0, 10.0, 'mg', 'IM', NULL, 'Adult', X'789c3334c84d57f0f4d5f70c53a8503004001bf403a3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137631, 516, 10.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c3334c84d57f00c53a85030040011b002de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137632, 516, 10.0, 10.0, 'mg', 'IV', NULL, 'Adult', X'789c3334c84d57f00c53a85030040011b002de', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137633, 516, 10.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c3334c84d57282e4d4a2e2d49cc4bcd2f2dcea954c82f02a2c41c20cb4c3723bfb408c848cc4bd1070a1b835497652602001d9b1350', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137634, 516, 0.1, 0.2, 'mg/kg', 'PO', 4, 'Pediatric', X'789c33d033d435d033ca4dd7cf4e5708f0d7f7f4d5f70c5308f4740100507e0672', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137635, 516, 0.8, 0.8, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb05230d0b3c84dd7cf4ed73732c950a85030342acf060055db06e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137636, 516, 1.0, 2.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d435ca4dd7cf4e57f00c532834d235c9000029ea04b1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137637, 516, 0.1, 0.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d033d435d033ca4dd7cf4e57f00c53a8300400290c04aa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137638, 3367, 130.0, 130.0, 'mg', 'PO', 1, 'Adult', X'789c05c1d10d80200c05c055de007e68fc730959a109446a9092b624747bef9298432933394b4759436c6ad9e035543883fb3b353054468d468bedc271eedf83742313b7f80163e918c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137639, 3367, 60.0, 250.0, 'mg', 'PO', 3, 'Adult', X'789cf3cc4b294d2ec9cccf53c84f5328c9a82ccacf4c51c8cc2bcbcf2905895a299819e81a991ae4a62b04f82b8478ba28a4e51729181aa428141465025925f90ac5a545e9a9459500b3481921', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137640, 3367, 16.25, 16.25, 'mg', 'PO', 1, 'Pediatric', X'789cb331cccdb7523034d33332cd4d5708f0574849cccca90400433e0666', X'789cbd566d6fdb380cfe2b823f27ad93a0d9100c0382f56e0b6e2f41db6fe7c15024c6e145160d49ce6a0cfdefa3ec3499dbeeba05bbfb2651d443f2115ff435d1ae2e722b4b486622595290de635de6481a35240391d4cec4a34d08959f9d9f7fc12d9467e48ab8c2f3a76e78e564053a97215e1ca7e3e9301d0d47e94dfa7296a6b3f1f86c7291a62fa6ad2ea880643d6b7e4de6ba448b3e381965ad28c06d8b72d35430cbecdc06d41420b30321791d368d23d442166043662fc9f34afc49aef4ac7d4575002f682dfac833f1c94993d937549664c5478edecfc4f5f55f8bd6a57af5bd57772c0a726520eefefecc3b8376db6e8eeeddfbf53c6107cdbbcf1179ae6b1372f61b6dd10b78493e082735b61e0bb8adc8d70e06e23e64b4ffd4ae1195a36ad318798b1cc268929685587e125aa26932bbb0ba6e23891c1c2feec8d41d0fd37438bed8dfb9595c8a3539314a35a322af0209b659806b7e8d9736b22544df1daadf155d665f8d4ae220a767e38b5e982c1e4e9a99988ccffa0793e168ccf2695ffa9a853410afa62fb7c58f0e5f77877d424f60e1ba0285d2e44baa6a238fa97e20c24161a5558db8e2535b64fc2897997d2f55e8a871e8b751b8b06b4ef8762b94b49682588170b5012d38cd39d9c14a2374cbf54cc81db398d97750318cba179f9ade0fbd7c3ecd2f635be9947d8e363f20246cf008dc8ff379d8837e1ef573250314e4909defcae90d59ae71b41ad51364cf8d01573431af95e1b6751e9bdf8139f4e43438cf65d3b6b221c6ea617a0bc200ee84c79feb1de3417e05523df6e609c0e41ab8f0eabededbd6fc406c9a8af6e581be3c968ad460a994fcd8dc23d99cf5187087a1116e6f37e9fbd911155b5fcfce95f49bccbe5d08740e3b9633bb940e7cd88047f910e5d9d4ffcf6279c8daff10cc89267eb5676ea42ba5224345d3b3f54e9af5d0e03acec00fc010649837defc71ab1c74bdbc4de3138c7e00b5913c1ccb9cd6f95c3d1abd4bc7e34a05cf8f0487872a8cb45aac1ab132a4b65ce5ed695d05b985386c626fa7f8623b105c5881aa6e10c75f8285531a29403e379efa05ad78c07f37477c63b5a392bf07377b3f7de0bfc0c953fd07f03f31e5e3cdfc70333fdcec75bf474efe3be85e3defd4b9e1dddd7d034b6c53e6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137641, 3367, 32.5, 32.5, 'mg', 'PO', 1, 'Pediatric', X'789c33cccdd735aeb4523036d233cd4d5708f0574849cccca904004c6d06cf', X'789cbd566d6fdb380cfe2b823f27ad93a0d9100c0382f56e0b6e2f41db6fe7c15024c6e145160d49ce6a0cfdefa3ec3499dbeeba05bbfb2651d443f2115ff435d1ae2e722b4b486622595290de635de6481a35240391d4cec4a34d08959f9d9f7fc12d9467e48ab8c2f3a76e78e564053a97215e1ca7e3e9301d0d47e94dfa7296a6b3f1f86c7291a62fa6ad2ea880643d6b7e4de6ba448b3e381965ad28c06d8b72d35430cbecdc06d41420b30321791d368d23d442166043662fc9f34afc49aef4ac7d4575002f682dfac833f1c94993d937549664c5478edecfc4f5f55f8bd6a57af5bd57772c0a726520eefefecc3b8376db6e8eeeddfbf53c6107cdbbcf1179ae6b1372f61b6dd10b78493e082735b61e0bb8adc8d70e06e23e64b4ffd4ae1195a36ad318798b1cc268929685587e125aa26932bbb0ba6e23891c1c2feec8d41d0fd37438bed8dfb9595c8a3539314a35a322af0209b659806b7e8d9736b22544df1daadf155d665f8d4ae220a767e38b5e982c1e4e9a99988ccffa0793e168ccf2695ffa9a853410afa62fb7c58f0e5f77877d424f60e1ba0285d2e44baa6a238fa97e20c24161a5558db8e2535b64fc2897997d2f55e8a871e8b751b8b06b4ef8762b94b49682588170b5012d38cd39d9c14a2374cbf54cc81db398d97750318cba179f9ade0fbd7c3ecd2f635be9947d8e363f20246cf008dc8ff379d8837e1ef573250314e4909defcae90d59ae71b41ad51364cf8d01573431af95e1b6751e9bdf8139f4e43438cf65d3b6b221c6ea617a0bc200ee84c79feb1de3417e05523df6e609c0e41ab8f0eabededbd6fc406c9a8af6e581be3c968ad460a994fcd8dc23d99cf5187087a1116e6f37e9fbd911155b5fcfce95f49bccbe5d08740e3b9633bb940e7cd88047f910e5d9d4ffcf6279c8daff10cc89267eb5676ea42ba5224345d3b3f54e9af5d0e03acec00fc010649837defc71ab1c74bdbc4de3138c7e00b5913c1ccb9cd6f95c3d1abd4bc7e34a05cf8f0487872a8cb45aac1ab132a4b65ce5ed695d05b985386c626fa7f8623b105c5881aa6e10c75f8285531a29403e379efa05ad78c07f37477c63b5a392bf07377b3f7de0bfc0c953fd07f03f31e5e3cdfc70333fdcec75bf474efe3be85e3defd4b9e1dddd7d034b6c53e6', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137642, 3367, 65.0, 65.0, 'mg', 'PO', 1, 'Pediatric', X'789c33d63534aab4523033cd4d5708f0574849cccca90400355d05c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137643, 3367, 65.0, 65.0, 'mg', 'PO', 1, 'Pediatric', X'789cb33334aaccd751b031b3c84eb7523033cd4d5708f0574849cccca90400660907dd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137644, 3367, 130.0, 130.0, 'mg', 'PO', 1, 'Pediatric', X'789cb33334aaccd751b033b3c84eb752303436c84d5708f0574849cccca904006c2a0808', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137645, 623, 0.25, 6.0, 'mg', 'PO', NULL, 'Adult', X'789c33d03332d535cb4d5708f05728b4d03532c9000028b80480', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137646, 623, 0.01, 0.2, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d33534a8cc57c82f52b03136c84eb75230d03330d435d03352c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c80000561b0e60', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137647, 623, 1.5, 20.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334a8ccb75230d433d53532c84dd74f49ac5408f05748c92ccb4c494d5128b4c80000a5170a2f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137648, 3025, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6523032cd4dd75130350091860660ca084429942426155b2b1882a5418a1492130b8a0120cd11a5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137649, 3025, 200.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789c558d410e82301045aff20f402218d940e2c2b061a589272874aa0dd086e928f4f6341a8d6edfcbfbbff1812aecf37cbae1724667758dab289604cb373bb50dd662193258d733a940e822ca54ecb48a9897010f277644f1b39241eee4fe8a97fe24355a677c059dfe038e87af63c534464c9e09640cf5629fb401fba73604', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137650, 3025, 100.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c358c410e82301045aff20f40e340645312576c5c09f104854e4983d0306dc4dede26c6edfbefbf3e44d6a8895443b42d181e98bcedf04c469246d3fed8d8ab82f1a9cfb582df67611319532e826acbef624dc671ae1deebb0b1ab664236e57fa6f62845f195b10063bc773f26ffe02438f27d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137651, 3025, 200.0, 200.0, 'mg', 'PO', 2, 'Adult', X'789c558d410e82301045aff20f402218d940e2c2b061a589272874aa0dd086e928f4f6341a8d6edfcbfbbff1812aecf37cbae1724667758dab289604cb373bb50dd662193258d733a940e822ca54ecb48a9897010f277644f1b39241eee4fe8a97fe24355a677c059dfe038e87af63c534464c9e09640cf5629fb401fba73604', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137652, 3025, 200.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c73c92f4eb552303230c84d5708f05748ca4cb156082e492c2a010a9a42c4025d7481c20a1586e5d93a0a9979c945a989c5a90a49954005baa6407dfa2989950a85e5d9d60a9e7969f9560a2940238b15ec4c0c6072458945a939950ab9f945a90aa96969a9c9259965a900e4ad2716', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137653, 3025, 100.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c358c410e82301045aff20f40e340645312576c5c09f104854e4983d0306dc4dede26c6edfbefbf3e44d6a8895443b42d181e98bcedf04c469246d3fed8d8ab82f1a9cfb582df67611319532e826acbef624dc671ae1deebb0b1ab664236e57fa6f62845f195b10063bc773f26ffe02438f27d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137654, 3025, 50.0, 50.0, 'mg', 'PO', 2, 'Adult', X'789c3335c84d5708f05748ca4c010012660348', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137655, 3025, 25.0, 25.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2ab1523032cd4d5708f05728cc2856a8302ccfd651c8cc4b2e4a4d2c4e5548aa04cbeaa724562a1496675b2bf826560035181840c400b80914f4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137656, 18716, 12.5, 12.5, 'mg', 'IM', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db6523034d233cd4dd751300293a606b9e9d60a667a209ebea942ae8f42717e8eb582a72f10870100e5a8100b', X'789ced586d6fdb3610fe2b843f75401cbf2cc93abb0860381b12604e8c242d304c85408b27893545aa24e5d829f2df77a4fc26476d62ef05c3d00f7144ea786fcf73c7b3bf34982e9250d20c1a3dd2186b95814de92397d038228d420bb79d5a9b9b5eabf5c0a7901d2b9db827deda953691a639b0905a77a8dbee9e35db9d66a77ddf7edb6bb77b3ffe7cfcf6ece4a47de66521b25c4983925f1a039671c98dd5d4edf92d0b73afe57e91438f0ca4e580b678d40fe43805a96ccabddd405e80e6333c38833eb903e69f7057199a00f955e9ccf448a77b7c9a2547a4eb3f4fdb59d22767c76ed53a25d96fc428d1275723fcfb10c85b55583044c5a4ea578fdc682a02395459a624b9d79401b9c6cca101e71365eab1ef9f402754e263991fc0850fb9986c47fd845b964e04b8d51f1f7125b89cfac526fc4aacaf40a422fef4d1d918b042d810f3c1655249ed400874944724529271ef578041babc34cb8491f10db19c0572441724c1bc12ca4a492a0853065c929c68b3bb94fe9ca28e6b5a18a0ad99ca5056264ee9b650eb6ad4bafa403e9f34cf52a77adef388b4bc42ffbaef812a371c225723926b88416b6044cd40fbdd91729e10c3a3a9048320ac9c983897ef2cd5b647da68b793e271ae34b18a20963340104ba63850315a677ee3d8bc73b85787e25c83c5cb68af0e855b87d0da46eb0e102f6bdc3d5032680c8c53abd1500d8b6a226edc48b1080779ae312b2c8c950ecfbbe102a8362f11d001d6c1244f4b36ad0952f2b1cc3d2b343a41185d1c6d21e299f72d9e16b9c3bfedf54c37647d8f6f857a006309c4b18b028fbb33811ccc144764b18235d160f263c2001137864afb9ce6ce7557392bf5db3427e3dbebfe3294b5cb350cae78d7e996e74895ca13c084c29ac8559dd8c164ac7aa43838aa4d61d4d4ecba34b682a82fce43d3daa856cbd337aac773f33bd5be53ed2f50edf5bddab3ed2e878853118e555e08ba6978ebeb5a4322a98c16e496aeaebe615d87bcc57141d4b5d36b8584fa54189b81b4bbc580cb4bc851736d271ed2c2634cd98c1b4cd003b729494b79c2b39c725da7f47573c84e602f5f25176eae2c854dc865b8d6b0bc545e9f81dddcfdab29f81b93be27d7864a62e1716c57510dd32e712ed606a4c18630e376e11a8e1be55b91ca7225d1240eca780e1f0c79d7250be507576a5d8bca972f70d6c5a2e038de2abd5895069ac2d21c122e3f95de06923b4f9a04272834cab143b84f813157c6f6fd431cb0990b22bc051a3d0fb10efb3bb4ac8aaa1cfec306458df7a265b93105d63fcddcfcff063b896b50e738ddbb871f024973093490fa2b91d7ef1f91985a0cf90d97b1eb1da8c7007f2cf075200514539583e4a8d6a638f44f54b4b0ab1d9a682a0be1b70c7f76c179a4dd178a4a4c4cab07e41a1a7786ca3619c889287ceb43aaf935e38f8f4b21bcd7e262b56b9476f8ae61d987ebff8f0ceff2e63f95e27fdc993dcb709c529dd14809952caa4d868ab829788cdfc07f6a764e48aadde003a84b096e32bcfb713c02440e2287d22ff3484379a10f7f1f9f9cb60ff06504514ab1a964a18ac341f4ecf700897a402c2f79e4094d946b416eea8ac0b5296c4b92f93e95e3ad8fcbcb0e5efd11e4c837d377477894a2fbd2cf8387cc0000e14018559d2fd73f50ec39567c55c50b5ffdb68457f729ce452023a896eebbf7f9bdbaa016511af1c8fd20c1607ebe6fd84f4f7f021a203ee7', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137657, 18716, 6.25, 12.5, 'mg', 'PO', 3, 'Adult', X'789cb35230d33332d53534d233cd4d5708f05728c94c01002dd2050d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137658, 18716, 12.5, 25.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dac5448cf2c4b55484c49c92cc9cccf4bcc5148c92f4e55c84f533034d233d53532cd4d5708f05728cc28060054c90e65', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137659, 18716, 12.5, 25.0, 'mg', 'PO', NULL, 'Adult', X'789cb3523034d233d53532cd4d5708f0d7f7f4d5f70c532834d135cb00005127066b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137660, 18716, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dacb0523035c84dd74fc92f4e5508f0d7f7f4b5563032850978860100b3670a47', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137661, 18716, 25.0, 25.0, 'mg', 'PO', 2, 'Adult', X'789cf3cd2fc9cccf5328ce4ccece4b2d2eb6523032cd4d5708f05748ca4c01009355099d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137662, 18716, 25.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789c0b4e4d492cc9cccfb3523032d53535c84d5708f0d7f7f4d5f70c53a830040087ff087a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137663, 18716, 50.0, 50.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dacb0523035c84dd74fc92f4e5508f0d7f7f4b5563032850978860100b3670a47', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137664, 18716, 0.1, 0.1, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73ccc9492d4acf4c5648cecf4bc92cc9cccf2bb65230d033cc4dd7cf4e5708f0572834cb0000eee30c2a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137665, 18716, 12.5, 12.5, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523034d233cd4dd74fc92f4e5548292dcacc4b574849acd45130828b16661403001daa0dc9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137666, 18716, 0.5, 0.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf34dac5448cf2c4b55484c49c92cc9cccf4bcc5148c92f4e55c84f53282d5028c95730d033cd4dd7cf4e5708f05728cc280600af1010a7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137667, 18716, 0.25, 1.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf34b2c2d4e4dd42fcbcfcd2cc9cc4bb75230d03332d535cc4dd7cf4e5708f0d7f7f4d5f70c532834d135cb500808f2b306007f1b0e79', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137668, 18716, 25.0, 25.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523032cd4dd74fc92f4e050020710496', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137669, 18716, 0.5, 0.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf3cd2fc9cccf5328ce4ccece4b2d2eb65230d033cd4dd7cf4e5708f057283434ca500808f2b356082e492c2a014bea1a662824a5a6e517a52a94142596a5e60000ce601544', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137670, 18716, 25.0, 25.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523032cd4dd74fc92f4eb556f0cc4bcbb752282d4e55c8c92f4f2d2e51484d4b4b4d2ec92c4b550029000077eb107e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137671, 18716, 12.5, 25.0, 'mg', 'PO', NULL, 'Pediatric', X'789c0b4e4d492cc9cccfb3523034d233d53532cd4d5708f0d7f7f4d5f70c53a830040096df08db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137672, 18716, 25.0, 25.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523032cd4dd74fc92f4e050020710496', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137673, 180, 400.0, 400.0, 'mg', 'PO', 1, 'Adult', X'789c333130c84d5708f0d7f70c534849cccca9040029990529', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137674, 2559, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f0d7f70cd35148cbcfc9c92f4f4d5148aa54303432d5353285482a149a640000f9410bd6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137675, 2559, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50d0282e2d2e49cccc4b4d51284acd494d2c4ed50400a93d0ac7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137676, 2559, 250.0, 250.0, 'mg', 'PO', 1, 'Adult', X'789c333235c84dd7354c5708f0d7f70c530874010027df0473', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137677, 2559, 500.0, 500.0, 'mg', 'PO', NULL, 'Adult', X'789c333530c84d5708f057283434ca50d0282e2d2e49cccc4b4d51284acd494d2c4ed50400a93d0ac7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137678, 2559, 500.0, 1000.0, 'mg', 'PO', 1, 'Adult', X'789c333530d035343030c84d5748ad2849cd4b494d51284acd494d2c4e5508f05708740100a5090a3e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137679, 2559, 125.0, 125.0, 'mg', 'PO', 2, 'Adult', X'789c333432cd4d5708f05770f27401001404031b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137680, 2559, 250.0, 375.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353637cd4d5708f0572874f4050020010416', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137681, 2559, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Adult', X'789c33cd4dd7cf4e070006cb020b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137682, 2559, 250.0, 375.0, 'mg', 'PO', NULL, 'Adult', X'789c333235d0353637cd4d5708f0572874f4050020010416', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137683, 2559, 8.0, 30.0, 'mg/kg', 'PO', 1, 'Adult', X'789cb3d03536c84dd7cf4ed74f49ac5408f057087401003624057f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137684, 2559, 30.0, 30.0, 'mg/kg', NULL, NULL, 'Adult', X'789c73c957c8cb2f5148ad484e4d4d513036c84dd7cf4ed74f49ac54c82f523004b300d1ed0b9e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137685, 2559, 8.0, 30.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789cb3333452a84c4d2c2ab652b0d03536c84dd7cf4ed74f49ac5408f05708740100867908be', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137686, 2559, 500.0, 1000.0, 'mg', 'PO', 1, 'Pediatric', X'789cb3333452a84c4d2c2ab652303530d035343030c84d5708f0570874010064a8070b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137687, 2559, 2.5, 2.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d233cd4dd7cf4ed74fc92f4e55d0c84dacc8cc2dcd553034020983c4341502fc1552cb528b2a81820a19f9a545c500ba1310f8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137688, 4440, 250.0, 250.0, 'mg', 'PO', 2, 'Adult', X'789c0b2e492c2ab152303235c84d5708f05748ca4c01003c4005e2', X'789ced596d6fdb3610fe2b070305362cae1da74e51b55f3cbb5b36a49917671bb6b91068f12c71a1488da4dca845fefb8e921d47aa5b3b5e516ca8bfd82275ef7cee05e2bb1637791c2a96622b80d64b97689bdf8854706c1d412b37d26f27ce6536e874de886b4c1f6b13fb27d16952dbc8b00c79c89c67ea757ba7edee71fbb87bd57d1af47b41ffd9e3feb3d3a727cf4a5a8c9cd0ca12e5bbd680a74209eb0cf37be596c39b52ca559161305503e544a4d5229796293755236d598cf09d36a90da0d7ef3ef73f9d7e7a3e55973a776841cfa12e37006d9804c76612dd51b5b085c9b3a91aea34d50aae0ce30817140c12fa07339ab4aad2da7c76dfe05bda2ac5f8d59faf692585ba2e176bcbeb266f8f6683fef6b5d732e0b97421792b545c8bcb06ab5a13146f73834721a37d15618d61e2987165a8d218c63fc14cf0a97ac50a102a32c82c56af3a9cb6fe7ed27e0af460a7ea8a4ed400d7f47e46441c284cee060cda8cd422380da3ced04bba09e0f8711f4a09ad7a806e3f12b0d2cdff96e5bb9f7669fc18b960ce8868df730a7b359693f629147aaa7a5d20afae2bc7c86f2e169468bcf27f1d14a8a2f2f3a8e9caee2138fde6b32afcb7e8f812e3f5404c4e328c0493e15867b9646be8ad623636182ba6a2022ee9ad8aa7541dc9b17316b9921a8cb0d7019c9f6cc2ef252a12bd01ec65b5a26a3d3443092f8ebb018c7099a2a58fbdfea3a93a1b05f0bd5820b0b9f3ce9399851594b0637a71a181f1bf72eb52f465fe2eb53e9dd026f86879861939bd317d2b8f4882038e73a190df37eafefe0340fde163d8de2546be5d672bb630620e636d0469a91ac6fffe6c9a60fbdc87f36911f1c0b41dd2c46198505c441b927620259ab8f0552192ccda8e9fddf6d032e00b3416c34b64d1fb5a36772c2374deb026364ce5524785d3d5717a443a9da1128c4a09e6d7abe76fa5d61c78e107442b18d19ee7594e7f680a9760ca48825f0ee2984a9ff5589961c216421b2aa4b988046752382a9823cc4a0aadbc3e32400b0e992da2a4b261e27081cab67fd489b254c66ca1b8d129120a699024a795158ecab42ba8c856de4fd56fc225dcb0377e1eac5a8d05310736a3d9d06d6a58e549f989b11e10a50dde787f4785cd30b3fef182e516e9bf3355bfea5454b57630e3f44c890a191d361980224e1c486dc9859160c6249e6764f41bc21ffadd33649c4509faf76fdf2e375fe65942c94fa467228af28cb67e304690a9a20a57e9b47773512e078e95f64d24624689685d6e66746a24f587944c31d48168048d502d47661aa6994d28d42627b1fe88ce84b1b91336ddabde3530b3c350dc60202df7aae73dc06d1755a3aec9594375bb947bb475191ed03bb0976435ce35a477a8fe6bda9a8c0fc17ebbc4066778c759b77105e81d4cbc23ad49a8f2603bfb92aec6bb4a9ceddc779435fe7abaed00ba157d58d2d723b1ccce1d02b1a2acf1aff2783bff1d6543ff32fb773160455a8f4659047688424557e3f5d5603b674975bb1cddbff8c6d1eca587ce71e81c87ce71e81c87cef1d1ce7128937b7e773e64dc21e3f6cab871c24cca222d755cd4f2ee8cc9795b8a3906d03f6d9f7621a1e9ea151212b524a006704e839701a2f653d20265f11c86bf8f9ff4bb019c0c9e8047b1c73b65c1cb9bc8607519f38b21872133226546c802be7ad1eb3e825c45095331f2af8f80920c3b738cd0eef191e3157a41645ea8e7e1207aef6269d91069624bb5d386d2d2d02bb250e282f9fba3e1c50496f7317eaeb44ea4b914e012624bb4dce7f3ce04311c48ab6b862cbf6e37efb86c7303c830941698e234824acdf832cdf629124ba53b74f925611d96754b1f7ab7d504f96e6e3e44435809094948b8164230bfbdfd07b090f66d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137689, 4440, 250.0, 250.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac54c8cc4b2e4a4d2c4e55303235c84dd74f010a159ae89a2b0019c500b1610a84', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137690, 4440, 1.5, 1.5, 'g', NULL, NULL, 'Adult', X'789cf34dacb05230d4335548d74f49ac04001d110409', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137691, 4440, 20.0, 20.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c333250c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4c010073be08cc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137692, 4440, 250.0, 250.0, 'mg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab15230323550c84d5708f057087401003a370568', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137693, 4440, 1.5, 1.5, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb05230d4335548d74f49ac04001d110409', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137694, 4440, 20.0, 20.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c333250c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5148ca4c010073be08cc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137695, 4440, 250.0, 250.0, 'mg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab15230323550c84d5708f057087401003a370568', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137696, 4440, 1.5, 1.5, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb05230d4335548d74f49ac04001d110409', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137697, 11147, 75.0, 75.0, 'mg', 'PO', 2, 'Adult', X'789c3337cd4d5708f05770f27451a85030554849ac2c0600380b05ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137698, 11147, 3.0, 3.0, 'mg/kg', 'PO', 2, 'Pediatric', X'789c33ce4dd7cf4e5708f05770f27451a85030554849ac2c0600488a0675', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137699, 11147, 30.0, 30.0, 'mg', 'PO', 2, 'Pediatric', X'789c3336c84d5708f05770f27451a85030554849ac2c0600375c05a4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137700, 11147, 45.0, 45.0, 'mg', 'PO', 2, 'Pediatric', X'789c3331cd4d5708f05770f27451a85030554849ac2c060037cf05aa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137701, 11147, 60.0, 60.0, 'mg', 'PO', 2, 'Pediatric', X'789c3333c84d5708f05770f27451a8304d0100200b041a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137702, 11147, 75.0, 75.0, 'mg', 'PO', 2, 'Pediatric', X'789c3337cd4d5708f05770f27451a85030554849ac2c0600380b05ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137703, 11147, 30.0, 30.0, 'mg', NULL, 2, 'Adult', X'789c732e72ce51b033365428c957303350c8f5d1cfcdcc2b2d49b5523036c84d5770f2745148cb2f5230554849ac2c060029430d57', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137704, 11147, 30.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789c732e72ce51b033345428c957303650c8f5d1cfcdcc2b2d49b502f272d3150a53122b15d2f28b144c1580ac62003db70e32', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137705, 11147, 30.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789c0dccb10dc2301005d0557e09154188266d82444105139cec0f58f2d9d2f982f008ecc1644c12de00ef74bbcea805e719934df9f7f9ee07e865a7a92cce1187411f90bbd3c017ade349ad3149ee2d35841e32b171a3b8b238e262e2e9ff95eaf00abe0319714494deb62b359726c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137706, 11147, 30.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789c358cb10d42310c0557791bf0111d1dcaa7a340fc090c31c152eca0c491c808ecc1644cc26f68ef74775c2e339ee4c2e60dc5108ab9582fbde1a0d79ec94b1d3873152fc694310be5d1a421d490bfefcf76829e36ba36ce7b2c622933769326c4d218145725cdb97284a8721472ce03745f19e2ffc6afdb832cf10f54a63630', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137707, 343, 1.0, 1.0, 'mEq', NULL, NULL, 'Adult', X'789cb3d0335155c82c563054c8752dd4cff5010020620438', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137708, 343, 325.0, 325.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652305555b05630d70353167a2620ca44cf084c81086323d3dc74206d686aa090eb5aa86f68600064f8e8ba8035c045c10cb028001fd4156a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137709, 343, 1.0, 1.0, 'mEq/kg', 'IV', NULL, 'Adult', X'789c3354c8752dd4cf4e57f00c5348cacf292d5648c92f4e55c8cccb2cc94cccc9a954d0a833d4355248cc2d285648cb2f52482c4b2d4a4c4f55484c29cd29d1040088a11520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137710, 343, 0.5, 0.5, 'mEq/kg', NULL, NULL, 'Adult', X'789c33d03355c8752dd4cf4ed74fc92f4e55283434c8cdcc0300497006e8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137711, 343, 150.0, 150.0, 'mEq', NULL, NULL, 'Adult', X'789c33343550c8752dd437343000327c1432f35c4cc3013827056a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137712, 343, 150.0, 150.0, 'mEq', 'IN', NULL, 'Adult', X'789c1dcc410a80201445d1adbc495054a6a6d0026a0d8d458804f5572ab4fca4f93d57688eb0dd68679870a50e746061aa41225fb2a308172138af95c7aa77f4b8289b945c09907c543f1f10cccb20ebccdae9a4f27c53f21971', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137713, 1696, 2.0, 2.0, 'G', NULL, NULL, 'Adult', X'789c0bc92f49cc51c84f533052702f4acc2d06002e2b0566', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137714, 1696, 1.0, 1.0, 'G', 'IV', NULL, 'Adult', X'789c0dca4d0a80201006d0ab7ccbda48de2108d7417ba311074647fcc9ebd75b3f97b9b317dc2aa341032c8e047da9c26e489c47a786e5149d7017ca687135d8ab9f1805937b4460e97fcf448f90f9005e561b7f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137715, 1696, 1.0, 1.0, 'G', 'IN', NULL, 'Adult', X'789c15cd310ac3300c46e1abfc63ba84742884ae1dbab4a59013085bc1025b025b2ee9ed93ec8fefbd49d4594903df41318a8b29655cf12cb01f57286f8e19c97a6d188a6c10c56d4279c1567c96cb8807e58c6fa25a28fce186b3228d889ce5343c3182a98b76ebed00d6de8ecfb803a4da2ba9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137716, 1696, 20.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3cccb2cc94ccc5148cacf292d56c84f533032c84dd7cf4e57f00c5370828895a51629181a28e466e69596a4160300a38a10c2', X'789ced57ef4f1b4710fd5746fe94481cb6a154a95b55720c21a881d0e0269572d1697db7f66dd9dbbdee0f632be27fef9b3b30369002f9d246ca37ef7a7676e6bd3773b39f3b858bb3cc884a7606d4193b61e442542acf44ae8ace1675a2d3fc4f1942ed07ddee853a97d5b67533fea5baf71cf0b913b52c3211f8dc4e6fe7c7a4d74ffabd71efc5a0b73bd87bb1bddbdfdbebfdd0d8ca3c286b3c2c3f775e8afc7ce66c3445b30c72d178183626031a9aa0a66ae294b17a19544e62264d48cdc856b50c2aa8b924654a3551c13ab253aab5f015ac6146024ee6821d51b0d7ffa466df7a6566349c0ba5c54469159683d40cab3a6ac92efa7458c129f57b54bd49cd2bebaaa81b377e4047ef4998824edffe4cb93014bd6cb63c6ea8552e74135a851b015221e90418e3d46879aeedb9a89d350d0271b20ec225b6829868c9ab8f9fb0d2ca9cb70bfeefc81470cde61b18bdda1f26a286cfb92cc81abda4a975c8e4d4fa500b176245f0290b248b4de9144c735944273495b2b2ce95409333e5555d020991fbedd41c5b27296fd3b0d3690294a4e6543dbc9fc9b97412975dfba6e044ac04d58810dc6c915ffa6035b89a686b0baa9df43eba06da5f7eea317c5d70554a84484e0449bf521f584fa408be0b86b6087f5fa850925cd48009d939f977544e56f0cf495225bc67ea71b5f1d3e8014d6a0e6ae5835828bf45d2e3a0121a61223d0111e556cc984538bb0ad4a7e60f5348078bb9f441cd5aa5b07b669595a20c2e80b28dda802c35c8213587472b0c9e46ea0d855fb8e0e1123c5a3b98dd1ccc9e554299e71d5c7e73c9ad38ffdd312051d3291806668c5616eb5aba6c267c7016e132520677ae3c5e36121d590e48ad84da3d58e4bae1251b3915203eb1a1dd4307b6817d285144bb54dae83c4d9de5c2fb2bba656a7e33f6c29097c67395a346b986c77f0e216527e7ca46f0b7ff7e9c1af0751a35b42adc920eaa09a4e7abaf25041e1fc6888ddab48705f40ad5b9bbd5794f04308f3a6485f572c3746c03e84779ecd0a11315123b32481a7b4826fa554f42a1bba62b291341043d3bd3f682db4f1d7df97c9bf69db8a058b7b533559a0136a0494b2e6ac1ec41b9b91c90280ac561e18a1bcfe8e9815e5c71f1ac520bae9d3d6e821cc1c9196e18a1a4e8b414ae127943085b713f2ca456f3864fee1cd08e8960080edae2c4fd1ffb9f3a9b0c3080a71091080e5f923ba87c906a56069a082f8b7b10d9e955b3eef98cd37fd9ee6da2732be3a699c3be5bbabbd9a6e6c4ae6382866741a985a058f0febaff14dbf7a4306e1b7f166fc5bf6a4703808860937e132c3ab656e842fc45c2b78f1b2814bc6a9205b49d4b34515b49ecf2278c8392a084b1ee0ffa2dbd27674d67637894b91dd5431f94ef3abc539adf85f85f08f15b44fdb672be41d8ff27213f710c1e1620cecbec9d146bf0af9a5789e96162f98d8009b519ef5e2f6b1b7880b08603480dde28aae009a3bd15bc0b4020b6686e2bc46c665b043d6294920292ab6ac1a4a38f68a43b57eca7693216dda5d988104b01c8a29bb0ccfcd74e1db7027d7802593b7035899c49990db5b71b981c0fc7e383779ece422c30528d9cf065b283a7896a1e2acd72f77af95ae8400a6fabd0ae3fbc3d1e9e50b3a02435d7913889c70062c1fba00b1c920b5b0993346609467abd4cc24224ca24359e2149fb0e496e26d46e6ac63743bbdf58d10db35f09e446c20fc378f0f2f7c1d591ac3db231386fe0f5386fa377c3b3d7c94ed61eb9c7dbeed3bdeddee7ed8aad47480586190c374eaf53f0b8f7fecafa4b7e36c97bb4c3b56a6e857cb0c0b8c02f8c3757f4aeb5a7e351743cf953c22f017e62f3c3f38d0ab87caee405de80c7fb36f7fcef531bcce5e53ff348e2e2', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137717, 1696, 500.0, 500.0, 'mg', 'IV', NULL, 'Adult', X'789c0dc8310ec2300c05d0abfc0380d40c2cdd1958ba20b19bd40a5f2589151bdae3c31bdfd5e821077dc6659a6a39a782db0362f6a6ae880e93bcb115f4011beafe198a55bfcc7a82f7aaff951c0cf6a6c3517920cd093be385e50e36089ee26c3fdc3e253e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137718, 1696, 20.0, 20.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3cccb2cc94ccc5148cacf292d56c84f533032c84dd7cf4e57f00c5370828895a51629181a28e466e69596a4160300a38a10c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137719, 1696, 500.0, 500.0, 'mg', 'IV', NULL, 'Pediatric', X'789c0dc8310ec2300c05d0abfc0380d40c2cdd1958ba20b19bd40a5f2589151bdae3c31bdfd5e821077dc6659a6a39a782db0362f6a6ae880e93bcb115f4011beafe198a55bfcc7a82f7aaff951c0cf6a6c3517920cd093be385e50e36089ee26c3fdc3e253e', X'789ced57ef4f1b4710fd5746fe94481cb6a154a95b55720c21a881d0e0269572d1697db7f66dd9dbbdee0f632be27fef9b3b30369002f9d246ca37ef7a7676e6bd3773b39f3b858bb3cc884a7606d4193b61e442542acf44ae8ace1675a2d3fc4f1942ed07ddee853a97d5b67533fea5baf71cf0b913b52c3211f8dc4e6fe7c7a4d74ffabd71efc5a0b73bd87bb1bddbdfdbebfdd0d8ca3c286b3c2c3f775e8afc7ce66c3445b30c72d178183626031a9aa0a66ae294b17a19544e62264d48cdc856b50c2aa8b924654a3551c13ab253aab5f015ac6146024ee6821d51b0d7ffa466df7a6566349c0ba5c54469159683d40cab3a6ac92efa7458c129f57b54bd49cd2bebaaa81b377e4047ef4998824edffe4cb93014bd6cb63c6ea8552e74135a851b015221e90418e3d46879aeedb9a89d350d0271b20ec225b6829868c9ab8f9fb0d2ca9cb70bfeefc81470cde61b18bdda1f26a286cfb92cc81abda4a975c8e4d4fa500b176245f0290b248b4de9144c735944273495b2b2ce95409333e5555d020991fbedd41c5b27296fd3b0d3690294a4e6543dbc9fc9b97412975dfba6e044ac04d58810dc6c915ffa6035b89a686b0baa9df43eba06da5f7eea317c5d70554a84484e0449bf521f584fa408be0b86b6087f5fa850925cd48009d939f977544e56f0cf495225bc67ea71b5f1d3e8014d6a0e6ae5835828bf45d2e3a0121a61223d0111e556cc984538bb0ad4a7e60f5348078bb9f441cd5aa5b07b669595a20c2e80b28dda802c35c8213587472b0c9e46ea0d855fb8e0e1123c5a3b98dd1ccc9e554299e71d5c7e73c9ad38ffdd312051d3291806668c5616eb5aba6c267c7016e132520677ae3c5e36121d590e48ad84da3d58e4bae1251b3915203eb1a1dd4307b6817d285144bb54dae83c4d9de5c2fb2bba656a7e33f6c29097c67395a346b986c77f0e216527e7ca46f0b7ff7e9c1af0751a35b42adc920eaa09a4e7abaf25041e1fc6888ddab48705f40ad5b9bbd5794f04308f3a6485f572c3746c03e84779ecd0a11315123b32481a7b4826fa554f42a1bba62b291341043d3bd3f682db4f1d7df97c9bf69db8a058b7b533559a0136a0494b2e6ac1ec41b9b91c90280ac561e18a1bcfe8e9815e5c71f1ac520bae9d3d6e821cc1c9196e18a1a4e8b414ae127943085b713f2ca456f3864fee1cd08e8960080edae2c4fd1ffb9f3a9b0c3080a71091080e5f923ba87c906a56069a082f8b7b10d9e955b3eef98cd37fd9ee6da2732be3a699c3be5bbabbd9a6e6c4ae6382866741a985a058f0febaff14dbf7a4306e1b7f166fc5bf6a4703808860937e132c3ab656e842fc45c2b78f1b2814bc6a9205b49d4b34515b49ecf2278c8392a084b1ee0ffa2dbd27674d67637894b91dd5431f94ef3abc539adf85f85f08f15b44fdb672be41d8ff27213f710c1e1620cecbec9d146bf0af9a5789e96162f98d8009b519ef5e2f6b1b7880b08603480dde28aae009a3bd15bc0b4020b6686e2bc46c665b043d6294920292ab6ac1a4a38f68a43b57eca7693216dda5d988104b01c8a29bb0ccfcd74e1db7027d7802593b7035899c49990db5b71b981c0fc7e383779ece422c30528d9cf065b283a7896a1e2acd72f77af95ae8400a6fabd0ae3fbc3d1e9e50b3a02435d7913889c70062c1fba00b1c920b5b0993346609467abd4cc24224ca24359e2149fb0e496e26d46e6ac63743bbdf58d10db35f09e446c20fc378f0f2f7c1d591ac3db231386fe0f5386fa377c3b3d7c94ed61eb9c7dbeed3bdeddee7ed8aad47480586190c374eaf53f0b8f7fecafa4b7e36c97bb4c3b56a6e857cb0c0b8c02f8c3757f4aeb5a7e351743cf953c22f017e62f3c3f38d0ab87caee405de80c7fb36f7fcef531bcce5e53ff348e2e2', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137720, 17, 2.0, 30.0, 'mg', 'PO', 1, 'Adult', X'789c33d2353650c84d5708f0574849cccca9040021cf04a9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137721, 17, 2.0, 30.0, 'mg', 'PO', 1, 'Pediatric', X'789cb35330abccb75230d2353650c84d5708f0574849cccca954d028cec92f4f2d5228c92c294a2cc9cccf53282dd0040030bf0e8f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137722, 718, 210.0, 280.0, 'mg', 'IV', NULL, 'Adult', X'789c0b4a2cc84c5148cc4b2d2ec9482dce4c54c8cc4b294d2ec9cccfb3523032345028c95730b230c84d57d03006b14d1472d3f5b3d335153cc3145232cb32535253803a148c207229f9c5a9c50062e91a27', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137723, 718, 25.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc4b2d2ec9482dce4c54c84dcccc2b49cd4bcc4b4eb5523032d53535c84d57f00c53284a2d484d2c494d510808f2030091f51009', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137724, 718, 1.5, 3.5, 'mg/kg', 'IV', NULL, 'Adult', X'789c0b4acc2c4e4d51f0740eb05230d433d535d63355c84dd7cf4e57f00c5348cacf292dd651284a2d484d2c510808f203003a9a0ddc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137725, 718, 75.0, 125.0, 'mg', 'IV', NULL, 'Adult', X'789c0b4ecdac2a2d4ab5523037d535343255c84d57f00c5348cf2c4bcd53c8cc5328cecc4bcf495548c92f4e05001c550dc3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137726, 718, 125.0, 250.0, 'mg', 'IV', NULL, 'Adult', X'789c0b4ecdac2a2d4a5548294d5528c957c8c94f4ecc5148cc4b2d2ec9482dc94cb652303432d5353235c84d57f00c53c82f4b2d52303450c8cdcc03003ff012c6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137727, 718, 3.0, 4.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf34bcdcf4b2c49b552305628c9573051c84dd7cf4e57f00c030060da0763', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137728, 718, 5.0, 8.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33cccdd735ac2cb252305528c957b050c84dd7cf4e57f00c0300575406f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137729, 718, 5.0, 6.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d43534adccb752305528c9573053c84dd7cf4e57f00c030048050649', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137730, 718, 1.0, 1.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cc4b2d2ec9482dce4c54c84dcccc2b49cd4bcc4b4ed55130d43534adccb75230cc4dd7cf4e57f00c53284a2d484d2c494d510808f2030008af123a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137731, 5019, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c0bcecc4bcf49d54dc92f4e55284a4dcfcc4dcdb352f04d2dc9c82f294aad482c4955303550c84dd7cf3502004d480edd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137732, 13393, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137733, 871, 2.0, 2.0, 'mg', 'IV', NULL, 'Adult', X'789c33ca4d57f00c53c82f52f0f4050016cd037d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137734, 871, 0.1, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d03354c84dd7cf4e57f00c0300139e0344', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137735, 20833, 150.0, 150.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303435c84dd751303600520072ea07f2', X'789ced590b6fdb3812fe2b83000724806c4b7ec6eee100c5de3649e3ac2f4e3757d481414b63891b89d4929253efa2fffd8692e5579c36cd2db0b7400bb489247238df376ff68f235f65c154b0188f7a70e4465c3f7085e2c882a34c45e65d98a689eed56a8ffc01e3aa5481f98dd776966a4fb104fd294bcd8eba5d6f576ca7e2d8b776a7d7ecf4eaf5aa5def9e761af95af4522e85a6957f1cb97ecc05d7a962e65dfe2ac5cfb994db6582bd897045ca43fa55a528345fe0440ca46601c25ba962dd03a765c781050d9b7e4cc48dcc52d420e7b02bb9073f2b164d445fc6b11470ab988f704da849c22d3ea49912cc821ba67984bfe75a66b36d45bfd0ab94cd22344f9feee929e2e2217fd868bcafea0b48dcdff1e5de9ce4fa59944e092717c10e2707343b3a5fefdf239098a9102d100730fa197ef38f76317cf90aa65c8bef12fc72be72d923f4394b15f70ea11cb339a6cb1acee7dc63de12844c01b511c775883e700149b91f12b22f8a54bf428971821e67d17424932c621b464b3d460a03c1046970435f05b9570ffe331157cc4bf3d5a028047ad0a77ddc47052c4a91fc285d997edf503728e8b00378737393abf7553f827f912bf7e05a02f37fcd741a13b6d5977faebea430c039f936fa13713ea88d06f9f27196241116cbd7ecf6e0d55c6e7b8a7106341f0f9aab507f5fe53f5b871745e0bec5be1d810393fe9272dbd463290652713aa508c5bf97d19ee486ff63abfd756ef59d6982e29baa08173e1df33449b851842a58422ac18b98d635535049cfd2a55e71a0eb2f50699cde20f39e1e78c8ce63545c667b8a099684cb887de67a22ac09291370893ec66c22c6292e28b1572e6528342532bd14be9231e60b6fe567220c1393d3621681404fc968a98d1caa09725512f207540f8c1c9893cc3c5260ce7894292431d79884b48fa721a7b27a28a714c57847e901674a85c8f6859f7db8b6a0af00235c14adc26bd2c316252fa9cd9bc5247d236543e44b84acd7eec878ce00df96b8b773badeb923ff791b7efb847cef74bd77bab577e78c2d5ff8b6d0edc5fb52d6767e9198cdea1d3907dcedeba2f637ec482bfdf00505a45cf9a7a12a7a93bf4744ef27a21f21fd23a47f84f4e190fe5f63e33523e95f0e7a1432f2384f463258ee403f67d1bc12f139f6a0de0c27628804866ca7e31e5cd104a5a86553298d67d1f20d34dc2618f8669aa794f6d3674f6131d67f505c201cd75bff804c78210532fa27afe8b9866836d3e953399fbade93db8801450c328d1a12eaf262060a053598a6415bf074090bcec0e78a4ea4be33e4339ee609f542d048384745fb1ec92dc193c2f47666789473c8d34e1e424206284c0fb9f50a2e5e81e306cd69c2c3ddd2f136136642bdbc23b7620a693e1a5a3064463b096f2dc094a6d72adc860831132cc86712a362a278ccd492befa529bd522b7904754808f69a19945d05920a887d71621f02125aef286bd478ff093f0a597db692c3d4e3d3bf44969eaa6231829c3a087f02ea3dc446fb10a97f9e7f52e1941ee1b55a8db4efb8d633bc7ad939e737adaad385da75d055ff21e3876d5a93b76ed57af4acb5a95a6dd76aaf06994cd86340ad4dbdd46b3d16ddc4fc43b09eed882339611502016ded3e001e3e19a0357008d1406d80281258992cc0b8d69421e84308ba4f48915d49a8aa2b1674a198760822668c43b4d2b0bae255136a71c0e2931eac654cc3d3aed1cc9a5c1d59a686005713bdffb928689000def64259fe751b36294d6f5d1d84bc35c2a18706ddc11fa8502f91a9a39a88ee437139f92ac1c83a430b4d21cb5c078463ee0b42cc364e3be0adb373c5b6435ebcd46c73664bd0f99ff7bb8147201030bc6917ce4423f70b8b52846f181a45dac78b360b28ef5073a8f8c5a5cc395d784661c1bad8630b833b14006ae8c53739557341a25a40fc6550369cc72ce3096e45b79a9b226478567ec9c9383a95bd0728e1dfba4d76e3b95ee169686ed9cb6ea5dc232626a91cb3cb76044349a1a4d9e7f858f5cc3e5d906474602bd8dde94b66774905f287d2535d990e570cc0d25d4496f364373eb686c5094209a36c3a5954ba257843488c8ad4921a3ad7d6a41a3757a5c6f9cf488e946a5d9de286cb46dd94d87145edd46c2312b753921bb2ae9679464a892c840513b43661c48b5309aff3bc3197a26c205f399199d172685ea9230cc5213747ab5002e84f7062e99c84c8093aaa755d3472a46be4db82f5d6364f858f8df0da7fc48ce7b5b1264ee538de14c9e2a129e54ba847c45936f611abb4d60dba7c7dd56d3446db3d9adb4b6e176ec56abdbec10dcf21a761f2f6aca023363392ec8f3e33c7008f519e523134143d720f5b1f40bf830760b686b97279d3a84ed17c6fd25414f29d383c9013ca0d91dc81f3e6208fd3d0f38e4cd260a73e08322d5efe1dff2763792147486395eba5071679897810b35c38d1f15ee7f11278c2b93344b160f3bbbddb1a0d93e3e2d7cbdd3da26b3dd6a353a2670f7a1de517127ad7e7919546b75b75298fe56124b6cc62353e7b649781efd93585fddf31c0079b90b335a43ec1cd7c961baf50a3d6f63ac379b9d8e4d18efd0d876486e3af6423e9f2b5334ae086bc85384bbb37546ff4ab52992a94134dc297bdb99d1a0312b3ceadf324124e4d93ea54e245f3d5bee26f1b2c6ed4b29b378de1214ce402a3db37a5d05cb9770fc4e218a470ac393bc1236df38ed63c78454a5dede4ede8da673daa91b7e428c284260f47ebbe8bb54c2e523dc8dd7f498e800b7dfafb9e76ecd7547f4cf193df447c39afb6e5c734721bd199fd3df51bf763d746ba3feb50b4149e19ac1645d7eacedd6803ad8285b553bc3c16e7f71a8a89abeca5cfe6943b4c244aab4f4bbaf97cadaf395166e997e30ff6744d6a7a7afbac4d3e2c9a831f657ed90d15b6c95d38655e49727f5347fbbe94e9cb6533bff38aada3b7fda5bf15bef3a8d46a3d5beffdebeefcb97ff0223556864', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137736, 20833, 150.0, 300.0, 'mg', 'PO', 1, 'Adult', X'789c333435d035363050c84d5708f057284c01001e0303ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137737, 6639, 8.0, 8.0, 'mg/kg', 'IV', NULL, 'Adult', X'789c0dcabb0d80300c05c0555e091529598105e80db68c453e083b426c0f57df8ca2d3a9a03d3a656c8d5f3c627a04867e211ae694fe3382b858350fb985410e825bd52c58567073f900a03318fd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137738, 12260, 200.0, 400.0, 'mg', 'PO', 2, 'Adult', X'789c333230d0353130c84d5708f05770f27451c82f5230d13503f23dc3407c0080620810', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137739, 11196, 0.075, 0.075, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d0333037cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca000089a10951', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137740, 11196, 0.1, 0.15, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d033d435d03334cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca00009a8909d7', X'789ced5a8d6fdb3616ff578800055ac0766c27e952f730204b57245b7397a64181613a08b4f42471a1488da4dca843fef7fd48c51f8abd4b5c6477dd2d40025be4e3e3fbf8bdc7f768fdb6939a3a8f152f6967c2762e7962b414656d777a6ca736d20f16ce5576b2bbfb495c5139d026f7dfc46e97d626865794c6dcf925e3e1f8657f38ea8f8697c3c3c9706f323c1c1cbe3ad8df1f065a4a9cd0ca82f2b79da3b4144a5867b81f0b438eae0397cba6a2091365592b6debaa32642d572e526fb4e539b1b7da9476c2868383dea87710a90b5d3bb24c67accb74c2ceffd5634e5722e1b2c74e3f46ea5897a556ecd2f094d83fa1bd9d9c1b9d1b9e0501ebe9aa8c3718727c2ac93ffdfc6f3c49a1aeda073f7794d6d2c5104aa8bca3c0065e3b27c48d8b2199b2958436b1a15fdaf9b832ba2a1ac9af85edb0190e86df1c94f9ee55be9bf206cab054cc444a29fb75342e22f5c181e5847dfbb26095b6aebf64fe9a9daa4c4f184f7fa9ad63a9b6c4a6dc622594b764ea92499a910c2e5c51d16bf54eccc86c2be8a88fffffbeac3f8a5451f325c28eef97f5937085506cbcbf41e49424568a8c19525cb2ac566153a6b48322f46bcd1d7db162f7e1eeeb85d25dd03f61e96bc7d257eda1bb70fa7bbae8ff47eb2dcfd7734a057746240f3d631f06e6787cd754070fb3d563269cc789cbff992a5b7af2434589e0323ed7552df9d26173c1cf0de58aaba46117985579e46bb7c5d83170966b832f917ac71317183023ec95a7831a564c65c36a6579469b7071e1f1bb0944a1829b44ea2a84185b1a63c272388049fd89600b4309ea4652de8cde2e3d56c2b609d8c3b20681615c81cf60b294124330dbeb605f5d31d4ca796d049f30eb6dcf5ef637069be7d8065cad9c9077636e196f276f26210253ca84a2340299643a08b0e4671f4381b59d1601f92770df70229f5005576f8cfed6718f20c5712164da3faff3827d48b421f6ed683859ccdf32e2a58653fe445b7ca1145b24953f8eb5fb3bbe37be556c896d2c54bce0b0830d978cbba1793fdb057dece9e3a48d7201e16f82fb9fa2f6af11b5eb9dee53d83e56d83ee5c1871a74cb8ae4582bc49d50a94836d423475292c9915a344b24b776d7df9645aa682a3296a0834351e5da798e7c619846f043313103b71959f6fcf423cbb4295f444afa526e25ca590d559e7f7f81a5d59c862464375a368e189f2a0c72894dc8f69058600998d3796bc3803929e1906424beb2f797cc362a35ba244cf23a641d54ec184799e8498276ab73915a9bcc7829504015c2abd2741861c0228b592887ec2794bf68db443723e54180eace306e4cd1b8a214dc7668a686a74dc20d00d319877258cdce4e3ba3c7276f579e15cb083681109019d4b633f79de4c9d5e6a913612bae44b26976ded988b2e2c200adae3359b471b732bd1dd09678ba63f1fbcfc6f7977167c1cded85e3cce32fbe209eac8376532efe0048eaba4bd7bd580d00f0686b8f74c0b529ab429770d19dd38eb5335e2e91910940477761b501f0232554d6eedc43b7003901c8e3b38f481067ef22f5dd8f6c264c6dfb08269d0c98a2aa401bc35dd1f89e04f4caf67fd085b2bed95820dae96bd89f2a9f33202396f9bbe7c60a78912b3e6f8322d5f20be4884bff5caf3e7a4dbc250c1cee4d887e8118a904abb86cc558d9d592f85cc336b04ba35bbc4a1662df85d60bfcc06c3e415956b7565c8bab0dc1739b44ae0065c4c7d2542d7b9f5a560d880da6e443ae24897c50079148769df7e6147d9183fae554270d8a170a70af0dfee0c5824a9f5730c495df13d2433918226509b8320ee75ac137d4dfed6579073bce809b098221c829b0e7294f8a3b2ac0f748d9a818919e11856dfe5ec1083cc49106f9ee4c97a2edf8047c5faa201ff2726007636b0b17b9566e7f7a3851dd1a1779b7a0404f2952438f79a7543854b86c17973c5764dba59937a8c74cfbb866d7dd207c2e9be4d6441ce6057feb1fdebdbdb40c191ab9dde7e0402a850765a05d75a8df02e7d675d8a4b1155581032ac80272e5f361e52d571914987e6fc36dd18abce0928acf9f613aebb395c67188b0a4fa2ab8d6af2c80ed9573285253a35552e071eb8b86a70cf194211e9e21ee9e2f4f29e26f90229e9cfc1775f2b6f7ed05470e4d909ff2a6e3ed132eb3be4fe913b63738e8ef0f072f8bd76cbc870ff6bcf0bf46aeb637f342fb458f8d0e07872059bba8e9d08c06df8066ad4b5a90cc2fa66f3327b2523197c717f8eb557aa4ce087ae210b2e584b58ca189b7d38c648336f3a7f3fd0334967b47fbccdbc8bf2f00547e7f0d7c861707804e80e2d578b0ff0c0d98f1e01d0ff69eb1e7ff183df30d59c1bd1c2fbec0c667e41743b05867f151b2f6eec359fb76058e8384cb44f8534af83ea6105381c3a237ff6ad965bf3d6d93d03382d36cd15b6c7b3b4f141f49abbb2f612c3d814ebe92f33e3952a7a13af083385084ff8100449049c30b5bc2eefeed1ef03ecaf23792eecacee5e4bd42ffe74dd696c7abcbe7f795a8797cc9d02da6a8d289c7d7d6117973f33b2abcf14f', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137741, 11196, 0.1, 0.2, 'mg/kg', 'PO', NULL, 'Adult', X'789c33d033d435d033ca4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca000093f509a3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137742, 11196, 0.15, 0.2, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d03334d535d033ca4dd7cf4ed74f49ac5408f05748c92ccb4c494d51283434ca00009abb09d8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137743, 4278, 20.0, 20.0, 'mg', 'IN', NULL, 'Adult', X'789c3332c84d57a830d451484c49c92cc9cccf4bcc51300289a5e417a72a64e629581ae402c9cc3485e4920a8582d4a2e2cce2121d85b4fc9c9cfcf2d41485a44a88f242635d0b858ca2628580203f90520003321ce0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137744, 4278, 30.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789c3336d03533c84d57700d5208f0574849cccca904002fd20574', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137745, 4278, 0.25, 0.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d03332d535d033cd4dd7cf4e5708f0572834d135cb00003d1505aa', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137746, 4278, 10.0, 10.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523034c84dd74fc92f4e55282d5028c95730d435020a6403c5122b01afa50a8a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137747, 4278, 0.6, 0.9, 'mg/kg', 'PO', 3, 'Pediatric', X'789c33d033d335d0b3cc4dd7cf4ed74f49ac5408f05748c92ccb4c494d5128c94cd10df4740100b58a0abf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137748, 2758, 150.0, 450.0, 'mg', 'PO', NULL, 'Adult', X'789c333435d0353135c84d5708f0572834cb00001fba041f', X'789ced5ced73da4613ff576efce1193c3518f0eb433a99c176e2b83131358e279d92d11cd221ae96ee943bc931edf87f7f764f4248202caca47d92860f4d82d8fddddebeddeeeae85f5b8e8a5c4b509f6d75c8d6a9c78543fda9cdc5d60ed98a94874f276118e8ceeeee677ec7fc86542efe8bef2e106b5bd18039160d91a7dd6c1fd69bad7aab79d33cea1c343b7b878de3bdbda3bd7d43cbec904ba181f2afad732698a29ef977c81e0cfbcd34601d72154e981a0a2a423ee232e4f6509c494d5d465e4be5eb0eb9e8ed908bdb1dd2bf22b5a303df7d415a074dfc6baf69fec267bb07fee5f6509c4adf9782dc28ea30f20ef60beca71e9333e9a35156a8477814d291c7f0d3ef1fe1136cf6ce7c980b3997ab5c59dd39ede34744ef3a91175ab01d2edcdcd60ba499a9c86ae728fb579da1800dd7f771d3a8844f8793a178cd950e0920830673df3e90d650f4e843879847bb0e9018d571612b46357388e2fa8ec831a8ab411c3e867fd0904cb80b762048ae4193173d5cb6dd6cd6db474d8343a76009a0bfe70e607c3aacb7da0b721c222112cd65386ca6325cf400f5b600f4b60cb4fedf18f83606de3fcef06ee56d884a3f659e17793ce4daea4badf9c89b5a4ec4ac505abdeb41d7aabd171e7238d67bcdb673ca3e6c82004d72e776d0b9082cfaebf19b0679090ff1196874f66c287e6f7f2c587c102a1634acfe84aaa9705188dc02c6658d118f71334d02bbd0053027d40e99e2e00db7d4e5021c288f9309cba148414f2ece00f5681568ffe26cc1b548adc73da7ee4b074c9e7530146edfe00c0568897ce621d8c566e310847a90820d8554043ecb07d8a3d80d941c81fbdadc217c4c8424f0c066cc01bf47bb815268e83311a20b90da80dd33c560c9d4b09f8eb3ebb840497d6e36478543343cb6272494281d1d8366487b7f022e4c6cd003b7a947b80f2bde335ca3509d23a6f992160f631b1b73e0968fea894586a2eb85c607ea87a988870b24592fcd511a2f3de7f7b3edfc1a8190a8b2daa151f1cdc5d9f60b12614cdc9231e8511b7d102ec6b37cb0b085b5325512cd6be4f48665080175ce9db1ed1a0819e21ccadc72e520e773da1c46a2ae728019619c6b37e9b362fa5c3c8736f973933f37f9f387cb9f55236f317d6c426f137acf0dbdef3e78be8ed32f86d2c6eb375eff2d7bfd0fe49fcba7dcc641bf7d07fd1ead54654859357e219e2818cd7eee88f26226b1350bbd1cebcf2df2993168923d67287e6edfb9d0b662cf7937eb8377b35d6bab9dd7e981a14ca88c4e5fc610072b218e276510894475d222be14689d9f5b8d72c9ca711bedfa974b176fb0bd5a92c33a8224ceb99a6a71a1fa51a360b116e9a10a4019a713c8d68a41566c1fd4f7cb96cfcd151ac0d1da6bec2dc1c7c393c631c92081e88e0417b621bcf5dfbd58413951e0b7e69cea49079e870bee0b5414e424ffc9e8279e2335ebed8c99217f3c2174bb71503f9e899c9b2cb55279fb57382a0299cd902a07beac9485ccd338cae06754f2b4ead379d8bc9f2b9a87a5df9649fd8f9b72bde9142b1c4f81fd5a7b89b0385333f2291deff3a038c3a319f70bcd98d977819c57a191b1872976c7eada51c872b2b47d593f984aec06721acc3a95399c52a970bab70e43ba91a2f11a17912ee8edcb44a82f156f58abf107ee3312d76d8174247e5c35d30ba52d6d28ac560e188e52152fecdb287b2f9d8416f984f4fd48f0705aefda9f22aec0f67dc12248f49c5ab5977bbe5c0870281921f4ebc9d9056e9cf3e105075e50c0acc845b6271497701e3d618c7975b230b46e2fc22e0555be2259981543748ab1ec90d4549fe6e5c19a35e0b7e4c28b45c8c687373ebcb60fff33ceb2e4a21b6ff93ebde5abdb6de9e5dac6707f87e1fe1ff2addfa8c7be15301b07c47d19441e9d7b443a3c53cc1554d853720ddf0ae8073be464282ea91d1aeaf8bdb30ddd8a2b15671abfbfdc7f41a0ae6750c38ef0ed74487ceedded0a1912c56c703526609f4371cd04f548dce4939ab99504dd4ddafe6f0fc53b49a8f347a493a11a7cd451107866fe65661513e64b20f7a6a063cc8001533c948201eeecf150bc6101c86a3f67a5731c9be3571d32600cbe420e271e47549c862c6ab27c2c92725809476ef8b4d204e5c029ab85ac5686f531c9e32254940b87db052e513878f4a87d679dc8871ce51bee4e62e9c056e9cd046e730f5c986a2dc1f542f0783083521346d1253453f72c9943292e239d194491cf139c4c85e64f30387a14f5c0d10488790f98675cdb203b9caef03df819da9779531cd66aee0a0e6b430f9daeb743e8c8913e4737b415f503bd639c0844c39b7e724c469e940e3ef3231b4431c116159e7db3667e2fa781aee731e54e71a66b7b00bb8b771ee1f4f66cecf07128674bd3367ec9bb61a3d0b55f10c7d4c924f2c733dbaae1e17765b7af20f433cf89ae0327bd66d635a3f67a296110fb418e6e0d57ba9928e98fa43d0d65c0a0fc188aaea0c164ead107cce583104a0ea1ebbfc889d090fb0653e10003a09d2b2a222fcbf84acb6042dd223325c5aa1439f1ce5229de5170174af0adcc2d785a7cf27553afeb537c67734df504ca9948e10a43f10b8d30638228ef151c3754a10c6fa6810c4160504bbab760e2b111f2901a1cfb11ce83fe692fca1e248b1a2fc75ae2c8e165ecb5cee5e439710e6595a1cb211738ad9433873fb375395e4a99e32ff09072a898c902262b65caeb2ee7626ba86f466f19fa1c16ba673982a1caf1cdfcb89c37a5ccf1a7de5f0e3027cd216482a61c234b9cdc19fad6324f51bbb5493d9bd4b3493dffb6d4f3ad4576954675e39eff5af7c4d9a14fa10b90ee34dff2516f5cf7f8d8bc5adcafef810bf618780af40bdaef904b681ed40b72fa5b7fffa009c7db83ad183a5587bc575cb01d02ad1ece7e7acc9e50012cd88475ed9824b985287568a630d0958de2273677a8b7431c0699dc5ca1825c3b8adc5de805f1bdb032b3874abd0a189eeb19c0d20f2fd2cb30641c791e71b15742813f53bc725543669fffc9088b4f711c2645490f25c576c2af03c5a843a8926069ec6d715487ad5700e1086a875e4bc08ea16d858638f289072783a793df601804a075180bc845a3d7803e3744055e4b50129b7d3a93a657660f78c72cf92546002272f147ac0ebc67d63174efae6e888ba85413b05aa4934546d045e3280e422ac4a11974e5113a04916051f2b285178508ec38320bf6e803c19b07c97d8ef839a9393939f0b71ef0e544466a1bdf4a9b363c6b32a2e13bcfc9f11c23dc650563a62e65c9b115bbd4427ad52a0a428d7a0f1987c5a702ac81f340d8fb88c79e85f639686aa2f8486a389009488103ef2ade95fe9cd21a607041630dffb1f286f82dcbc7dc602874a46d16009ec776750206fa8e74443d6f8abfd8198ad87cf14c84d4ee31278cbc29c9b22adc2efa1a705c0f45fa91d420d88c15c66616831380e426a1411ffc04224c05532ed04368262f9420263e030599ffc8145f3801692a21ce79dedf5c40c082243581269fea90f980918e7d00ff436b280478390de1d0fad086ba3b1602ac043a537207c23d340246f813a6b96c40bdf704f59c30b33394e91ca231205da2f18d0909e66f4a30eb6406524e64c2ef55838c2903203c693fec5759315969f6b2e4e96a1a0e5923215a1f9a069ff465ac5064bb52aef1f3b802c55f3dccb6b3434e76c8e90e39df32cdcdcce7a686323e1f52d81548e9db1c5601e3962bc8d4a036b3d902800fadf5a4a0c2dc428f34712bc1bcc25030efc1006266b902a0ebe7e2f0c8af00d31b0cba15d48917822aac76daadafe0bc28d53e343a0df22ae00e1e044e259d41cbf70783faa29aaa2e1b78c1d1b46d2e13ac488025eb9b0879c75c33bad48b88ef1ac40544a83f252bf4ea329100c0870ed2e4876a2ae949451f205b527cf982957045777cd3c0dce4454cfc59692790c670b05b81f32df40c9ae316745140aeb9f0ee1c86bc1a9c5cfe54056a09e96dffb4129089edb8c2d4c10ee9fac12911ccfd5a5081ac62e20153581b15abb93c7d26dcc4a7ca3697262bc9403d88c1cac61e4cb85b99b98fc519245b9f2b3ae2c56152aa8619c87de4b9500655d10140e04b7661833275d0a82205443d7c302e5a11e1146b8bd8adc85831ec148b82f759380e766870b27e294ec52d7519763d029a8f6a1edeb5a18d0c9f16a2d4b69a454e2205859ecbd41ab402d049a4ee26d273f00e0094c301b579159801345c12341b4c12a17cea85f009dcbf0adc6f605f2842697cb542c6aff2ec2a48af158500d0c685c3c8a30ad92b79ce898aec2722a1b42a602e975f144a7d0a6d47a40c841f817a71a65005e80d65beb14d84dd81add8b43024dba5a5f248718919cabcb55e2f1e7b5cdb4b3139f1a83f758c48b438a8cacabeded49601e46b7fde9e54a92eaeb97dc7c250f3156294274c902399f8443ea1f7c515e4124c57503c7d972b3f1c0208e94fedc232b2acfa8ea751120e0128fd1575571c4665caed2b760fa791f13be6c16381856d713c968974ea49e8aca00805f5e45eab3c3b9167806ad8b6a668db15b6f83ad219bb09669b54a60aad57b6c53e5e60d4f37b8c915e11f100f47179e6b2199dfc18a393e75e5e64ccea7a5ae67c633e9fd3a4d6a35c547e11528cb4eeff6c4d5b09cfe3c7c7c7c7ff01babff34a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137749, 2758, 150.0, 450.0, 'mg', 'PO', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303435d0353135c84d5708f057a8503004007c6407e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137750, 2758, 450.0, 450.0, 'mg', 'PO', NULL, 'Adult', X'789cf34dacb052303135c84dd74fc92f4e5508f057d0c8cc4b2e4a4d2c4e4d5128ca2cce56c84f0300dde20c4b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137751, 2758, 1200.0, 2700.0, 'mg', 'IM', NULL, 'Adult', X'789c33343230d035323730c84dd74f49ac54f0f45548c92ccb4c494d512834d33534ca000096330969', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137752, 2758, 600.0, 600.0, 'mg', 'IM', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303330c84d57f0f455a85030040060c50717', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137753, 2758, 600.0, 600.0, 'mg', 'IM', NULL, 'Adult', X'789cf34dacb052303330c84dd74fc92f4e55f0f405003362057b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137754, 2758, 1200.0, 2700.0, 'mg', 'IV', NULL, 'Adult', X'789c33343230d035323730c84dd74f49ac54f00c5348c92ccb4c494d512834d33534ca000096c30972', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137755, 2758, 600.0, 900.0, 'mg', 'IV', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303330d0b53430c84d57f00c53a8503004007c6707e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137756, 2758, 4800.0, 4800.0, 'mg', 'IV', NULL, 'Adult', X'789c33b13030c84dd74f49ac54f00c0300190003cd', X'789ced5ced73da4613ff576efce1193c3518f0eb433a99c176e2b83131358e279d92d11cd221ae96ee943bc931edf87f7f764f4248202caca47d92860f4d82d8fddddebeddeeeae85f5b8e8a5c4b509f6d75c8d6a9c78543fda9cdc5d60ed98a94874f276118e8ceeeee677ec7fc86542efe8bef2e106b5bd18039160d91a7dd6c1fd69bad7aab79d33cea1c343b7b878de3bdbda3bd7d43cbec904ba181f2afad732698a29ef977c81e0cfbcd34601d72154e981a0a2a423ee232e4f6509c494d5d465e4be5eb0eb9e8ed908bdb1dd2bf22b5a303df7d415a074dfc6baf69fec267bb07fee5f6509c4adf9782dc28ea30f20ef60beca71e9333e9a35156a8477814d291c7f0d3ef1fe1136cf6ce7c980b3997ab5c59dd39ede34744ef3a91175ab01d2edcdcd60ba499a9c86ae728fb579da1800dd7f771d3a8844f8793a178cd950e0920830673df3e90d650f4e843879847bb0e9018d571612b46357388e2fa8ec831a8ab411c3e867fd0904cb80b762048ae4193173d5cb6dd6cd6db474d8343a76009a0bfe70e607c3aacb7da0b721c222112cd65386ca6325cf400f5b600f4b60cb4fedf18f83606de3fcef06ee56d884a3f659e17793ce4daea4badf9c89b5a4ec4ac505abdeb41d7aabd171e7238d67bcdb673ca3e6c82004d72e776d0b9082cfaebf19b0679090ff1196874f66c287e6f7f2c587c102a1634acfe84aaa9705188dc02c6658d118f71334d02bbd0053027d40e99e2e00db7d4e5021c288f9309cba148414f2ece00f5681568ffe26cc1b548adc73da7ee4b074c9e7530146edfe00c0568897ce621d8c566e310847a90820d8554043ecb07d8a3d80d941c81fbdadc217c4c8424f0c066cc01bf47bb815268e83311a20b90da80dd33c560c9d4b09f8eb3ebb840497d6e36478543343cb6272494281d1d8366487b7f022e4c6cd003b7a947b80f2bde335ca3509d23a6f992160f631b1b73e0968fea894586a2eb85c607ea87a988870b24592fcd511a2f3de7f7b3edfc1a8190a8b2daa151f1cdc5d9f60b12614cdc9231e8511b7d102ec6b37cb0b085b5325512cd6be4f48665080175ce9db1ed1a0819e21ccadc72e520e773da1c46a2ae728019619c6b37e9b362fa5c3c8736f973933f37f9f387cb9f55236f317d6c426f137acf0dbdef3e78be8ed32f86d2c6eb375eff2d7bfd0fe49fcba7dcc641bf7d07fd1ead54654859357e219e2818cd7eee88f26226b1350bbd1cebcf2df2993168923d67287e6edfb9d0b662cf7937eb8377b35d6bab9dd7e981a14ca88c4e5fc610072b218e276510894475d222be14689d9f5b8d72c9ca711bedfa974b176fb0bd5a92c33a8224ceb99a6a71a1fa51a360b116e9a10a4019a713c8d68a41566c1fd4f7cb96cfcd151ac0d1da6bec2dc1c7c393c631c92081e88e0417b621bcf5dfbd58413951e0b7e69cea49079e870bee0b5414e424ffc9e8279e2335ebed8c99217f3c2174bb71503f9e899c9b2cb55279fb57382a0299cd902a07beac9485ccd338cae06754f2b4ead379d8bc9f2b9a87a5df9649fd8f9b72bde9142b1c4f81fd5a7b89b0385333f2291deff3a038c3a319f70bcd98d977819c57a191b1872976c7eada51c872b2b47d593f984aec06721acc3a95399c52a970bab70e43ba91a2f11a17912ee8edcb44a82f156f58abf107ee3312d76d8174247e5c35d30ba52d6d28ac560e188e52152fecdb287b2f9d8416f984f4fd48f0705aefda9f22aec0f67dc12248f49c5ab5977bbe5c0870281921f4ebc9d9056e9cf3e105075e50c0acc845b6271497701e3d618c7975b230b46e2fc22e0555be2259981543748ab1ec90d4549fe6e5c19a35e0b7e4c28b45c8c687373ebcb60fff33ceb2e4a21b6ff93ebde5abdb6de9e5dac6707f87e1fe1ff2addfa8c7be15301b07c47d19441e9d7b443a3c53cc1554d853720ddf0ae8073be464282ea91d1aeaf8bdb30ddd8a2b15671abfbfdc7f41a0ae6750c38ef0ed74487ceedded0a1912c56c703526609f4371cd04f548dce4939ab99504dd4ddafe6f0fc53b49a8f347a493a11a7cd451107866fe65661513e64b20f7a6a063cc8001533c948201eeecf150bc6101c86a3f67a5731c9be3571d32600cbe420e271e47549c862c6ab27c2c92725809476ef8b4d204e5c029ab85ac5686f531c9e32254940b87db052e513878f4a87d679dc8871ce51bee4e62e9c056e9cd046e730f5c986a2dc1f542f0783083521346d1253453f72c9943292e239d194491cf139c4c85e64f30387a14f5c0d10488790f98675cdb203b9caef03df819da9779531cd66aee0a0e6b430f9daeb743e8c8913e4737b415f503bd639c0844c39b7e724c469e940e3ef3231b4431c116159e7db3667e2fa781aee731e54e71a66b7b00bb8b771ee1f4f66cecf07128674bd3367ec9bb61a3d0b55f10c7d4c924f2c733dbaae1e17765b7af20f433cf89ae0327bd66d635a3f67a296110fb418e6e0d57ba9928e98fa43d0d65c0a0fc188aaea0c164ead107cce583104a0ea1ebbfc889d090fb0653e10003a09d2b2a222fcbf84acb6042dd223325c5aa1439f1ce5229de5170174af0adcc2d785a7cf27553afeb537c67734df504ca9948e10a43f10b8d30638228ef151c3754a10c6fa6810c4160504bbab760e2b111f2901a1cfb11ce83fe692fca1e248b1a2fc75ae2c8e165ecb5cee5e439710e6595a1cb211738ad9433873fb375395e4a99e32ff09072a898c902262b65caeb2ee7626ba86f466f19fa1c16ba673982a1caf1cdfcb89c37a5ccf1a7de5f0e3027cd216482a61c234b9cdc19fad6324f51bbb5493d9bd4b3493dffb6d4f3ad4576954675e39eff5af7c4d9a14fa10b90ee34dff2516f5cf7f8d8bc5adcafef810bf618780af40bdaef904b681ed40b72fa5b7fffa009c7db83ad183a5587bc575cb01d02ad1ece7e7acc9e50012cd88475ed9824b985287568a630d0958de2273677a8b7431c0699dc5ca1825c3b8adc5de805f1bdb032b3874abd0a189eeb19c0d20f2fd2cb30641c791e71b15742813f53bc725543669fffc9088b4f711c2645490f25c576c2af03c5a843a8926069ec6d715487ad5700e1086a875e4bc08ea16d858638f289072783a793df601804a075180bc845a3d7803e3744055e4b50129b7d3a93a657660f78c72cf92546002272f147ac0ebc67d63174efae6e888ba85413b05aa4934546d045e3280e422ac4a11974e5113a04916051f2b285178508ec38320bf6e803c19b07c97d8ef839a9393939f0b71ef0e544466a1bdf4a9b363c6b32a2e13bcfc9f11c23dc650563a62e65c9b115bbd4427ad52a0a428d7a0f1987c5a702ac81f340d8fb88c79e85f639686aa2f8486a389009488103ef2ade95fe9cd21a607041630dffb1f286f82dcbc7dc602874a46d16009ec776750206fa8e74443d6f8abfd8198ad87cf14c84d4ee31278cbc29c9b22adc2efa1a705c0f45fa91d420d88c15c66616831380e426a1411ffc04224c05532ed04368262f9420263e030599ffc8145f3801692a21ce79dedf5c40c082243581269fea90f980918e7d00ff436b280478390de1d0fad086ba3b1602ac043a537207c23d340246f813a6b96c40bdf704f59c30b33394e91ca231205da2f18d0909e66f4a30eb6406524e64c2ef55838c2903203c693fec5759315969f6b2e4e96a1a0e5923215a1f9a069ff465ac5064bb52aef1f3b802c55f3dccb6b3434e76c8e90e39df32cdcdcce7a686323e1f52d81548e9db1c5601e3962bc8d4a036b3d902800fadf5a4a0c2dc428f34712bc1bcc25030efc1006266b902a0ebe7e2f0c8af00d31b0cba15d48917822aac76daadafe0bc28d53e343a0df22ae00e1e044e259d41cbf70783faa29aaa2e1b78c1d1b46d2e13ac488025eb9b0879c75c33bad48b88ef1ac40544a83f252bf4ea329100c0870ed2e4876a2ae949451f205b527cf982957045777cd3c0dce4454cfc59692790c670b05b81f32df40c9ae316745140aeb9f0ee1c86bc1a9c5cfe54056a09e96dffb4129089edb8c2d4c10ee9fac12911ccfd5a5081ac62e20153581b15abb93c7d26dcc4a7ca3697262bc9403d88c1cac61e4cb85b99b98fc519245b9f2b3ae2c56152aa8619c87de4b9500655d10140e04b7661833275d0a82205443d7c302e5a11e1146b8bd8adc85831ec148b82f759380e766870b27e294ec52d7519763d029a8f6a1edeb5a18d0c9f16a2d4b69a454e2205859ecbd41ab402d049a4ee26d273f00e0094c301b579159801345c12341b4c12a17cea85f009dcbf0adc6f605f2842697cb542c6aff2ec2a48af158500d0c685c3c8a30ad92b79ce898aec2722a1b42a602e975f144a7d0a6d47a40c841f817a71a65005e80d65beb14d84dd81add8b43024dba5a5f248718919cabcb55e2f1e7b5cdb4b3139f1a83f758c48b438a8cacabeded49601e46b7fde9e54a92eaeb97dc7c250f3156294274c902399f8443ea1f7c515e4124c57503c7d972b3f1c0208e94fedc232b2acfa8ea751120e0128fd1575571c4665caed2b760fa791f13be6c16381856d713c968974ea49e8aca00805f5e45eab3c3b9167806ad8b6a668db15b6f83ad219bb09669b54a60aad57b6c53e5e60d4f37b8c915e11f100f47179e6b2199dfc18a393e75e5e64ccea7a5ae67c633e9fd3a4d6a35c547e11528cb4eeff6c4d5b09cfe3c7c7c7c7ff01babff34a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137757, 2758, 300.0, 300.0, 'mg', NULL, NULL, 'Adult', X'789c3333d035343250c84eb75230363050c84d5708b4f0d053b0030a82c44c4ce16200cf2609e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137758, 2758, 300.0, 300.0, 'mg', 'PO', NULL, 'Adult', X'789c333630c84d5708f05728b450a8503034504849ac2c06003c1205da', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137759, 2758, 300.0, 300.0, 'mg', 'PO', 2, 'Adult', X'789c333630c84d5708f05770f27451a85030574849ac2c06003b5c05d6', X'789ced5ced73da4613ff576efce1193c3518f0eb433a99c176e2b83131358e279d92d11cd221ae96ee943bc931edf87f7f764f4248202caca47d92860f4d82d8fddddebeddeeeae85f5b8e8a5c4b509f6d75c8d6a9c78543fda9cdc5d60ed98a94874f276118e8ceeeee677ec7fc86542efe8bef2e106b5bd18039160d91a7dd6c1fd69bad7aab79d33cea1c343b7b878de3bdbda3bd7d43cbec904ba181f2afad732698a29ef977c81e0cfbcd34601d72154e981a0a2a423ee232e4f6509c494d5d465e4be5eb0eb9e8ed908bdb1dd2bf22b5a303df7d415a074dfc6baf69fec267bb07fee5f6509c4adf9782dc28ea30f20ef60beca71e9333e9a35156a8477814d291c7f0d3ef1fe1136cf6ce7c980b3997ab5c59dd39ede34744ef3a91175ab01d2edcdcd60ba499a9c86ae728fb579da1800dd7f771d3a8844f8793a178cd950e0920830673df3e90d650f4e843879847bb0e9018d571612b46357388e2fa8ec831a8ab411c3e867fd0904cb80b762048ae4193173d5cb6dd6cd6db474d8343a76009a0bfe70e607c3aacb7da0b721c222112cd65386ca6325cf400f5b600f4b60cb4fedf18f83606de3fcef06ee56d884a3f659e17793ce4daea4badf9c89b5a4ec4ac505abdeb41d7aabd171e7238d67bcdb673ca3e6c82004d72e776d0b9082cfaebf19b0679090ff1196874f66c287e6f7f2c587c102a1634acfe84aaa9705188dc02c6658d118f71334d02bbd0053027d40e99e2e00db7d4e5021c288f9309cba148414f2ece00f5681568ffe26cc1b548adc73da7ee4b074c9e7530146edfe00c0568897ce621d8c566e310847a90820d8554043ecb07d8a3d80d941c81fbdadc217c4c8424f0c066cc01bf47bb815268e83311a20b90da80dd33c560c9d4b09f8eb3ebb840497d6e36478543343cb6272494281d1d8366487b7f022e4c6cd003b7a947b80f2bde335ca3509d23a6f992160f631b1b73e0968fea894586a2eb85c607ea87a988870b24592fcd511a2f3de7f7b3edfc1a8190a8b2daa151f1cdc5d9f60b12614cdc9231e8511b7d102ec6b37cb0b085b5325512cd6be4f48665080175ce9db1ed1a0819e21ccadc72e520e773da1c46a2ae728019619c6b37e9b362fa5c3c8736f973933f37f9f387cb9f55236f317d6c426f137acf0dbdef3e78be8ed32f86d2c6eb375eff2d7bfd0fe49fcba7dcc641bf7d07fd1ead54654859357e219e2818cd7eee88f26226b1350bbd1cebcf2df2993168923d67287e6edfb9d0b662cf7937eb8377b35d6bab9dd7e981a14ca88c4e5fc610072b218e276510894475d222be14689d9f5b8d72c9ca711bedfa974b176fb0bd5a92c33a8224ceb99a6a71a1fa51a360b116e9a10a4019a713c8d68a41566c1fd4f7cb96cfcd151ac0d1da6bec2dc1c7c393c631c92081e88e0417b621bcf5dfbd58413951e0b7e69cea49079e870bee0b5414e424ffc9e8279e2335ebed8c99217f3c2174bb71503f9e899c9b2cb55279fb57382a0299cd902a07beac9485ccd338cae06754f2b4ead379d8bc9f2b9a87a5df9649fd8f9b72bde9142b1c4f81fd5a7b89b0385333f2291deff3a038c3a319f70bcd98d977819c57a191b1872976c7eada51c872b2b47d593f984aec06721acc3a95399c52a970bab70e43ba91a2f11a17912ee8edcb44a82f156f58abf107ee3312d76d8174247e5c35d30ba52d6d28ac560e188e52152fecdb287b2f9d8416f984f4fd48f0705aefda9f22aec0f67dc12248f49c5ab5977bbe5c0870281921f4ebc9d9056e9cf3e105075e50c0acc845b6271497701e3d618c7975b230b46e2fc22e0555be2259981543748ab1ec90d4549fe6e5c19a35e0b7e4c28b45c8c687373ebcb60fff33ceb2e4a21b6ff93ebde5abdb6de9e5dac6707f87e1fe1ff2addfa8c7be15301b07c47d19441e9d7b443a3c53cc1554d853720ddf0ae8073be464282ea91d1aeaf8bdb30ddd8a2b15671abfbfdc7f41a0ae6750c38ef0ed74487ceedded0a1912c56c703526609f4371cd04f548dce4939ab99504dd4ddafe6f0fc53b49a8f347a493a11a7cd451107866fe65661513e64b20f7a6a063cc8001533c948201eeecf150bc6101c86a3f67a5731c9be3571d32600cbe420e271e47549c862c6ab27c2c92725809476ef8b4d204e5c029ab85ac5686f531c9e32254940b87db052e513878f4a87d679dc8871ce51bee4e62e9c056e9cd046e730f5c986a2dc1f542f0783083521346d1253453f72c9943292e239d194491cf139c4c85e64f30387a14f5c0d10488790f98675cdb203b9caef03df819da9779531cd66aee0a0e6b430f9daeb743e8c8913e4737b415f503bd639c0844c39b7e724c469e940e3ef3231b4431c116159e7db3667e2fa781aee731e54e71a66b7b00bb8b771ee1f4f66cecf07128674bd3367ec9bb61a3d0b55f10c7d4c924f2c733dbaae1e17765b7af20f433cf89ae0327bd66d635a3f67a296110fb418e6e0d57ba9928e98fa43d0d65c0a0fc188aaea0c164ead107cce583104a0ea1ebbfc889d090fb0653e10003a09d2b2a222fcbf84acb6042dd223325c5aa1439f1ce5229de5170174af0adcc2d785a7cf27553afeb537c67734df504ca9948e10a43f10b8d30638228ef151c3754a10c6fa6810c4160504bbab760e2b111f2901a1cfb11ce83fe692fca1e248b1a2fc75ae2c8e165ecb5cee5e439710e6595a1cb211738ad9433873fb375395e4a99e32ff09072a898c902262b65caeb2ee7626ba86f466f19fa1c16ba673982a1caf1cdfcb89c37a5ccf1a7de5f0e3027cd216482a61c234b9cdc19fad6324f51bbb5493d9bd4b3493dffb6d4f3ad4576954675e39eff5af7c4d9a14fa10b90ee34dff2516f5cf7f8d8bc5adcafef810bf618780af40bdaef904b681ed40b72fa5b7fffa009c7db83ad183a5587bc575cb01d02ad1ece7e7acc9e50012cd88475ed9824b985287568a630d0958de2273677a8b7431c0699dc5ca1825c3b8adc5de805f1bdb032b3874abd0a189eeb19c0d20f2fd2cb30641c791e71b15742813f53bc725543669fffc9088b4f711c2645490f25c576c2af03c5a843a8926069ec6d715487ad5700e1086a875e4bc08ea16d858638f289072783a793df601804a075180bc845a3d7803e3744055e4b50129b7d3a93a657660f78c72cf92546002272f147ac0ebc67d63174efae6e888ba85413b05aa4934546d045e3280e422ac4a11974e5113a04916051f2b285178508ec38320bf6e803c19b07c97d8ef839a9393939f0b71ef0e544466a1bdf4a9b363c6b32a2e13bcfc9f11c23dc650563a62e65c9b115bbd4427ad52a0a428d7a0f1987c5a702ac81f340d8fb88c79e85f639686aa2f8486a389009488103ef2ade95fe9cd21a607041630dffb1f286f82dcbc7dc602874a46d16009ec776750206fa8e74443d6f8abfd8198ad87cf14c84d4ee31278cbc29c9b22adc2efa1a705c0f45fa91d420d88c15c66616831380e426a1411ffc04224c05532ed04368262f9420263e030599ffc8145f3801692a21ce79dedf5c40c082243581269fea90f980918e7d00ff436b280478390de1d0fad086ba3b1602ac043a537207c23d340246f813a6b96c40bdf704f59c30b33394e91ca231205da2f18d0909e66f4a30eb6406524e64c2ef55838c2903203c693fec5759315969f6b2e4e96a1a0e5923215a1f9a069ff465ac5064bb52aef1f3b802c55f3dccb6b3434e76c8e90e39df32cdcdcce7a686323e1f52d81548e9db1c5601e3962bc8d4a036b3d902800fadf5a4a0c2dc428f34712bc1bcc25030efc1006266b902a0ebe7e2f0c8af00d31b0cba15d48917822aac76daadafe0bc28d53e343a0df22ae00e1e044e259d41cbf70783faa29aaa2e1b78c1d1b46d2e13ac488025eb9b0879c75c33bad48b88ef1ac40544a83f252bf4ea329100c0870ed2e4876a2ae949451f205b527cf982957045777cd3c0dce4454cfc59692790c670b05b81f32df40c9ae316745140aeb9f0ee1c86bc1a9c5cfe54056a09e96dffb4129089edb8c2d4c10ee9fac12911ccfd5a5081ac62e20153581b15abb93c7d26dcc4a7ca3697262bc9403d88c1cac61e4cb85b99b98fc519245b9f2b3ae2c56152aa8619c87de4b9500655d10140e04b7661833275d0a82205443d7c302e5a11e1146b8bd8adc85831ec148b82f759380e766870b27e294ec52d7519763d029a8f6a1edeb5a18d0c9f16a2d4b69a454e2205859ecbd41ab402d049a4ee26d273f00e0094c301b579159801345c12341b4c12a17cea85f009dcbf0adc6f605f2842697cb542c6aff2ec2a48af158500d0c685c3c8a30ad92b79ce898aec2722a1b42a602e975f144a7d0a6d47a40c841f817a71a65005e80d65beb14d84dd81add8b43024dba5a5f248718919cabcb55e2f1e7b5cdb4b3139f1a83f758c48b438a8cacabeded49601e46b7fde9e54a92eaeb97dc7c250f3156294274c902399f8443ea1f7c515e4124c57503c7d972b3f1c0208e94fedc232b2acfa8ea751120e0128fd1575571c4665caed2b760fa791f13be6c16381856d713c968974ea49e8aca00805f5e45eab3c3b9167806ad8b6a668db15b6f83ad219bb09669b54a60aad57b6c53e5e60d4f37b8c915e11f100f47179e6b2199dfc18a393e75e5e64ccea7a5ae67c633e9fd3a4d6a35c547e11528cb4eeff6c4d5b09cfe3c7c7c7c7ff01babff34a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137760, 2758, 450.0, 450.0, 'mg', 'PO', NULL, 'Adult', X'789c333135c84d5708f0572834cb50a8503034514849ac2c060043f9064a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137761, 2758, 900.0, 900.0, 'mg', 'IV', NULL, 'Adult', X'789cb33430c84d57f00c5328b40000114602f6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137762, 2758, 600.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c33333050c84d5708f05728b4c850a85030d73534504849ac2c0600529006c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137763, 2758, 300.0, 600.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc29b152303630d0353330c84d57f00c532834cb50a85030d73534504849ac2c0600916108e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137764, 2758, 300.0, 600.0, 'mg', 'IV', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb552303630d0353330c84d57f00c53a8503004007c1307e0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137765, 2758, 650.0, 650.0, 'mg', 'IV', 3, 'Adult', X'789cd3303335c84d5708f174d1b456282d4e55f00c5348cb2f52284e2d4b2d4a55c8cc4b4b4d2ec9cccf2b0600fdce0d8c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137766, 2758, 10.0, 10.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834340200875b0915', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137767, 2758, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230cd4dd7cf4e57f0f4d5f70c53a85030040085700885', X'789ced5ced73da4613ff576efce1193c3518f0eb433a99c176e2b83131358e279d92d11cd221ae96ee943bc931edf87f7f764f4248202caca47d92860f4d82d8fddddebeddeeeae85f5b8e8a5c4b509f6d75c8d6a9c78543fda9cdc5d60ed98a94874f276118e8ceeeee677ec7fc86542efe8bef2e106b5bd18039160d91a7dd6c1fd69bad7aab79d33cea1c343b7b878de3bdbda3bd7d43cbec904ba181f2afad732698a29ef977c81e0cfbcd34601d72154e981a0a2a423ee232e4f6509c494d5d465e4be5eb0eb9e8ed908bdb1dd2bf22b5a303df7d415a074dfc6baf69fec267bb07fee5f6509c4adf9782dc28ea30f20ef60beca71e9333e9a35156a8477814d291c7f0d3ef1fe1136cf6ce7c980b3997ab5c59dd39ede34744ef3a91175ab01d2edcdcd60ba499a9c86ae728fb579da1800dd7f771d3a8844f8793a178cd950e0920830673df3e90d650f4e843879847bb0e9018d571612b46357388e2fa8ec831a8ab411c3e867fd0904cb80b762048ae4193173d5cb6dd6cd6db474d8343a76009a0bfe70e607c3aacb7da0b721c222112cd65386ca6325cf400f5b600f4b60cb4fedf18f83606de3fcef06ee56d884a3f659e17793ce4daea4badf9c89b5a4ec4ac505abdeb41d7aabd171e7238d67bcdb673ca3e6c82004d72e776d0b9082cfaebf19b0679090ff1196874f66c287e6f7f2c587c102a1634acfe84aaa9705188dc02c6658d118f71334d02bbd0053027d40e99e2e00db7d4e5021c288f9309cba148414f2ece00f5681568ffe26cc1b548adc73da7ee4b074c9e7530146edfe00c0568897ce621d8c566e310847a90820d8554043ecb07d8a3d80d941c81fbdadc217c4c8424f0c066cc01bf47bb815268e83311a20b90da80dd33c560c9d4b09f8eb3ebb840497d6e36478543343cb6272494281d1d8366487b7f022e4c6cd003b7a947b80f2bde335ca3509d23a6f992160f631b1b73e0968fea894586a2eb85c607ea87a988870b24592fcd511a2f3de7f7b3edfc1a8190a8b2daa151f1cdc5d9f60b12614cdc9231e8511b7d102ec6b37cb0b085b5325512cd6be4f48665080175ce9db1ed1a0819e21ccadc72e520e773da1c46a2ae728019619c6b37e9b362fa5c3c8736f973933f37f9f387cb9f55236f317d6c426f137acf0dbdef3e78be8ed32f86d2c6eb375eff2d7bfd0fe49fcba7dcc641bf7d07fd1ead54654859357e219e2818cd7eee88f26226b1350bbd1cebcf2df2993168923d67287e6edfb9d0b662cf7937eb8377b35d6bab9dd7e981a14ca88c4e5fc610072b218e276510894475d222be14689d9f5b8d72c9ca711bedfa974b176fb0bd5a92c33a8224ceb99a6a71a1fa51a360b116e9a10a4019a713c8d68a41566c1fd4f7cb96cfcd151ac0d1da6bec2dc1c7c393c631c92081e88e0417b621bcf5dfbd58413951e0b7e69cea49079e870bee0b5414e424ffc9e8279e2335ebed8c99217f3c2174bb71503f9e899c9b2cb55279fb57382a0299cd902a07beac9485ccd338cae06754f2b4ead379d8bc9f2b9a87a5df9649fd8f9b72bde9142b1c4f81fd5a7b89b0385333f2291deff3a038c3a319f70bcd98d977819c57a191b1872976c7eada51c872b2b47d593f984aec06721acc3a95399c52a970bab70e43ba91a2f11a17912ee8edcb44a82f156f58abf107ee3312d76d8174247e5c35d30ba52d6d28ac560e188e52152fecdb287b2f9d8416f984f4fd48f0705aefda9f22aec0f67dc12248f49c5ab5977bbe5c0870281921f4ebc9d9056e9cf3e105075e50c0acc845b6271497701e3d618c7975b230b46e2fc22e0555be2259981543748ab1ec90d4549fe6e5c19a35e0b7e4c28b45c8c687373ebcb60fff33ceb2e4a21b6ff93ebde5abdb6de9e5dac6707f87e1fe1ff2addfa8c7be15301b07c47d19441e9d7b443a3c53cc1554d853720ddf0ae8073be464282ea91d1aeaf8bdb30ddd8a2b15671abfbfdc7f41a0ae6750c38ef0ed74487ceedded0a1912c56c703526609f4371cd04f548dce4939ab99504dd4ddafe6f0fc53b49a8f347a493a11a7cd451107866fe65661513e64b20f7a6a063cc8001533c948201eeecf150bc6101c86a3f67a5731c9be3571d32600cbe420e271e47549c862c6ab27c2c92725809476ef8b4d204e5c029ab85ac5686f531c9e32254940b87db052e513878f4a87d679dc8871ce51bee4e62e9c056e9cd046e730f5c986a2dc1f542f0783083521346d1253453f72c9943292e239d194491cf139c4c85e64f30387a14f5c0d10488790f98675cdb203b9caef03df819da9779531cd66aee0a0e6b430f9daeb743e8c8913e4737b415f503bd639c0844c39b7e724c469e940e3ef3231b4431c116159e7db3667e2fa781aee731e54e71a66b7b00bb8b771ee1f4f66cecf07128674bd3367ec9bb61a3d0b55f10c7d4c924f2c733dbaae1e17765b7af20f433cf89ae0327bd66d635a3f67a296110fb418e6e0d57ba9928e98fa43d0d65c0a0fc188aaea0c164ead107cce583104a0ea1ebbfc889d090fb0653e10003a09d2b2a222fcbf84acb6042dd223325c5aa1439f1ce5229de5170174af0adcc2d785a7cf27553afeb537c67734df504ca9948e10a43f10b8d30638228ef151c3754a10c6fa6810c4160504bbab760e2b111f2901a1cfb11ce83fe692fca1e248b1a2fc75ae2c8e165ecb5cee5e439710e6595a1cb211738ad9433873fb375395e4a99e32ff09072a898c902262b65caeb2ee7626ba86f466f19fa1c16ba673982a1caf1cdfcb89c37a5ccf1a7de5f0e3027cd216482a61c234b9cdc19fad6324f51bbb5493d9bd4b3493dffb6d4f3ad4576954675e39eff5af7c4d9a14fa10b90ee34dff2516f5cf7f8d8bc5adcafef810bf618780af40bdaef904b681ed40b72fa5b7fffa009c7db83ad183a5587bc575cb01d02ad1ece7e7acc9e50012cd88475ed9824b985287568a630d0958de2273677a8b7431c0699dc5ca1825c3b8adc5de805f1bdb032b3874abd0a189eeb19c0d20f2fd2cb30641c791e71b15742813f53bc725543669fffc9088b4f711c2645490f25c576c2af03c5a843a8926069ec6d715487ad5700e1086a875e4bc08ea16d858638f289072783a793df601804a075180bc845a3d7803e3744055e4b50129b7d3a93a657660f78c72cf92546002272f147ac0ebc67d63174efae6e888ba85413b05aa4934546d045e3280e422ac4a11974e5113a04916051f2b285178508ec38320bf6e803c19b07c97d8ef839a9393939f0b71ef0e544466a1bdf4a9b363c6b32a2e13bcfc9f11c23dc650563a62e65c9b115bbd4427ad52a0a428d7a0f1987c5a702ac81f340d8fb88c79e85f639686aa2f8486a389009488103ef2ade95fe9cd21a607041630dffb1f286f82dcbc7dc602874a46d16009ec776750206fa8e74443d6f8abfd8198ad87cf14c84d4ee31278cbc29c9b22adc2efa1a705c0f45fa91d420d88c15c66616831380e426a1411ffc04224c05532ed04368262f9420263e030599ffc8145f3801692a21ce79dedf5c40c082243581269fea90f980918e7d00ff436b280478390de1d0fad086ba3b1602ac043a537207c23d340246f813a6b96c40bdf704f59c30b33394e91ca231205da2f18d0909e66f4a30eb6406524e64c2ef55838c2903203c693fec5759315969f6b2e4e96a1a0e5923215a1f9a069ff465ac5064bb52aef1f3b802c55f3dccb6b3434e76c8e90e39df32cdcdcce7a686323e1f52d81548e9db1c5601e3962bc8d4a036b3d902800fadf5a4a0c2dc428f34712bc1bcc25030efc1006266b902a0ebe7e2f0c8af00d31b0cba15d48917822aac76daadafe0bc28d53e343a0df22ae00e1e044e259d41cbf70783faa29aaa2e1b78c1d1b46d2e13ac488025eb9b0879c75c33bad48b88ef1ac40544a83f252bf4ea329100c0870ed2e4876a2ae949451f205b527cf982957045777cd3c0dce4454cfc59692790c670b05b81f32df40c9ae316745140aeb9f0ee1c86bc1a9c5cfe54056a09e96dffb4129089edb8c2d4c10ee9fac12911ccfd5a5081ac62e20153581b15abb93c7d26dcc4a7ca3697262bc9403d88c1cac61e4cb85b99b98fc519245b9f2b3ae2c56152aa8619c87de4b9500655d10140e04b7661833275d0a82205443d7c302e5a11e1146b8bd8adc85831ec148b82f759380e766870b27e294ec52d7519763d029a8f6a1edeb5a18d0c9f16a2d4b69a454e2205859ecbd41ab402d049a4ee26d273f00e0094c301b579159801345c12341b4c12a17cea85f009dcbf0adc6f605f2842697cb542c6aff2ec2a48af158500d0c685c3c8a30ad92b79ce898aec2722a1b42a602e975f144a7d0a6d47a40c841f817a71a65005e80d65beb14d84dd81add8b43024dba5a5f248718919cabcb55e2f1e7b5cdb4b3139f1a83f758c48b438a8cacabeded49601e46b7fde9e54a92eaeb97dc7c250f3156294274c902399f8443ea1f7c515e4124c57503c7d972b3f1c0208e94fedc232b2acfa8ea751120e0128fd1575571c4665caed2b760fa791f13be6c16381856d713c968974ea49e8aca00805f5e45eab3c3b9167806ad8b6a668db15b6f83ad219bb09669b54a60aad57b6c53e5e60d4f37b8c915e11f100f47179e6b2199dfc18a393e75e5e64ccea7a5ae67c633e9fd3a4d6a35c547e11528cb4eeff6c4d5b09cfe3c7c7c7c7ff01babff34a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137768, 2758, 15.0, 15.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334cd4dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d5128b4c80000882b0957', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137769, 2758, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230cd4dd7cf4e57f0f4d5f70c53a85030040085700885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137770, 2758, 10.0, 10.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d51283434ca000090d8097d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137771, 2758, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230cd4dd7cf4e57f0f4d5f70c53a85030040085700885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137772, 2758, 15.0, 15.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334cd4dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d5128b4c80000882b0957', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137773, 2758, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230cd4dd7cf4e57f0f4d5f70c53a85030040085700885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137774, 2758, 20.0, 20.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3332c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d3b5c800009a8109b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137775, 2758, 30.0, 30.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cc29b1523036c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834cb0000b7ae0acd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137776, 2758, 5.0, 7.5, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d535d733cd4dd7cf4e57f0f4d5f70c53a850300400a40f094c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137777, 2758, 25.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3332d53531c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d3b5c80000addb0a4c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137778, 2758, 6.25, 13.3, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d33332d53534d633ce4dd7cf4e57f0f4d5f70c53a850300400c5620a0d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137779, 2758, 4.8, 4.8, 'g', 'IM', NULL, 'Pediatric', X'789cf34dacb05230d1b35048d74f49ac54f0f4d5f70c03003a710593', X'789ced5ced73da4613ff576efce1193c3518f0eb433a99c176e2b83131358e279d92d11cd221ae96ee943bc931edf87f7f764f4248202caca47d92860f4d82d8fddddebeddeeeae85f5b8e8a5c4b509f6d75c8d6a9c78543fda9cdc5d60ed98a94874f276118e8ceeeee677ec7fc86542efe8bef2e106b5bd18039160d91a7dd6c1fd69bad7aab79d33cea1c343b7b878de3bdbda3bd7d43cbec904ba181f2afad732698a29ef977c81e0cfbcd34601d72154e981a0a2a423ee232e4f6509c494d5d465e4be5eb0eb9e8ed908bdb1dd2bf22b5a303df7d415a074dfc6baf69fec267bb07fee5f6509c4adf9782dc28ea30f20ef60beca71e9333e9a35156a8477814d291c7f0d3ef1fe1136cf6ce7c980b3997ab5c59dd39ede34744ef3a91175ab01d2edcdcd60ba499a9c86ae728fb579da1800dd7f771d3a8844f8793a178cd950e0920830673df3e90d650f4e843879847bb0e9018d571612b46357388e2fa8ec831a8ab411c3e867fd0904cb80b762048ae4193173d5cb6dd6cd6db474d8343a76009a0bfe70e607c3aacb7da0b721c222112cd65386ca6325cf400f5b600f4b60cb4fedf18f83606de3fcef06ee56d884a3f659e17793ce4daea4badf9c89b5a4ec4ac505abdeb41d7aabd171e7238d67bcdb673ca3e6c82004d72e776d0b9082cfaebf19b0679090ff1196874f66c287e6f7f2c587c102a1634acfe84aaa9705188dc02c6658d118f71334d02bbd0053027d40e99e2e00db7d4e5021c288f9309cba148414f2ece00f5681568ffe26cc1b548adc73da7ee4b074c9e7530146edfe00c0568897ce621d8c566e310847a90820d8554043ecb07d8a3d80d941c81fbdadc217c4c8424f0c066cc01bf47bb815268e83311a20b90da80dd33c560c9d4b09f8eb3ebb840497d6e36478543343cb6272494281d1d8366487b7f022e4c6cd003b7a947b80f2bde335ca3509d23a6f992160f631b1b73e0968fea894586a2eb85c607ea87a988870b24592fcd511a2f3de7f7b3edfc1a8190a8b2daa151f1cdc5d9f60b12614cdc9231e8511b7d102ec6b37cb0b085b5325512cd6be4f48665080175ce9db1ed1a0819e21ccadc72e520e773da1c46a2ae728019619c6b37e9b362fa5c3c8736f973933f37f9f387cb9f55236f317d6c426f137acf0dbdef3e78be8ed32f86d2c6eb375eff2d7bfd0fe49fcba7dcc641bf7d07fd1ead54654859357e219e2818cd7eee88f26226b1350bbd1cebcf2df2993168923d67287e6edfb9d0b662cf7937eb8377b35d6bab9dd7e981a14ca88c4e5fc610072b218e276510894475d222be14689d9f5b8d72c9ca711bedfa974b176fb0bd5a92c33a8224ceb99a6a71a1fa51a360b116e9a10a4019a713c8d68a41566c1fd4f7cb96cfcd151ac0d1da6bec2dc1c7c393c631c92081e88e0417b621bcf5dfbd58413951e0b7e69cea49079e870bee0b5414e424ffc9e8279e2335ebed8c99217f3c2174bb71503f9e899c9b2cb55279fb57382a0299cd902a07beac9485ccd338cae06754f2b4ead379d8bc9f2b9a87a5df9649fd8f9b72bde9142b1c4f81fd5a7b89b0385333f2291deff3a038c3a319f70bcd98d977819c57a191b1872976c7eada51c872b2b47d593f984aec06721acc3a95399c52a970bab70e43ba91a2f11a17912ee8edcb44a82f156f58abf107ee3312d76d8174247e5c35d30ba52d6d28ac560e188e52152fecdb287b2f9d8416f984f4fd48f0705aefda9f22aec0f67dc12248f49c5ab5977bbe5c0870281921f4ebc9d9056e9cf3e105075e50c0acc845b6271497701e3d618c7975b230b46e2fc22e0555be2259981543748ab1ec90d4549fe6e5c19a35e0b7e4c28b45c8c687373ebcb60fff33ceb2e4a21b6ff93ebde5abdb6de9e5dac6707f87e1fe1ff2addfa8c7be15301b07c47d19441e9d7b443a3c53cc1554d853720ddf0ae8073be464282ea91d1aeaf8bdb30ddd8a2b15671abfbfdc7f41a0ae6750c38ef0ed74487ceedded0a1912c56c703526609f4371cd04f548dce4939ab99504dd4ddafe6f0fc53b49a8f347a493a11a7cd451107866fe65661513e64b20f7a6a063cc8001533c948201eeecf150bc6101c86a3f67a5731c9be3571d32600cbe420e271e47549c862c6ab27c2c92725809476ef8b4d204e5c029ab85ac5686f531c9e32254940b87db052e513878f4a87d679dc8871ce51bee4e62e9c056e9cd046e730f5c986a2dc1f542f0783083521346d1253453f72c9943292e239d194491cf139c4c85e64f30387a14f5c0d10488790f98675cdb203b9caef03df819da9779531cd66aee0a0e6b430f9daeb743e8c8913e4737b415f503bd639c0844c39b7e724c469e940e3ef3231b4431c116159e7db3667e2fa781aee731e54e71a66b7b00bb8b771ee1f4f66cecf07128674bd3367ec9bb61a3d0b55f10c7d4c924f2c733dbaae1e17765b7af20f433cf89ae0327bd66d635a3f67a296110fb418e6e0d57ba9928e98fa43d0d65c0a0fc188aaea0c164ead107cce583104a0ea1ebbfc889d090fb0653e10003a09d2b2a222fcbf84acb6042dd223325c5aa1439f1ce5229de5170174af0adcc2d785a7cf27553afeb537c67734df504ca9948e10a43f10b8d30638228ef151c3754a10c6fa6810c4160504bbab760e2b111f2901a1cfb11ce83fe692fca1e248b1a2fc75ae2c8e165ecb5cee5e439710e6595a1cb211738ad9433873fb375395e4a99e32ff09072a898c902262b65caeb2ee7626ba86f466f19fa1c16ba673982a1caf1cdfcb89c37a5ccf1a7de5f0e3027cd216482a61c234b9cdc19fad6324f51bbb5493d9bd4b3493dffb6d4f3ad4576954675e39eff5af7c4d9a14fa10b90ee34dff2516f5cf7f8d8bc5adcafef810bf618780af40bdaef904b681ed40b72fa5b7fffa009c7db83ad183a5587bc575cb01d02ad1ece7e7acc9e50012cd88475ed9824b985287568a630d0958de2273677a8b7431c0699dc5ca1825c3b8adc5de805f1bdb032b3874abd0a189eeb19c0d20f2fd2cb30641c791e71b15742813f53bc725543669fffc9088b4f711c2645490f25c576c2af03c5a843a8926069ec6d715487ad5700e1086a875e4bc08ea16d858638f289072783a793df601804a075180bc845a3d7803e3744055e4b50129b7d3a93a657660f78c72cf92546002272f147ac0ebc67d63174efae6e888ba85413b05aa4934546d045e3280e422ac4a11974e5113a04916051f2b285178508ec38320bf6e803c19b07c97d8ef839a9393939f0b71ef0e544466a1bdf4a9b363c6b32a2e13bcfc9f11c23dc650563a62e65c9b115bbd4427ad52a0a428d7a0f1987c5a702ac81f340d8fb88c79e85f639686aa2f8486a389009488103ef2ade95fe9cd21a607041630dffb1f286f82dcbc7dc602874a46d16009ec776750206fa8e74443d6f8abfd8198ad87cf14c84d4ee31278cbc29c9b22adc2efa1a705c0f45fa91d420d88c15c66616831380e426a1411ffc04224c05532ed04368262f9420263e030599ffc8145f3801692a21ce79dedf5c40c082243581269fea90f980918e7d00ff436b280478390de1d0fad086ba3b1602ac043a537207c23d340246f813a6b96c40bdf704f59c30b33394e91ca231205da2f18d0909e66f4a30eb6406524e64c2ef55838c2903203c693fec5759315969f6b2e4e96a1a0e5923215a1f9a069ff465ac5064bb52aef1f3b802c55f3dccb6b3434e76c8e90e39df32cdcdcce7a686323e1f52d81548e9db1c5601e3962bc8d4a036b3d902800fadf5a4a0c2dc428f34712bc1bcc25030efc1006266b902a0ebe7e2f0c8af00d31b0cba15d48917822aac76daadafe0bc28d53e343a0df22ae00e1e044e259d41cbf70783faa29aaa2e1b78c1d1b46d2e13ac488025eb9b0879c75c33bad48b88ef1ac40544a83f252bf4ea329100c0870ed2e4876a2ae949451f205b527cf982957045777cd3c0dce4454cfc59692790c670b05b81f32df40c9ae316745140aeb9f0ee1c86bc1a9c5cfe54056a09e96dffb4129089edb8c2d4c10ee9fac12911ccfd5a5081ac62e20153581b15abb93c7d26dcc4a7ca3697262bc9403d88c1cac61e4cb85b99b98fc519245b9f2b3ae2c56152aa8619c87de4b9500655d10140e04b7661833275d0a82205443d7c302e5a11e1146b8bd8adc85831ec148b82f759380e766870b27e294ec52d7519763d029a8f6a1edeb5a18d0c9f16a2d4b69a454e2205859ecbd41ab402d049a4ee26d273f00e0094c301b579159801345c12341b4c12a17cea85f009dcbf0adc6f605f2842697cb542c6aff2ec2a48af158500d0c685c3c8a30ad92b79ce898aec2722a1b42a602e975f144a7d0a6d47a40c841f817a71a65005e80d65beb14d84dd81add8b43024dba5a5f248718919cabcb55e2f1e7b5cdb4b3139f1a83f758c48b438a8cacabeded49601e46b7fde9e54a92eaeb97dc7c250f3156294274c902399f8443ea1f7c515e4124c57503c7d972b3f1c0208e94fedc232b2acfa8ea751120e0128fd1575571c4665caed2b760fa791f13be6c16381856d713c968974ea49e8aca00805f5e45eab3c3b9167806ad8b6a668db15b6f83ad219bb09669b54a60aad57b6c53e5e60d4f37b8c915e11f100f47179e6b2199dfc18a393e75e5e64ccea7a5ae67c633e9fd3a4d6a35c547e11528cb4eeff6c4d5b09cfe3c7c7c7c7ff01babff34a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137780, 2758, 25.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3332d53531c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d3b5c80000addb0a4c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137781, 2758, 6.25, 13.3, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d33332d53534d633ce4dd7cf4e57f0f4d5f70c53a850300400c5620a0d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137782, 2758, 4.8, 4.8, 'g', 'IM', NULL, 'Pediatric', X'789cf34dacb05230d1b35048d74f49ac54f0f4d5f70c03003a710593', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137783, 2758, 10.0, 25.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334d03532cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c8000092770984', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137784, 2758, 2.5, 8.3, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d233d5b5d033ce4dd7cf4e5708f057a85030040097da08e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137785, 2758, 1.8, 1.8, 'g', 'PO', NULL, 'Pediatric', X'789cf34dacb05230d4b35048d74f49ac5408f007002a9904cb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137786, 2758, 15.0, 25.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334d53532cd4dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d3b50000a3c309e6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137787, 2758, 3.75, 8.3, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d63337d5b5d033ce4dd7cf4e57f0f4d5f70c53a850300400bd3709e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137788, 2758, 4.8, 4.8, 'g', 'IM', NULL, 'Pediatric', X'789c33d1b35048d74f49ac54f0f4d5f70c03001eeb0413', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137789, 2758, 150.0, 300.0, 'mg', 'PO', NULL, 'Pediatric', X'789c333435d0353630c84d5708f0572834cb00001f770419', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137790, 2758, 150.0, 300.0, 'mg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb552303435d0353630c84d5708f057a8503004007c2107e0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137791, 2758, 1.8, 1.8, 'g', 'PO', NULL, 'Pediatric', X'789cf34dacb05230d4b35048d74f49ac5408f007002a9904cb', X'789ced5ced73da4613ff576efce1193c3518f0eb433a99c176e2b83131358e279d92d11cd221ae96ee943bc931edf87f7f764f4248202caca47d92860f4d82d8fddddebeddeeeae85f5b8e8a5c4b509f6d75c8d6a9c78543fda9cdc5d60ed98a94874f276118e8ceeeee677ec7fc86542efe8bef2e106b5bd18039160d91a7dd6c1fd69bad7aab79d33cea1c343b7b878de3bdbda3bd7d43cbec904ba181f2afad732698a29ef977c81e0cfbcd34601d72154e981a0a2a423ee232e4f6509c494d5d465e4be5eb0eb9e8ed908bdb1dd2bf22b5a303df7d415a074dfc6baf69fec267bb07fee5f6509c4adf9782dc28ea30f20ef60beca71e9333e9a35156a8477814d291c7f0d3ef1fe1136cf6ce7c980b3997ab5c59dd39ede34744ef3a91175ab01d2edcdcd60ba499a9c86ae728fb579da1800dd7f771d3a8844f8793a178cd950e0920830673df3e90d650f4e843879847bb0e9018d571612b46357388e2fa8ec831a8ab411c3e867fd0904cb80b762048ae4193173d5cb6dd6cd6db474d8343a76009a0bfe70e607c3aacb7da0b721c222112cd65386ca6325cf400f5b600f4b60cb4fedf18f83606de3fcef06ee56d884a3f659e17793ce4daea4badf9c89b5a4ec4ac505abdeb41d7aabd171e7238d67bcdb673ca3e6c82004d72e776d0b9082cfaebf19b0679090ff1196874f66c287e6f7f2c587c102a1634acfe84aaa9705188dc02c6658d118f71334d02bbd0053027d40e99e2e00db7d4e5021c288f9309cba148414f2ece00f5681568ffe26cc1b548adc73da7ee4b074c9e7530146edfe00c0568897ce621d8c566e310847a90820d8554043ecb07d8a3d80d941c81fbdadc217c4c8424f0c066cc01bf47bb815268e83311a20b90da80dd33c560c9d4b09f8eb3ebb840497d6e36478543343cb6272494281d1d8366487b7f022e4c6cd003b7a947b80f2bde335ca3509d23a6f992160f631b1b73e0968fea894586a2eb85c607ea87a988870b24592fcd511a2f3de7f7b3edfc1a8190a8b2daa151f1cdc5d9f60b12614cdc9231e8511b7d102ec6b37cb0b085b5325512cd6be4f48665080175ce9db1ed1a0819e21ccadc72e520e773da1c46a2ae728019619c6b37e9b362fa5c3c8736f973933f37f9f387cb9f55236f317d6c426f137acf0dbdef3e78be8ed32f86d2c6eb375eff2d7bfd0fe49fcba7dcc641bf7d07fd1ead54654859357e219e2818cd7eee88f26226b1350bbd1cebcf2df2993168923d67287e6edfb9d0b662cf7937eb8377b35d6bab9dd7e981a14ca88c4e5fc610072b218e276510894475d222be14689d9f5b8d72c9ca711bedfa974b176fb0bd5a92c33a8224ceb99a6a71a1fa51a360b116e9a10a4019a713c8d68a41566c1fd4f7cb96cfcd151ac0d1da6bec2dc1c7c393c631c92081e88e0417b621bcf5dfbd58413951e0b7e69cea49079e870bee0b5414e424ffc9e8279e2335ebed8c99217f3c2174bb71503f9e899c9b2cb55279fb57382a0299cd902a07beac9485ccd338cae06754f2b4ead379d8bc9f2b9a87a5df9649fd8f9b72bde9142b1c4f81fd5a7b89b0385333f2291deff3a038c3a319f70bcd98d977819c57a191b1872976c7eada51c872b2b47d593f984aec06721acc3a95399c52a970bab70e43ba91a2f11a17912ee8edcb44a82f156f58abf107ee3312d76d8174247e5c35d30ba52d6d28ac560e188e52152fecdb287b2f9d8416f984f4fd48f0705aefda9f22aec0f67dc12248f49c5ab5977bbe5c0870281921f4ebc9d9056e9cf3e105075e50c0acc845b6271497701e3d618c7975b230b46e2fc22e0555be2259981543748ab1ec90d4549fe6e5c19a35e0b7e4c28b45c8c687373ebcb60fff33ceb2e4a21b6ff93ebde5abdb6de9e5dac6707f87e1fe1ff2addfa8c7be15301b07c47d19441e9d7b443a3c53cc1554d853720ddf0ae8073be464282ea91d1aeaf8bdb30ddd8a2b15671abfbfdc7f41a0ae6750c38ef0ed74487ceedded0a1912c56c703526609f4371cd04f548dce4939ab99504dd4ddafe6f0fc53b49a8f347a493a11a7cd451107866fe65661513e64b20f7a6a063cc8001533c948201eeecf150bc6101c86a3f67a5731c9be3571d32600cbe420e271e47549c862c6ab27c2c92725809476ef8b4d204e5c029ab85ac5686f531c9e32254940b87db052e513878f4a87d679dc8871ce51bee4e62e9c056e9cd046e730f5c986a2dc1f542f0783083521346d1253453f72c9943292e239d194491cf139c4c85e64f30387a14f5c0d10488790f98675cdb203b9caef03df819da9779531cd66aee0a0e6b430f9daeb743e8c8913e4737b415f503bd639c0844c39b7e724c469e940e3ef3231b4431c116159e7db3667e2fa781aee731e54e71a66b7b00bb8b771ee1f4f66cecf07128674bd3367ec9bb61a3d0b55f10c7d4c924f2c733dbaae1e17765b7af20f433cf89ae0327bd66d635a3f67a296110fb418e6e0d57ba9928e98fa43d0d65c0a0fc188aaea0c164ead107cce583104a0ea1ebbfc889d090fb0653e10003a09d2b2a222fcbf84acb6042dd223325c5aa1439f1ce5229de5170174af0adcc2d785a7cf27553afeb537c67734df504ca9948e10a43f10b8d30638228ef151c3754a10c6fa6810c4160504bbab760e2b111f2901a1cfb11ce83fe692fca1e248b1a2fc75ae2c8e165ecb5cee5e439710e6595a1cb211738ad9433873fb375395e4a99e32ff09072a898c902262b65caeb2ee7626ba86f466f19fa1c16ba673982a1caf1cdfcb89c37a5ccf1a7de5f0e3027cd216482a61c234b9cdc19fad6324f51bbb5493d9bd4b3493dffb6d4f3ad4576954675e39eff5af7c4d9a14fa10b90ee34dff2516f5cf7f8d8bc5adcafef810bf618780af40bdaef904b681ed40b72fa5b7fffa009c7db83ad183a5587bc575cb01d02ad1ece7e7acc9e50012cd88475ed9824b985287568a630d0958de2273677a8b7431c0699dc5ca1825c3b8adc5de805f1bdb032b3874abd0a189eeb19c0d20f2fd2cb30641c791e71b15742813f53bc725543669fffc9088b4f711c2645490f25c576c2af03c5a843a8926069ec6d715487ad5700e1086a875e4bc08ea16d858638f289072783a793df601804a075180bc845a3d7803e3744055e4b50129b7d3a93a657660f78c72cf92546002272f147ac0ebc67d63174efae6e888ba85413b05aa4934546d045e3280e422ac4a11974e5113a04916051f2b285178508ec38320bf6e803c19b07c97d8ef839a9393939f0b71ef0e544466a1bdf4a9b363c6b32a2e13bcfc9f11c23dc650563a62e65c9b115bbd4427ad52a0a428d7a0f1987c5a702ac81f340d8fb88c79e85f639686aa2f8486a389009488103ef2ade95fe9cd21a607041630dffb1f286f82dcbc7dc602874a46d16009ec776750206fa8e74443d6f8abfd8198ad87cf14c84d4ee31278cbc29c9b22adc2efa1a705c0f45fa91d420d88c15c66616831380e426a1411ffc04224c05532ed04368262f9420263e030599ffc8145f3801692a21ce79dedf5c40c082243581269fea90f980918e7d00ff436b280478390de1d0fad086ba3b1602ac043a537207c23d340246f813a6b96c40bdf704f59c30b33394e91ca231205da2f18d0909e66f4a30eb6406524e64c2ef55838c2903203c693fec5759315969f6b2e4e96a1a0e5923215a1f9a069ff465ac5064bb52aef1f3b802c55f3dccb6b3434e76c8e90e39df32cdcdcce7a686323e1f52d81548e9db1c5601e3962bc8d4a036b3d902800fadf5a4a0c2dc428f34712bc1bcc25030efc1006266b902a0ebe7e2f0c8af00d31b0cba15d48917822aac76daadafe0bc28d53e343a0df22ae00e1e044e259d41cbf70783faa29aaa2e1b78c1d1b46d2e13ac488025eb9b0879c75c33bad48b88ef1ac40544a83f252bf4ea329100c0870ed2e4876a2ae949451f205b527cf982957045777cd3c0dce4454cfc59692790c670b05b81f32df40c9ae316745140aeb9f0ee1c86bc1a9c5cfe54056a09e96dffb4129089edb8c2d4c10ee9fac12911ccfd5a5081ac62e20153581b15abb93c7d26dcc4a7ca3697262bc9403d88c1cac61e4cb85b99b98fc519245b9f2b3ae2c56152aa8619c87de4b9500655d10140e04b7661833275d0a82205443d7c302e5a11e1146b8bd8adc85831ec148b82f759380e766870b27e294ec52d7519763d029a8f6a1edeb5a18d0c9f16a2d4b69a454e2205859ecbd41ab402d049a4ee26d273f00e0094c301b579159801345c12341b4c12a17cea85f009dcbf0adc6f605f2842697cb542c6aff2ec2a48af158500d0c685c3c8a30ad92b79ce898aec2722a1b42a602e975f144a7d0a6d47a40c841f817a71a65005e80d65beb14d84dd81add8b43024dba5a5f248718919cabcb55e2f1e7b5cdb4b3139f1a83f758c48b438a8cacabeded49601e46b7fde9e54a92eaeb97dc7c250f3156294274c902399f8443ea1f7c515e4124c57503c7d972b3f1c0208e94fedc232b2acfa8ea751120e0128fd1575571c4665caed2b760fa791f13be6c16381856d713c968974ea49e8aca00805f5e45eab3c3b9167806ad8b6a668db15b6f83ad219bb09669b54a60aad57b6c53e5e60d4f37b8c915e11f100f47179e6b2199dfc18a393e75e5e64ccea7a5ae67c633e9fd3a4d6a35c547e11528cb4eeff6c4d5b09cfe3c7c7c7c7ff01babff34a', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137792, 2758, 25.0, 40.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3332d53531c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d512834d3b5c80000addb0a4c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137793, 2758, 6.25, 13.3, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d33332d53534d633ce4dd7cf4e57f0f4d5f70c53a850300400c5620a0d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137794, 2758, 4.8, 4.8, 'g', 'IM', NULL, 'Pediatric', X'789cf34dacb05230d1b35048d74f49ac54f0f4d5f70c03003a710593', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137795, 2758, 10.0, 13.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3334d03534ce4dd7cf4ed74fc92f4e552834d3b5c8282a5608f057a85030d53534504849ac2c0600d6060b26', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137796, 2758, 2.5, 4.3, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb55230d233d535d133ce4dd7cf4e5708f057a850300400979e08e2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137797, 2758, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb0523031c84dd7cf4ed74f49ac040029ab0527', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137798, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a850303450008a170300e8ee0c0a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137799, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a85030d535345000ca140300ffe30c6c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137800, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d5128b4c850a8503034d0353451004a1503000b9f0c9c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137801, 2758, 7.0, 7.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33cf4dd7cf4e5708f05728b4c850a8503034504849ac2c060051b106e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137802, 2758, 300.0, 300.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303630c84dd74fc92f4e050023b604c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137803, 2758, 40.0, 40.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3331c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d512834d3b5c850a8503034d0353451004a1603000ac50c6f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137804, 2758, 30.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3336d03531c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d3b5c850a85030d735345000ca15030017070cd1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137805, 2758, 20.0, 40.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3332d03531c84dd7cf4ed74f49ac5408f0d7f70c5348c92ccb4c494d512834d3b5c850a85030d7353450004a1703003c1c0d9e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137806, 2758, 600.0, 600.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303330c84dd74fc92f4e050023d404c5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137807, 2758, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c73c957c8cb2f5148ad484e4d4d51303330c84d5728482d52c8cccb4a4d2ec9cccf0300bc4b0b87', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137808, 2758, 30.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789cf34dac50284a2c49b5523036c84dd7cfcdcc2b2d4955d048c957c8cb2f5148ad484e4d4d51303432004966e49716690200970a102c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137809, 2758, 18.0, 18.0, 'mg', NULL, NULL, 'Adult', X'789c73cbcc4bcc5148cecf4b4ecd2b294a2cc9cccf5328cec82fcd4951c8cb2f5148ad484e4d4d5130b4c84dd7cff5010087ef1075', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137810, 12024, 325.0, 650.0, 'mg', NULL, NULL, 'Adult', X'789c3336325528c957303335c84d57c82f4accc9a904520a45a9c92560766a596a51a5828942467e6951b14262b1425e6a6a4a6a8a8e425e7e0948636a45325000a8205d3f25b11200fbf01a40', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137811, 12024, 324.0, 324.0, 'mg', NULL, NULL, 'Adult', X'789c333632c94d5748ce482d4f4cca495548cb2f020036550630', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137812, 12024, 81.0, 81.0, 'mg', NULL, 1, 'Adult', X'789cb330cc4d57d0484a4caad454702c2ec82ccacc5348cecfcdcdcf534849cccca954484e2c4ac94c4c5628ca2cce56284a4d294d2ec90449e617a7020075ea1597', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137813, 12024, 325.0, 650.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334aaccb7523036325528c957303335c84d5708f057c82f520808522834d135cb00009d100922', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137814, 12024, 10.0, 15.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d23534acccb75230345028c957303455c84dd7cf4e5708f057c82f520808522834d135cb0000b78409f5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137815, 12024, 80.0, 100.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c45cc410e82301046e1abfc4b4d682858957005177a85b11dda069c890535dcde1017eedffb2ef4a199c6dca3b3a6b1168f588fb10eb46217f23b070e783a734a7bdcae78c99227d0c0f7922786ebccb94dd082ad6f5c8525b1e0608e7fe5b78882374c3c4307782d2a5456f8441279fe0218652bd5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137816, 12024, 1.0, 5.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c0b2e29cacf4eb552305428c9573055c84dd7cf4ed74f49ac5408f0070079bb087d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137817, 12024, 90.0, 130.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789cf32a2d4bcdcbcc49550872b452b034d035343650c84dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d135cb00004deb0e24', X'789ced576d6fdb3610fe2b077f4a003b961d274d856180ebac2f7b698d38fb3415064dd11261eaa8919463adc87fdf9de43876d3364db00f1bb04f91e887a7e3730f9fbb7ceaa4aecae6280ad589a133f6a5761a3b5de854cef04a1e42e9e37eff46af5471625dc64fbabf07f4d28952a57311183f8c86e7bd68d01b44d7d18b7874110f4627672f87d1e8b4c12a19b4454fc84f9d370a9513a6790e6ad36cbfae4b152738c6a04b2382322a24d84df0fd6cfcee32c14beb45a6e0b575858f218805fdde85541951abb4e7082ebcdaadcb5cddf0e36e4161504ecb9eb4143add2d5bcaa2016bcc20ab0a026e82c294207721a5287d655482135b1416e1da8954c17ba28df2d892d185576251dfbf8d67e3047fe7840982c264ca6bd905c167ab9d0abb97ed411b82aac53e47b7b4d464c96f7f7ca437a371d5bcdc7336fe2cc62395db4753fcfb380dc78f076861b71f39b7715a9930a7aa107307753c1d9e41b0707e161559c3afa9e90fd12943f3acd6cad53082dc56ce83f0804a11df5d401b78a3da485a2040d64f459de0e970448176055d5a472299cc12bc18d0fad182883fbe631e645ba35468fa92142ed54282d37e45df4fab865d48ad57cf267c32fb0e9e09d4923455944020dd7d89a8f1daea142a4fd2e2cc736d52a7483cca974aea86ab9053ae70a3430e6bcd52f535a6ce168a945f2966ab399b5d2678a56ab5fb39c1d74c73174aa131c11f07c3dac6705099e907aecaf40afe1cf5cef30487bdc18041838831833328b2feea21ec177123bc58e9182e22bae9510be34ac151aad79a6f4e033de6ad1529ce8058aa85d354bbd145efc530e7808c1f8cba74408570da3bbb8fd26e41d2010743a9e87454566751906c642e902e5382b3e0ec8a6ed780b33ddbcb62fa21c19fabb542fee0d538869794e769748080834c9fab8503c61f5705c3e73b78ab8f595be9f9d496155dcc9d3fde7d62ea548602650d57f42b6609c63081a3810fbd21928b394d2e44c676dc854b383a75fb4b09fe2ae8ca71d018dee192fca6558b14c8576da1c091afa560abc0f2219b8256a531805ec2c44d0cfc3088c8a9ee85fa56951451ee80ed4f84f6ac3705ba20c5b982dcf6b9ac7e7ee4c789bde436d682fd5ce37c17614bf2c46270740f522dbf40f1d818e5b29a65248df0becf5d91f4b52d14ab4ff89017a20b2ed7a883f6ecdd2920dd0303a53575e99f76d8ad7f12615ecdaf94900fb3fa42c0ce8c1a98ad0e71334545b933bfa399305ad6ecf0c7706d375aea503f70861e4cb656d31c2328aa7c46a9802747366963c315b7d25c7b28c8c0a4c6c676d9a2e48ab69576c377f8ce918a32d882aee49b775019a91caba4b0cee51436c19f36554ab4af15d02bf7e9a6ff164292e0c90754d68c027cca045fd12d976479a5f04582d71a89eecaf34c90694b4da2109d43566fbfcfb4bfc5cf770f3cf3fdedf3ddf6833efa4f58c2ff5516cfeeceffa5424f73e188206b6c561f54fbad30cb9ed14bea6ec3a8771ed150ba4d888c57489dc6c09df837457c58a37d11c3d696b90e92c74bb6fcc6d1694ea0fe52ffc5ccf116ee9fb4835d6d2cb7adc139f66eaf79ba92b534d66e6aaa17cfbe1a73bdd0c13aeed4958792a1c84e4b8fd60791195217314e67a356ee494bacb6bb2113d8dad64dd99fe190a4faf9d8787b68d7dfbe05fb236e2bebd6f23ffb8544caddb03937fd1bf2af97dbd78ef5b4997fbebff3ebf11f92f3844f349be7bbcdadd4afd49286039ae50e6d8de371b89b9b136ebafe84a6f7be685939c943f1c4c25037b8fd1b2fba1eb8', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137818, 780, 0.25, 0.25, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b652c8cccb4a4d2e494cca495528cecf292dc9cccfb35230d03332cd4dd7cff5b156004b9580844c75140c75148c72d3015c7116ac', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137819, 780, 40.0, 40.0, 'mg', NULL, NULL, 'Adult', X'789c3331c84d070002a50139', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137820, 780, 20.0, 20.0, 'mg', NULL, NULL, 'Adult', X'789cb3553032c84d070004ad0194', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137821, 780, 1.0, 1.0, 'mg', NULL, NULL, 'Adult', X'789cb35530cc4d57482acd4d2d49cccb4c4955b055303550c84d07005ee10777', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137822, 780, 0.5, 1.0, 'mg', 'IV', NULL, 'Adult', X'789c15cc3b0e80201045d1adbc0508410d8bb0d2ca7e1207b5c0e19be8ee85eedee6186d510423fc89658724186dd5d46e5b351687fba18363a5c2489c833c99875681a9204e6ac62535e56e787a6f5f3dc46134dd0b9c70d0f703ddfe1f9f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137823, 25911, 30.0, 30.0, 'g', NULL, NULL, 'Adult', X'789c33365048cf55c82f4acc01120a05a9450a45a9c925a5b9005e67083e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137824, 25911, 1.0, 1.0, 'g/kg', 'PO', NULL, 'Pediatric', X'789cb333cccdb752305448d7cf4e5708f057c82f520808522834cb00d17e0081500892', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137825, 3182, 200.0, 200.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492dd151303230c84d070082a508e3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137826, 3182, 200.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333230d0353130c84d5708f057284c49ac0400245304b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137827, 3182, 400.0, 400.0, 'mg', 'PO', NULL, 'Adult', X'789c333130c84d5708f05728b4c80000146f0359', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137828, 3182, 3.3, 6.6, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d633d635d333cb4dd7cf4e5708f057284c49ac0400351705bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137829, 11398, 500.0, 1000.0, 'mg', 'PO', NULL, 'Adult', X'789c0bc9a82ccacf4c51282ec92fcab552303530d035343030c84d5708f057c8c94f4cc9cc4b5748c92f4ed55148cbcfc9c92f4f4d5148aa543032852a2934c90000eaa5158c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137830, 11398, 50.0, 300.0, 'mg', 'PO', 3, 'Adult', X'789cf3cccb2cc94cccb1523035d0353630c84d5708f05708f17451d0484a2c4e4d51c8cf53284e2d4b2dca2ca9d404002aec0de6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137831, 11398, 50.0, 50.0, 'mg', 'PO', 3, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb5523035c84d5708f05708f1740100694507b7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137832, 11398, 50.0, 50.0, 'mg', 'PO', 1, 'Pediatric', X'789cb333abccb752303550c84d5708f0574849cccca9d451484e2c4a4d2bcdc9a954282d28c92c294a2c494d01001a5e0e7b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137833, 4432, 15.0, 25.0, 'mg/kg', 'PO', 1, 'Adult', X'789c3334d5353255c84dd7cf4e5708f0574849cccca954d0c8cc5348cecf4dcacc4b2cc9cccf5328cf2cc950c82fc9482d52484c4fcd2b29d60400e371129d', X'789ccd565d6fdb3a0cfd2b449e36208993ac5957e3be64e98616e86e8b2c6ff31028326df3461f9e24b70d86fef7514ebbd6d947b13c5cec29a24c5187e4d161bef672d7942b2334f652e8bd0b95d0eb2658d5eb43af712a6e5621d43e4d921bdaa01e5a57c615255d5f2f9da8315f89108f4c4693d783d178301e2d47c7e974924ea7c3c9c99bd1c971eb8b3290359e3dbff666b926433e3811f7daad80b76d94e5b6c634333313684d3690cc4c1f045b83e5dbcc9c5a2f4a84f7d669cf5e0bdb04f4600be8464ce1d2099599b9d5da1a583a9123fccbf9fab4c5d2ac9fc2b9e3ad20d60aa3f5e9335b8acca6351e713d027abe4a4f7cef3ec7e8b3bc5161c5e0c9949d6cc7d3c1640aba4c36255c5d422e486de105199056afc9b4c9c00d850a6ca8d001276f827ff96749b410ae3027111cc95fc2e8a238e08a8f354a126a7565eb4689c76e3fdc72e5b034c2c82d2cf8ab2933eed33c331742865da28efc2685735370bf5b03c843ecab8ecd5ca0110af2167d6448fe5fe343b431291c7e6930465e0b8f39702c8faed110890e0aaf5179a002e66eaee09fe3137d917058e6476b8f47293ca9c097a33755662e179979058198335073e56f1037f707c6a3c1789ac69fef4726478357aff9d4196acb75565b4fbe13743f148822f0f2ec349ea9397df990d9a104ddafeef3343d8d2a503f1c5b4911b0b48ef8961d6be7d6f07b229393fc4937674aa12bb7102c4825bc4f62ad33736ec49a1485f683a8393c73222058070e6beb025c936fb8919ef84d6251709e1e5ee0b01c02b59df7fdc87e11b8b187107d965fa3f3b85aa0903fa2fe49c0de4774649baedf651d5b62b07114c8df37c9067b4b9273eb7531ec8a15a5a613c388c6a348aeada6d8908489e15c8522e37a5b87b7c42b3673212b7cba62b60bf2bcb878bf0464f6ee5472efce675fe34159edd7e6af4beb7f01f4a7da5a09a785b4ca96db0eb233a18a81a20253980ca7832356880fc891ac22af53b820a66a66dedd4a87bbb1d56a5c1ff851087500900f282bc16350af6cb19ac91f86ebb9a97830f17bd35b69d7fc3e982302fcd6f07061c58a8354dfe3e3b9da875035ac9bba16e4b8b02051a9ef0e5e279aa71ad5ea5e1e0e991888ab99f2b6fb0fa059a3938d6239f4878ae17e8cdf0b61c79bb5efeeee1b4c281b98', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137834, 4432, 15.0, 25.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3334d53532cd4dd7cf4e5708f0574849cccca90400333905c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137835, 4796, 40.0, 160.0, 'mg', 'PO', 1, 'Adult', X'789c3331d0353433c84d5708f0574849cccca90400261604ef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137836, 4005, 37.5, 225.0, 'mg', 'PO', 1, 'Adult', X'789c73ad2849cd4b494d51284acd494d2c4eb5523036d733d5353232cd4d5708f0574849cccca90400eb820be6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137837, 4005, 75.0, 375.0, 'mg', 'PO', 1, 'Adult', X'789cf3cccd4d4dc94c2c4955284acd494d2c4eb5523037d5353637cd4d5708f0574849cccca954c8cc5330d2355648c92ccb4c494d5148c92f4e2d060022ad12c9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137838, 527, 7.5, 7.5, 'mg/kg', 'IM', NULL, 'Adult', X'789c33d733cd4dd7cf4e57f0f4d5f70c53283434ca000034c40550', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137839, 527, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Adult', X'789c33cd4dd7cf4e57f0f4d5f70c5328b4c8000028ca04c0', X'789ced586b4f233916fd2b56be2ca326cf868689e64b087483ba612202a8479316725c37556e5c768deda2a91df57fdfe3ca830045076a34a39576bfa52af6f17d9c7bee75fdd9886c1e5f6b9e52a3cf1a8354de702175639b3572abc2abc4fbccf5dbed6ff286d296b171f825dbeb2b9db03ca3e89afbb0a1d7e9bd6b76bacd6ee7a2b3d7dfd9ebf7765bbb7beff677df966b497869b4c3ca3f1b1f4893e5aafcede9aedc7e5164d49f68e06b13ab421827239ae843e3784cecbdb1a9eb33a9bf02874f153167541e1027fadce49e1c33333688b05b3a6f79f8a7cf4e4eb7d9c9d5440f4d9a1acd2e2c8f889dc167400547166ee4d375ebbee355794478fafd0b9e94d437e5c3bdb50fcd7c51d8d6d77fff124e1944b9f2d7f050eaf8412c0eb8f06425577078b6306da2f75abb69dcbe89e156fbe48afdd1ed2513fdebf9443f7cbd8fb7975a98345352704f11bbbc3899e8de6e270d6bd8c1c9e1ebbc2e6d1d5124b9b75254d97b4646e32487fc753bebc6dcb12ebb383e3a7bc6f8133de3da3bd666c344aac8927eea0c3b1d7c66ddd62e8bdb112f6a583ece482094d72393e58adf937069fcc852acb916053bc7bf3a9e80388713fd093958d068cc67e40b76a96fb4f91608471aa999c7018c0d5904c7ec50b1dd4e73bfc362794bc1c3666f2759fcd1ed3477977ff4769a3bfbcb3f7ee92e5fefec37f742508e0ffbf3372ecf32452969a0afc2bfd8f6760d0f0775f7d70eeafdbcfc637fcd82aa83daa343e63cb79e2da28e7c6d336d1e1c7d4c19e22016feb233e3d921cda4a6a86ef13c8ef8e6f2390c62355fecaea5be5e212c2a6968348a5eea2830fe4986074a918d0be60d138a3bd70eda578349435e2aceb59cf51fe027902eeb483be943807d889f9a4914c444db922b32cdb8b4f378469414d15ca12628532d728b459e69ca126bbcb943ac217978933b08e07c2baa98e791f4c616ed5b725e4ec165cb66b9164f808051a2b435e51580e5db3477a24488a4231e5e934224ac518527c6a71a7acb15fc412c5e1fa841741b02727d4e5c3c4d470560630cb933b97ba42aab80485f40eafcdac3d9cab7fbc795535365c40d0fed639c23352b116d3cb47bce9cd01a1e9c7ba4e8b6c50e2ecf822ed95000dc06e62be3825481845afa1cb9bd22eb656c828e7d9d1fc040016276e1f6e3e3362ad53f1684c7e1ff6f8ac2df6dcb6b1b5fc2510ac22813170f8c3ae66ad65472467dd64bd8161479ff1d4bd0b1d9e39aff69a24f096718255dda87826a24e5e84e589af7974b3843618d4838c697b41c65c4fcbfc5282064c4d5369b42e25c1098b79d31b3726a9c4199426ea63922b08dc3133995e8a819784130c515da27e4a46bd529630d9d9106e27f3d5ea8db5c113655f3477a18aaf1443bd09232e0296adf4be556ee72ae5481086144911aaea665a7c35fb7c8318c2bd8fa561b7cf1bc8ce97950d7c523db32168dcb339a953407b68033680773f4f11b985060ea8cb11e7af84dfa8409528a7dc30ac6579e82449758bab270065ccc4fcc6858b2a503a10ae72905c6aaa280ffb90b61352ce29ee3a137d17c6e045280985983d4e5be34101a1cadd986d56f7fb0fa7ee19a67c1a60fd6e4191ba07d5bca580692163a86c99883eddad4c8a2bc6c48472d36e3042009073fefd439717112da07ca53f21f9735ba7d6961c8fe07cb533632f380866dbfdab8e479498d80da5abab3cd0eb6d9709b7d689472b8e45c6053e3bc8123d6609f411a2d0da41a1857d2a2d010b6d2d90a80cfdd9759c1910c6dc05c16d782390aa56084110210cbcc55008d5f8b23f3b4465c4ec7e3418dd34fcf2bb76d3a6d38683eb3f305e1e759d26247196e5936955165d04e369ddf625f090368bd587d6a31f0cf88c21b0c5df492ac95157246310f15e21e039eb5580c406b1343b5580d00b42159ea43754436e6df587e07b5e40cf335872535e978dc0adaa472d2ffaef464239d5b0c9d58d6d8f951d1d4c9e082ab2ac8171edcbe876147e3834f6fea403d41fa381a56016d4acabcb6a7e580e0b26d3648b3216e11716d99780495993a29c6101b2e37d561de5cbf8bdd2ce55610fabeae65035728c16793bdd98a44c6b5a9320aa317d43695964f65759d6cb46009729bab1873509d2000e2162aa805a2e9b2561d2b50f67828395a136118868b39afd8cc528e1b7a55f5be0a2792e17699d78aeb3a4e4d9706a814b08b6348a845ae81c0b4ef7f6cc4a60e357294470b2b38d9bc1c36780d921ce4f626312a0a5f1b310f675cc82a98cdb3176176b4264b1646e156e2f104fad781fb0df9c514ca192dc697f02542d4f1efbde528005752d8876b71d85ea79a0e6c2e7e5008e337ffda3416502ccd5faaa511c7c523b725449a23bee1525807e898535a26270ff7035c438b5a357925a7569a20515acea4a82cc8c7443e954e3ca9c944f1b4884a8b7875516d9c4f0a6132e8757a7f3fa933289d4b7143de3bf917cc98d7354647c66fab07c8c7541b681e9aefd3c12f7c03d0262d44e510b9c998f99703831680c9dff2f89956b4096664e916bda8241d29bcd661acadaec68d83bd32b8586106457422390369a4aa93a7759cad70695d81fd5487c8ef73b796364da214325b6bfa1f51e64d797bf4cb6b5775b903e8cbd34f2effff72f2bff1e5e4355fe2be7fff0fa5ead194', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137840, 527, 250.0, 250.0, 'mg', 'IM', 2, 'Adult', X'789c333235c84d57f0f45570f274010013cb0311', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137841, 527, 10.0, 10.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3334c84dd7cf4e57f0f4d5f70c53a850305408f170f50300463e05f3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137842, 527, 7.5, 7.5, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33d733cd4dd7cf4e57f0f4d5f70c53283434ca000034c40550', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137843, 527, 5.0, 5.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c33cd4dd7cf4e57f0f4d5f70c5328b4c850f0758c5030d4335548d74f49ac04008389086e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137844, 12802, 40.0, 80.0, 'mg', 'PO', 2, 'Adult', X'789cf34dcccb4cd42f28ae4ccec82fce2cb65230315028c957b03050c84d5708f05770f2740100d72c0ae6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137845, 12802, 10.0, 20.0, 'mg', 'IM', 1, 'Adult', X'789c734c2e2d4955484ccf2c492cc9cccfb3523034d03532c84d57f0f4552834d235c9d05130017173132b14521233732a0185030f50', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137846, 12802, 20.0, 80.0, 'mg', NULL, 2, 'Pediatric', X'789c734c4f553034d03534b75228cec92fcfa95428c92c294a2c4955282d5028c95728492c4a4f2d5148c92f4e553032d0b530c84d5770f2740100f0a81199', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137847, 1744, 30.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492db1523034d5513036d051303350f02f4acc5108cecf292dc9cccfb3028ae6a6eb9b2ae4fa0000041b114b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137848, 1744, 15.0, 60.0, 'mg', 'PO', NULL, 'Adult', X'789cf3cdcc495128c957c8cd4f492d4a2c49552848ccccb3523034d53533c84d5708f0572834d135cb500808f203003a150d49', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137849, 1744, 360.0, 360.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303633c84dd74f49ac04001f0e045b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137850, 1744, 60.0, 60.0, 'mg', 'IN', NULL, 'Adult', X'789c73c92f4e2d56b03333c84d57482c4a5528021239950ab9f940766a5a5a6a72496659aa42669e427e41667e668a6e5e22885f905892999a57520c00b04816a5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137851, 1744, 15.0, 30.0, 'mg', 'PO', NULL, 'Adult', X'789c73ce2f4dcfb0523034d53536c84d5708f0572834d135cb500808f203006c57077a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137852, 1744, 120.0, 120.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb052303432c84dd74f49ac04001edc0455', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137853, 1744, 45.0, 270.0, 'mg', 'PO', NULL, 'Adult', X'789cb3523031d5353237c84dd74f49ac5408f05748c92ccb4c494d512834d135cb500808f20300ae2f0a23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137854, 1744, 30.0, 60.0, 'mg', 'PO', 1, 'Adult', X'789c0b2e492c2ab1523036d03533c84dd74f49ac5408f05748c92ccb4c494d510874d14dca4cd15128c948cd53c8cc4b2e4a4d2c4e5548aa44551fe4070014eb1630', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137855, 1744, 60.0, 60.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb0523033c84dd74fc92f4e55282d5028c9573032070b24560200924b0997', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137856, 1744, 0.5, 1.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d63553a8ccb75230d033d535cc4dd7cf4e5708f0572834d135cb500808f203007d86081e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137857, 1744, 15.0, 30.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d7353452a8ccb7523034d53536c84d5708f0572834d135cb500808f20300696c0753', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137858, 1744, 15.0, 60.0, 'mg', 'PO', NULL, 'Pediatric', X'789c3334d6353457a8ccb7523034d53533c84d5708f0572834d135cb500808f203006f6c0788', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137859, 1744, 60.0, 60.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523033c84dd74fc92f4e55282d5028c95730860824560200924c0997', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137860, 1744, 1.0, 1.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d23555a8ccb75230d435d433cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d135cb500808f2b356f04dacb0523036c805ab0100e4111102', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137861, 1744, 1.0, 1.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d3353454a8ccb75230d435d433cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d512834d135cb500808f2b356f04dacb0523033c805ab0100ef7e1136', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137862, 17400, 0.18, 0.18, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65230d033b450c84d5728494cca492d2906008ead099f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137863, 17400, 0.54, 0.54, 'mg', 'PO', NULL, 'Adult', X'789c33d0333551c84d5708f0572834cb5048292dcacc4b5728484dcc5628cf2cc948294a2c4fcc5128aecc2d28c9cf2d060053781017', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137864, 17400, 2.88, 2.88, 'mg', NULL, NULL, 'Adult', X'789c73c957c8cb2f5148ad484e4d4d5130d2b3b050c84d57d030345328494cca492d29d65428482d524849ac040018c80d43', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137865, 17400, 0.72, 0.72, 'mg', 'IN', NULL, 'Adult', X'789c73c957c8cb2f5148ad484e4d4d5130d0333752c84d57d0305128494cca492d29d654c8cc53485428cecc4bcf495548c92f4e05008f901027', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137866, 17400, 0.36, 0.36, 'mg', NULL, NULL, 'Adult', X'789c4b75770b5230365028c957b034b05230d0333653c84d572834cb000057a70698', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137867, 17400, 0.18, 0.18, 'mg', NULL, NULL, 'Adult', X'789c4b75770b52b03136b05230d033b450c84d572834cb0000383c0548', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137868, 17400, 0.18, 0.18, 'mg', NULL, NULL, 'Adult', X'789c730d0e72d1f770b15230d033b450c84d572834cbd051c8cdcccbcc4dccc9a95448c94ccca9ac4a4cca49050001ba0d87', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137869, 17400, 0.36, 0.36, 'mg', NULL, NULL, 'Pediatric', X'789cf3cd4f492d4a2c4955c8cc2d48cc2cca4dcd2b51d070cec8cc49d10d284dcf5048ce492c2e5670d2b45230d0333653c84d572834cb0000fcfe117a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137870, 17400, 0.18, 0.18, 'mg', NULL, NULL, 'Pediatric', X'789c0b4e2d4b2d4a55c8cc2d48cc2cca4dcd2b51d070cec8cc49d10d284dcf5048ce492c2e5670d6b45230d033b450c84d572834cb0000d44f10b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137871, 17400, 0.36, 0.36, 'mg', NULL, NULL, 'Pediatric', X'789cf3cd4f492d4a2c4955c8cc2d48cc2cca4dcd2b51d070cec8cc49d10d284dcf5048ce492c2e5670d2b45230d0333653c84d572834cb0000fcfe117a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137872, 17400, 0.18, 0.18, 'mg', NULL, NULL, 'Pediatric', X'789c0b4e2d4b2d4a55c8cc2d48cc2cca4dcd2b51d070cec8cc49d10d284dcf5048ce492c2e5670d6b45230d033b450c84d572834cb0000d44f10b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137873, 684, 300.0, 600.0, 'mg', 'PO', NULL, 'Adult', X'789c333630d0353330c84d5708f0572834d3b5c850d0c8cccd4d4dc94c2c49d52d4acd494d2c4ed554c82f5228343402cab9066902007be30f11', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137874, 684, 4.0, 4.0, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c732cc84b4d54c8cc53c84bcdcf4b2c49b5523051c84dd7cf4e57f00c53c8c94f4cd15128c948cd53304288161a1a650000f6ae1146', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137875, 153, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137876, 266, 25.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c3332d5353230c84dd74f49ac5408f05748c92ccb4c494d510874d14dca4c010084fa0931', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137877, 266, 25.0, 50.0, 'mg', 'PO', 1, 'Adult', X'789c3332d53535c84dd74f49ac5408f05748c92ccb4c494d510874d14dca4c01007fa10904', X'789ced5a6d6fdb380cfe2b423edd80bc77d9ba6c1810a41ddabbadebdaee80c379673016130b91254f92d36643fffb51ce4bf3e2364bd7bddde54b10db14453e7c4853923f97b8c906a182044b6d563a4f85d14a4b889c56582ab35266a47f103b97da76ad7629869854b519f87fa2b62e6f230329f2109c1fd6ac379f54ea8d4aa37e51df6fd79bede67e75fff1d3a7cf9ee5b21839a19525c9cfa50e4f8412d619f0f7f25b0eaf722d17e314db81ea282762fa6b1c2a2b4618a8e7814ab5036b4596309b82116ac0b8c80c3a11d16306926beb906c446630c2d469c3403918683f57a00eb48501b257da24b6cd9aad72ab5e6ed4eb813ad39943cb749f2d1bd6666f0dc84075759268c52e0c706427041f0def48be0044d65bf4ef9a6e39e849f4577f7fa02b29d430bfb87174d5c3cd01581b41f3dce8bb1d9ccd9a4f6763c3e9d8703ef6fa83f7a6c333e94202909e2d85abc0fbd221c70496a49aad4ab35e4f06350e6376fa962c1b098e9cbd3ba8f4040f148584a11fc5c80c1d0970f4f052b898b03f7a15a872a022614c4cf35bba62da044a611a1b4d26323b56dce824477001766ff7d11cae159a9145ad3b0c3a77605c9b359ad55632f002ef0e6ed37e433b619372981a9180192f4d4624ab3cf6fedfa5490f416222a03cc7be2214cf22e4ab86376e81f2dd71916a02b01c9efc75d409bb92d00d8f8f8f6bc77faee89c9916a8f71673e49975a03818ce9c4170092af79c2534a75011dd2029a7d91c42e813026cff72c8fa14ca4b6d2c2a4f419a9c893efbc36b23ab02f5868439de68c8a7fea8b997cab93d45e1398bb5e493b12f5b2c39fc587b4d61677ea4a314a51c7ff9d84ffeba084d616ce6f270082e740a2e26262f7adcaa4f0839f3fa6dbfcf24f450b2cc16f1a813290c47991c5076d83b354d99b308e99dcabfa856108c9b93d80b2d558479ca7cc1d8b9e89286e21cbb5bd5c96c4c381f33a9213fb22cac96a85d5dd8d5855d5df839eac203e76261aaef9271978cdf2619bfb6e017d07547b21dc98a49f660cc5865dd8e1abf3435fe0fe15b2b94ffa1f83d802fabf0fc38671e76e62fdf5acb273f454ecb44435de6369b556173f9355dd9abee11f186b754504ff1ab365b12cad29ceab3b2bb996deb3d43e8d0ba6543a892ef3d25786ac93fcd555ba8095e346651ec2b23f8fd30d9dcacff34a07c67d3b6e4fd798a9100199eea34937003e8ccb2538303052a1ab3336187ec95dfbb36816ab36e5118ce5091ae820cea9aae642f1af5320395196a447cbd8628737ecb9dc63091a4208c7f93b459a49533400d8a88fcce4d510e2095bae25ced42e6ed61c047c24eb77d583c915f98e55ecbe6423036af600ffce9893f1950031b0a451dfe54cd7421fbcd505bcb92ef09db03066a4b4e771791586374474a3483b1af30916f7a6afe702b5033ac0335c13a50ab109727d0076ab1170954877361c90ffaf58dcb7d8f7516956ea6d4d1a2f4eca86584d45a856708d1bad7457438472374b62c070ad2782ce1caef8c9e3b1ca1b295df75acbc8bb30d9840397d4551c2940a94490825456d9b96e37c3fd5e349fc9c5831092bfaf0eb3416520071999326aa8689df07ba0ad4086c9449e1fce09c003a572fdc7816843e0849eb9640a12407fc4c940222e981a4345a89489959b2da0b8331f1d8c5748f144bcc863aa5ce934206034341963a1abbc916b08bc9ad5e7e9d8b142d82f3b3bc25ac1450cd85da4827c2e736e9ed71faef0d8e0c24a9ad117554a092cc4612a7f7081fe10d43f0ce02872826532979fb99dfc8f28f3f7da216d692a4d589d212c9c56df36e17dabb42bbb68afda562fbe3adddb6b78e81981469a907cbdb5a4720fb1529fad8668dea5ea519b3df52205a38e689f6a8cc1a7bd5fd4ae349b5454f3ce946c812a4a934510aed236a89a6573669b3d7f4985a93c3abc8ef70f853f8f7466c7bce9e1bfc06a318f24e4df7c34eb4f6ad4167fa71c027b4855f0f585a083317a37f27381f03ad465a66fe14ca65bd4c6279b6cef5ebe09349de5c825f26d3cd9ed5269dbc1ae9f67449ed05ffa0a78ed0f1e6dca3d3430c3bd2eae597b03f0eeb2e9c85d1fbcc461edcfbbec7ee77b4d0fdeaa38505b3377c0d31159cf55e7d2a28c4ebe55af9e230d59425245766efd30b7d407f5f6e0bfaf5f5bf1f87c6ce', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137878, 266, 12.5, 12.5, 'mg', 'PO', 1, 'Adult', X'789c0b2e492c2ab1523034d233cd4d5708f057087401003ab30577', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137879, 266, 100.0, 400.0, 'mg', 'PO', 1, 'Adult', X'789c333430d0353130c84d5708f057087401001af1039b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137880, 266, 25.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c3332d5353430c84dd74f49ac5408f05748c92ccb4c494d510874d10df4740100844c08df', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137881, 266, 25.0, 25.0, 'mg', 'PO', 1, 'Adult', X'789c3332cd4d5708f057087401000ee602b0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137882, 266, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c15cc410a80300c05d1abfc1be846105c0a22b8f600d1a6b568534803c5db5bb78f61f6c2a8d12e142371a40ea64c96586c42a21751ce06adb28ca14fa1730dc91b2bc67ac36745cd5a58a204cceb82e8b1fdb7e3e10f2fd520f9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137883, 266, 25.0, 25.0, 'mg', NULL, NULL, 'Adult', X'789c1dcb410a80201005d0abfc1b0891abc05dabec10434e2aa993e6c6db476d1fbc9d061c1f8de96174c1a4b347158778228c9bdb458973a40541d2af1b8c465eabb290866ff658626198397be5ec0b88ff1b86', X'789ced5a6d6fdb380cfe2b423edd80bc77d9ba6c1810a41ddabbadebdaee80c379673016130b91254f92d36643fffb51ce4bf3e2364bd7bddde54b10db14453e7c4853923f97b8c906a182044b6d563a4f85d14a4b889c56582ab35266a47f103b97da76ad7629869854b519f87fa2b62e6f230329f2109c1fd6ac379f54ea8d4aa37e51df6fd79bede67e75fff1d3a7cf9ee5b21839a19525c9cfa50e4f8412d619f0f7f25b0eaf722d17e314db81ea282762fa6b1c2a2b4618a8e7814ab5036b4596309b82116ac0b8c80c3a11d16306926beb906c446630c2d469c3403918683f57a00eb48501b257da24b6cd9aad72ab5e6ed4eb813ad39943cb749f2d1bd6666f0dc84075759268c52e0c706427041f0def48be0044d65bf4ef9a6e39e849f4577f7fa02b29d430bfb87174d5c3cd01581b41f3dce8bb1d9ccd9a4f6763c3e9d8703ef6fa83f7a6c333e94202909e2d85abc0fbd221c70496a49aad4ab35e4f06350e6376fa962c1b098e9cbd3ba8f4040f148584a11fc5c80c1d0970f4f052b898b03f7a15a872a022614c4cf35bba62da044a611a1b4d26323b56dce824477001766ff7d11cae159a9145ad3b0c3a77605c9b359ad55632f002ef0e6ed37e433b619372981a9180192f4d4624ab3cf6fedfa5490f416222a03cc7be2214cf22e4ab86376e81f2dd71916a02b01c9efc75d409bb92d00d8f8f8f6bc77faee89c9916a8f71673e49975a03818ce9c4170092af79c2534a75011dd2029a7d91c42e813026cff72c8fa14ca4b6d2c2a4f419a9c893efbc36b23ab02f5868439de68c8a7fea8b997cab93d45e1398bb5e493b12f5b2c39fc587b4d61677ea4a314a51c7ff9d84ffeba084d616ce6f270082e740a2e26262f7adcaa4f0839f3fa6dbfcf24f450b2cc16f1a813290c47991c5076d83b354d99b308e99dcabfa856108c9b93d80b2d558479ca7cc1d8b9e89286e21cbb5bd5c96c4c381f33a9213fb22cac96a85d5dd8d5855d5df839eac203e76261aaef9271978cdf2619bfb6e017d07547b21dc98a49f660cc5865dd8e1abf3435fe0fe15b2b94ffa1f83d802fabf0fc38671e76e62fdf5acb273f454ecb44435de6369b556173f9355dd9abee11f186b754504ff1ab365b12cad29ceab3b2bb996deb3d43e8d0ba6543a892ef3d25786ac93fcd555ba8095e346651ec2b23f8fd30d9dcacff34a07c67d3b6e4fd798a9100199eea34937003e8ccb2538303052a1ab3336187ec95dfbb36816ab36e5118ce5091ae820cea9aae642f1af5320395196a447cbd8628737ecb9dc63091a4208c7f93b459a49533400d8a88fcce4d510e2095bae25ced42e6ed61c047c24eb77d583c915f98e55ecbe6423036af600ffce9893f1950031b0a451dfe54cd7421fbcd505bcb92ef09db03066a4b4e771791586374474a3483b1af30916f7a6afe702b5033ac0335c13a50ab109727d0076ab1170954877361c90ffaf58dcb7d8f7516956ea6d4d1a2f4eca86584d45a856708d1bad7457438472374b62c070ad2782ce1caef8c9e3b1ca1b295df75acbc8bb30d9840397d4551c2940a94490825456d9b96e37c3fd5e349fc9c5831092bfaf0eb3416520071999326aa8689df07ba0ad4086c9449e1fce09c003a572fdc7816843e0849eb9640a12407fc4c940222e981a4345a89489959b2da0b8331f1d8c5748f144bcc863aa5ce934206034341963a1abbc916b08bc9ad5e7e9d8b142d82f3b3bc25ac1450cd85da4827c2e736e9ed71faef0d8e0c24a9ad117554a092cc4612a7f7081fe10d43f0ce02872826532979fb99dfc8f28f3f7da216d692a4d589d212c9c56df36e17dabb42bbb68afda562fbe3adddb6b78e81981469a907cbdb5a4720fb1529fad8668dea5ea519b3df52205a38e689f6a8cc1a7bd5fd4ae349b5454f3ce946c812a4a934510aed236a89a6573669b3d7f4985a93c3abc8ef70f853f8f7466c7bce9e1bfc06a318f24e4df7c34eb4f6ad4167fa71c027b4855f0f585a083317a37f27381f03ad465a66fe14ca65bd4c6279b6cef5ebe09349de5c825f26d3cd9ed5269dbc1ae9f67449ed05ffa0a78ed0f1e6dca3d3430c3bd2eae597b03f0eeb2e9c85d1fbcc461edcfbbec7ee77b4d0fdeaa38505b3377c0d31159cf55e7d2a28c4ebe55af9e230d59425245766efd30b7d407f5f6e0bfaf5f5bf1f87c6ce', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137884, 266, 50.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c3335d0353230c84d5708f057087401001841036d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137885, 266, 50.0, 200.0, 'mg', 'PO', 1, 'Adult', X'789c3335d0353230c84d5708f057087401001841036d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137886, 266, 25.0, 25.0, 'mg', 'PO', 1, 'Adult', X'789c0b2e492c2ab1523032cd4d5708f0570874010031970518', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137887, 266, 1.0, 3.3, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d435d633ce4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d10df47401009b7d09ad', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137888, 266, 3.3, 3.3, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34dacb05230d633ce4dd7cf4ed74f49ac54282d5028c957303230c805f301ab320a52', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137889, 266, 125.0, 375.0, 'mg', 'PO', 2, 'Pediatric', X'789c333432d5353637cd4dd7cf8d33d24f49ac5408f05748c92ccb4c494d5148ca4cd10df4740100bdca0ae4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137890, 266, 375.0, 375.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303637cd4dd7cf8d33d24f49ac040032aa058d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137891, 3592, 1.0, 1.0, 'g', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652305448d73756c8f5010054a106c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137892, 3592, 7.5, 7.5, 'mg/kg', 'IM', NULL, 'Adult', X'789c734a4c2e492dca4ccc51f0cc4b4b4d2ec9cccf2bb65230d733cd4dd7cf4e57f0f4d5f70c53283434ca00002cf70d63', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137893, 3592, 7.5, 7.5, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c734a4c2e492dca4ccc51f0cc4b4b4d2ec9cccf2bb65230d733cd4dd7cf4e57f0f4d5f70c53283434ca00002cf70d63', X'789ce556db6ee33610fd95819f76513bbed4de04425f6c6f1735daa441ba1714f5c2a0a8b1c49a1aaabc381116fef70ee5248e1da341b68be6a16f22359c39e7cc85fcd2ca6cc817244a6c25d0fa59f0572d15b5dad00a56c7bdc2fbca25ddeeb55a6179626c1ebf5477cfd4492b2acc16c2c71383dee04da7d7eff47bef7ba7c9e84dd2eb9ff48767a3d351638bd22b438e2dbfb4c659a948396f45dc6bb63cde345eded71526731ab381c9752d8d5319cee9ad71224778676ce912e843defd1eca5fe674658247076609fb3e13989db761f6b1091dd287d137bce545aa31aefef8cc2bad68d52c7630f6e33fadcb81fde6738c32ce82f60b86ae28df233911d2a35542c38c96b7d012383d199579779533f4eeec23fcd51f147362c660527408151343f2ae0d815722fb33388f195cfbc87e36f904df41ef640837f06acc8b4edc7acd42367690193e930ac7070c81431b4ad0b846ed9ea750c3eb123325bc55f25f71fb8ac0bf5528d9f3e2d254418b5d3dddc5beb498932059c395722b78c7508c4de0ed9150ad2b24f67484c0d44e358c7a9db35e02b95a6304db190c3917cd9f7eaf33baff3318764e07777f7ee8dfef0fcfe27e6b9fcee6297aff11a4678a3e35c44da52853f288e463add1e6357803520be7ba71b2707411a22da82537b30b7aa93c42c1bd6d1d92535ead95afe7642363506525942db9b8db90615167db1e6e8334248365230f8455618d37374a024f02dee12e98d3f62857b50899e264d7c0fdb246e755ca15626119483ef2c56eb68ed89630ecb975736ab6cae064e321530e450c859a45b346d7cc44a4c493486826827ca2e26d4339c360506d28545e6c3bce5b143e128b5e0d099e555d454bc1716270d4195a5d7f4552c6d93a4ab9b842211f27e562275623f38ca4c5a6f96dec8b6be50b782cfd3dec36ec083d60706e284a7c7b72a76c8562d56565021fdfce94395dec6938d146ae449ce34d5ff2bcb2e82ac5698e19ab8415ba76ca41659c534c7a8b50500d36cef77840ec5f19471a7aa2855c2d26e666f14958e2163ad424ec24e9feeabfb13c87bd1ea7158f4113fe39330f70c0abe335fcfa56cd3bbb36ec17687a2bee110453539607f7eb4f282c6b039aa56e8357c4390dfcc5e5e4556ee634f970c1cd1269b1de845ca3b8e6bacd9e3bcc5e3e1d8705f2ffcec70bb03f4cc04bd2ffd6b19ffb642a04df1792eb34aff74108bdec68b5c404069d21149687e739b22ba3952b1398fe7e09c3516f4e3fde3092edd3f603c33e26f05320ce5116828768b930cbc5583e7a7bcf885f6e4be4d9bc6d3aee2b8f8a9f8b35f902e380e6457affbe93a835a435a4f16dc03af213c0aad438c3172330b4c07a3e17e566f337da8f5a30', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137894, 325, 400.0, 400.0, 'mcg', NULL, 1, 'Adult', X'789c0b4a4dcecfcd4dcd4b494d514849cccca95448ccc9c92f4fcc4b4eb55230313050c84d4ed74f49ac54d0c8cbcf2b284a4dcf4bcc2bd1cf494c2e492cc9cc4bd7d4513043560453011437451647680000c4a92663', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137895, 325, 1.0, 1.0, 'mg', 'IV', 1, 'Adult', X'789c0b2d5028c95730cc4d57f00cd3f7f455c82f5208f0574849cccca9040071c00865', X'789cd556db6edc3610fd95c13e3580bcabf52569f450609d348881ba3136a95faa40e092b312615e04928a2d04fef70ea9bd3a9bb8d997a26fd270383c738673385f47c275756598c65101a37756495e312ec5288351e754343621b4be984ceee51deab17575fc92937d5fcf1d6b51542cc42da7f9e9cb937c7a32cd3fe5af8a8bb3e2ec6c9c9f4ea7f934f9220fd21a4f9e5f4733a1a5913e38166dc914f02145f9d4b758c0ad0c8c5c4af3d67a5623bcb34efba23473db05f46097b01fa280abdbc9d57506d631559a0fa1410731415fc0d22a1630832f434cb87c9df0748b5d488f640a6ca130fefdfd99fe943477c34f5c9b894e858ad04853efe19d23b75aa311284030a97a604ad97b6638a5719ee7a0793d11ac875f8c35adc3da3013268af140c04dfd228397bb4e6b0fb25fecdab71b4a938a00b108207029b944c3fb0c34d64cd985623ec465835a32a2ecaf168285a9ae078a8821b8f930402dcd359326a019d0e6e3733d1c470e11eec901bc717f3efe75c771ed145776615e63686c70f840ec138407021afa2222596da53acd4b7341fff788774714e5068564c1d18d3c5098832c95a6fb111d7a4b4769a45952563ea374a730805e1b4fce7b5bc0102a1f9f6d567f3b87b84044ae4c4724f5b1452e99aa6e6cdb29b6ed99755e3703ddbc877962baa4cb3f2bcd1f03f3d68093fe2e1aaf12d4f40bb15774ec8c3965a74024ba0a303624720c8ad2bcc796c59b7370f14de3ac897c2a6e1b62d6eb023455d120dd7b69b843e66307584f79fd54d2dfcfec79397a1b756c70f69534d526c2880edc06dee7e6f9b01bff2afa579c2e706d9d24f08fa9446fac21dd9146487ea04033a5d0d57dbc1b9c9ad14fa2da1e25395fd079ace6c8f8b7a71c0838fa884edaee101aaa1cb78437c9edfeb943425a3fd1e14b2620909420551734c96e1345c89116a71a537fffc93a8f2c03657d5264d6b61864a0ce217e969da7a33290ce91ec2ea4a2decfc02bc41604c976e716b1cb9e6279b639fe75864fb9f9dfa4f89f02fd59016e98d38c5b65eb7e0ff17ba696274a2eb148ef005bac2463a531a5f9fd81246378b993241d71f835f286d108a02bbbac66fc9b498232a7060aa44ad48901a9639b5e38bbdcbc0b19dc379237203dc91847ef99eb695aa0c181a60d5249747d20d96b2d75bea477a0ed1c8921bdac14b1e9b5147d1c2cc0f786c68de411e70b9b627b7a8ed76967694b434c4b11036c57c6c7bc0f88d54c79bb97ebed66b6d979ec8ed5e1ef06fbb16aaeb65597afab9d6da4988f8fff003c8c8f7e', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137896, 325, 0.4, 0.4, 'mg', 'PO', NULL, 'Adult', X'789cf34dcccc2b49cd4bcc4b4eb55230d033c94dd74f49ac5408f057d0c8cbcfd32d284a4d074a96e8e7242697249664e6a56b2ae41701155a2029842902c920d40100728b1edd', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137897, 325, 1.0, 1.0, 'mg', 'PO', NULL, 'Adult', X'789cf34d2dc9c82f294aad482c495528c9afc84cce2ca9b45230cc4dd74f49ac5408f00700da510c23', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137898, 325, 5.0, 5.0, 'mg', NULL, NULL, 'Adult', X'789c33cd4dd72f4f4dcd06000c4002e5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137899, 325, 1.0, 1.0, 'mg', 'IV', 1, 'Pediatric', X'789c2b2d5028c95730cc4d57f00cd3f7f455c82f5208f0574849cccca9040075200885', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137900, 325, 0.1, 0.1, 'mg', NULL, NULL, 'Pediatric', X'789ccbcc4b4bcc2b29d65130d03354c84dd74f49ac0400401b0630', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137901, 325, 0.3, 0.3, 'mg', NULL, NULL, 'Pediatric', X'789ccbcc4b4bcc2bd135a9ccb752282d5028c95730d03356c84dd74f49ac0400898c091e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137902, 325, 0.4, 0.4, 'mg', NULL, NULL, 'Pediatric', X'789cb33351a8ccb75230d03351c84dd74f49ac0400275a04c8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137903, 1611, 1.5, 6.0, 'g', 'IV', 1, 'Adult', X'789c33d433d5354b57f00c534849cccca9d45148c92ccb4c494d5128b450c8c82f2d2a0600a2900a90', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137904, 1611, 0.5, 2.0, 'g', 'IV', NULL, 'Adult', X'789c73cb2c2a2e5170c92f4eb55230d033d5354a57f00c53a8503004006516070f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137905, 1611, 2.0, 2.0, 'g', 'IV', NULL, 'Adult', X'789c334a57f00c53482d4b2daa54b050c8c82f2d2ad603004073067b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137906, 1611, 30.0, 120.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c3336d0353432c84dd7cf4ed74f49ac54f00c5348c92ccb4c494d5128b450c8c82f2d2a0600b8dd0b38', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137907, 1611, 10.0, 40.0, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523034d03531c84dd7cf4e57f00c53a8503004008839087d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137908, 1611, 6.0, 6.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052305348d74f49ac040016ed03ab', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137909, 3826, 0.5, 0.5, 'mg', 'IV', NULL, 'Adult', X'789c33d03355c84d57f00c53284a2cc84c5128282dce502834d635cd55d0c84dac50b05530d0333051c8cdccc9c94c2f4accd5cf4ed7040094830fbf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137910, 3826, 1.0, 1.0, 'mg', 'IV', NULL, 'Adult', X'789c33cc4d57f00cd3f7f4d52f2e4d0ad44fcd4bc92f294a4cce484dccc9a9542834d635cd0500d0db0be5', X'789ced595b6fdb3614fe2b07060624806f712e2b8cf5c17586d6c03a7b4d9697b91068ea58e24c912a49a5518bfcf71dcab163c96e62a749171479316491e7fef15ca8afb5d06451a05882b52ed47acee85428acd5a19619e95fc5cea5b6db6a7d16334c9ada44fe49b456775a6e588a61c09c27e8b43b278df641e3a07ddefeb57bf4aa7bf0aad93e39ee74dac55ee44e686569e7d7da5b5468982c9e1d5e15e4e7798addb1ea292778ac25893091e063f541670e2de829f4c24428619d619e53170617adc1fbd660d83aebd70155a86985c7c8641d144e3229be605887d1b00e8e54e64cb6741abb98c9c4f3edeb24d10ace0d0b11fe243fd82e2c8cabfb27fcc2ea70c6e4f9ca3b3d42558781d5a9d3254f64935503afe995631389fedf3f1fe91fd9332bfedc1a5cb1740bd75708ae3f7a39bd30932e38d556a8a8e4d00d7ad5cef284344fc8813c9890e5393326ce5d9c08166813f42e8289d47c56e2d36e1e431291b781a22d4248331bc3a7c3c671027b09bb82d7d06eb68f2011528ac8b0a4358bf66b6507783dfbcc8482f18024a275c1de5cbccdad238bf87e49e44121cf47970cf8abb51a5b99cf656f903034115314626dd398390c9cbe125cb8bcccba71b8647ed65f637dd06e1cb6933a78c30e21d496f8af4b1abc39ab07a3bf4f2b7e3a6ab49b27de57a32168b314029f8e1a27f12697e45cea546224582bc94323981536102acc8a9055f4ee4048802b4ec2c12f60b5ccfc262083c009822f844cc8bc2ae60e28163afc484454d1f8028967098927745a15013f91d71e6acadaa17806b63c950edb97c9428d11527a70863253f8a8e52de85482445d0bfd1c5298285515311a12841b9d8d58bb3b696dc17b630adb21793da288056837b0bce156247482b18730e1b7dd2cc4249d7d02f4771cc98ac0ffb9baed06881dcbd80b229e13229ec285dfaa6a3fab0f1fd1be1dabdf0f32f0e9b4d8b1029ea5c80593c148a79964b76e5a881e198c14533c870fb4aaa2318dc5fdb1fa8371b71892d594290746d81970a6947630413099c41068b2a6f91a1593309f1fbba034b0f0dfccba04152dbec3d4e7ce6f2d0f144ea7de9c4b04a1887f9108814e87b2a9f4723d396dddd4fc6d3524570dbc7f4a3ef5f71af3cd3e64c192c3cdbcdcd78af4a3580abec1a13d2969b8cec169e09259dbf2d7246335322261268748b28c533df1a04e0db5273625cf14c1260a4515407f06b21b8da01d3c66c9040dbd88242e691f00835e7889c662f001195fd7796327e435c8cafb6eea1484b95d14c1b1aa8f95a35cb6521829ac538828a40aacd49fa99b275328ba2cd11945127ea3f12f897c6b9f53c4338b1464aa783e8f12908ae2370782c70737c82c416dd8014eba65548e494702569e6a87ca167ffae4150f449b0ac39c263f8748deb5f3d5b72b7eaba6c3e20ea76c244971222d425b872b349aca7061d51b9951810ee152d8622dc4857292711fdf3909e6de20414f54249caf1413c1ea60b314cd54f8d30833f457504eaccd815b417a4318ee47f5a2c758252269b75c2b41bc9fe37985a0c46d253cf7735add5ce2d2bf89da3da6f95d25bad588df4dbbdc393fdb3f29ead78ae40bec5f60bf02fbe780875d47fb989984712d7554be577ac7e4b421c514bbd0691e436cec58bd476245b3944dba10cf3b92b1fafd8af49ef738c6b730633554169defc1e64512f60617fbf01a3a8da344d0893acde61f0ed6771cc7e60126bc47aaef8a940af434e8ad5f8c8c283f589a3f998bb5cc0b9d1799c102b553996df52e7c7e58dcaa3ca03d440c7ad2ea720ba39c58029c93fbfa8682e4b3142528844f99e03372d914c96d1cd7beb8c0f2baef3bbe6bacc8dfeebbc62a41f930dda5fc16a7ec863cf0e441411edc929724dde5879d3eccdc5e98d2f1bcbefe0f7cc721d3', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137911, 3826, 1.0, 3.0, 'mg', 'IV', NULL, 'Adult', X'789c33d435ce4d57f00cd3f7f4d50f76d64fcd4bc92f294a4cce484dccc9a954283434d03536c8d551c84dac50305648c92f4e2d060086ef0fbf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137912, 3826, 0.4, 0.6, 'mg', 'PO', NULL, 'Adult', X'789c33d033d135d03353c84d5708f057c82f52f00cd3f7f4d50f76562834d135cb0000780f07e1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137913, 3826, 0.01, 0.03, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d03330d435d0333056c84dd7cf4e57f00cd3f7f4572834d435ca0000577f06b2', X'789ced595b6fdb3614fe2b07060624806f712e2b8cf5c17586d6c03a7b4d9697b91068ea58e24c912a49a5518bfcf71dcab163c96e62a749171479316491e7fef15ca8afb5d06451a05882b52ed47acee85428acd5a19619e95fc5cea5b6db6a7d16334c9ada44fe49b456775a6e588a61c09c27e8b43b278df641e3a07ddefeb57bf4aa7bf0aad93e39ee74dac55ee44e686569e7d7da5b5468982c9e1d5e15e4e7798addb1ea292778ac25893091e063f541670e2de829f4c24428619d619e53170617adc1fbd660d83aebd70155a86985c7c8641d144e3229be605887d1b00e8e54e64cb6741abb98c9c4f3edeb24d10ace0d0b11fe243fd82e2c8cabfb27fcc2ea70c6e4f9ca3b3d42558781d5a9d3254f64935503afe995631389fedf3f1fe91fd9332bfedc1a5cb1740bd75708ae3f7a39bd30932e38d556a8a8e4d00d7ad5cef284344fc8813c9890e5393326ce5d9c08166813f42e8289d47c56e2d36e1e431291b781a22d4248331bc3a7c3c671027b09bb82d7d06eb68f2011528ac8b0a4358bf66b6507783dfbcc8482f18024a275c1de5cbccdad238bf87e49e44121cf47970cf8abb51a5b99cf656f903034115314626dd398390c9cbe125cb8bcccba71b8647ed65f637dd06e1cb6933a78c30e21d496f8af4b1abc39ab07a3bf4f2b7e3a6ab49b27de57a32168b314029f8e1a27f12697e45cea546224582bc94323981536102acc8a9055f4ee4048802b4ec2c12f60b5ccfc262083c009822f844cc8bc2ae60e28163afc484454d1f8028967098927745a15013f91d71e6acadaa17806b63c950edb97c9428d11527a70863253f8a8e52de85482445d0bfd1c5298285515311a12841b9d8d58bb3b696dc17b630adb21793da288056837b0bce156247482b18730e1b7dd2cc4249d7d02f4771cc98ac0ffb9baed06881dcbd80b229e13229ec285dfaa6a3fab0f1fd1be1dabdf0f32f0e9b4d8b1029ea5c80593c148a79964b76e5a881e198c14533c870fb4aaa2318dc5fdb1fa8371b71892d594290746d81970a6947630413099c41068b2a6f91a1593309f1fbba034b0f0dfccba04152dbec3d4e7ce6f2d0f144ea7de9c4b04a1887f9108814e87b2a9f4723d396dddd4fc6d3524570dbc7f4a3ef5f71af3cd3e64c192c3cdbcdcd78af4a3580abec1a13d2969b8cec169e09259dbf2d7246335322261268748b28c533df1a04e0db5273625cf14c1260a4515407f06b21b8da01d3c66c9040dbd88242e691f00835e7889c662f001195fd7796327e435c8cafb6eea1484b95d14c1b1aa8f95a35cb6521829ac538828a40aacd49fa99b275328ba2cd11945127ea3f12f897c6b9f53c4338b1464aa783e8f12908ae2370782c70737c82c416dd8014eba65548e494702569e6a87ca167ffae4150f449b0ac39c263f8748deb5f3d5b72b7eaba6c3e20ea76c244971222d425b872b349aca7061d51b9951810ee152d8622dc4857292711fdf3909e6de20414f54249caf1413c1ea60b314cd54f8d30833f457504eaccd815b417a4318ee47f5a2c758252269b75c2b41bc9fe37985a0c46d253cf7735add5ce2d2bf89da3da6f95d25bad588df4dbbdc393fdb3f29ead78ae40bec5f60bf02fbe780875d47fb989984712d7554be577ac7e4b421c514bbd0691e436cec58bd476245b3944dba10cf3b92b1fafd8af49ef738c6b730633554169defc1e64512f60617fbf01a3a8da344d0893acde61f0ed6771cc7e60126bc47aaef8a940af434e8ad5f8c8c283f589a3f998bb5cc0b9d1799c102b553996df52e7c7e58dcaa3ca03d440c7ad2ea720ba39c58029c93fbfa8682e4b3142528844f99e03372d914c96d1cd7beb8c0f2baef3bbe6bacc8dfeebbc62a41f930dda5fc16a7ec863cf0e441411edc929724dde5879d3eccdc5e98d2f1bcbefe0f7cc721d3', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137914, 3826, 0.01, 0.03, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d03330d435d0333056c84dd7cf4e57f00cd3f7f4d52f2e4d0ad44fcd4bc92f294a4cce484dccc9a90400e8a30cef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137915, 3826, 0.01, 0.03, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d03330d435d0333056c84dd7cf4e57f00cd3f7f4d52f2e4d0ad44fcd4bc92f294a4cce484dccc9a90400e8a30cef', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137916, 3826, 0.01, 0.01, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c33d0333054c84dd7cf4e57d0c84dac5030d033017215f28b802c639044ae91a64280bf7eb0b342a189ae590600349d0c9a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137917, 2901, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137918, 1, 60.0, 60.0, 'mg', 'PO', NULL, 'Adult', X'789cf34b2c4ecc5148cecf4b4f2d2ec9cccfb3523033c84d5708f0572834d135cb500808f20300da5b0b3c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137919, 1, 60.0, 120.0, 'mg', 'PO', NULL, 'Adult', X'789cb3523033d0353432c84d5708f057c8cf4b4e0500278d04d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137920, 1, 5.0, 30.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d235abb45230d53536c84d5708f0572834d135cb500808f203004fbd0661', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137921, 1, 30.0, 30.0, 'mg', 'PO', NULL, 'Pediatric', X'789c33d33534aab4523036c84d5708f0572834d135cb500808f253f00f5230c94dd7cf4ed74f49ac5448c92ccb4c494d512834cb000057810eaf', X'789ce5566d6f1a4710fe2b2b3e251204705de2d0a812c26d6329d8083bfdd09c8586dde16ee47db9ecee115f23fff7ce1e766c30aa63a4b495fa01e9d89d999d79e6edf9d252becae7160cb686a2350d5829876581ca93c5565bb42aafd34d11631986ddee67ba42f3caf93c7d51778742901e4a54738849efa07730e8f4fa9d7eefa27734ecf5868747affaafdf1cbd1934b22823391b58f24b6ba40c590ad1433a6b8e225e37562eea1287993d46e96c8e21828d996d6736d4a6845838430623499670017214bf3a6f022bcc5c153108b7149bc687627a96d9b133c65971e141a1386508c2509c570a96a8dae214afd71f7f70741eaf3bc78dc3d5e2a1cf377c1461a131fdfb78c9ff34d9abe6cfbdf30fbd7e1ad10d69b67f6f672bd8a74d9d6f29dc5c267f47aad271ce4091cd37403e85005adcbede8034e8999c91129f0e3b83424c67a7999d7a829282c99aeb4effe056c45989fb027467f31bcaed4e721dca141541f4247785f3f6a01e8ac0398c7517974b92206b615d1409db85a6c0359bd983ce80c57eecfcf038d40147c7778f6ec4d94c1c9abc7b957715d442d18a142af1695064f6e746651bb7e701d384765ea224d0f3a92b2b0df74d7217dd0e938c23e616acace733d6d882e3eba51843c4dc79fe680b583952a20a28c88a25f91005e3c99d10d1b7365d4c5ebd07191b67e69ec2d586fd5faea5c7c838b0a18547604b86f4d54f82bc2736439a622d3c96cedf4ad9caa7a4f1e7926b3d88179a0ca53b05115e66f663ff72870b33b40ccb8e7c8fa14a9e89cf140b7e87a50471fd9337b8eebb87869e82ff3b40b99dadff0d96ff46a0db60ff3391eeffca33a7c3d859de6464154fb5c7b361a435fabc16d109a921846edaf169dd59c9bb202d16e13cbb21f971f1e26dff50bd1493d1d9492adecc9ee30a3d8a82572e836e039bff7a381e1db39d07c1f08e9d90565de314f26add546b0b099e27b4e4191938b96cfc5d735dd49e7ba5d922cd41ae6b8986a02d8e27bcb4b7f049afd39f153fcf2acef34399fd4d43c5c1c01ed88d148712703e4390df3657cfd193ab36e52627991d2d6991d993200b765ef2e6e46aa5b0a3cfd6446393d17834ceb7390b21b268b0fc6b735507672c41664f819301dd554a1857d31d7277f998fe3e7ef4d0932be5d9616c03f1df88e3fb79f1cc4a9a16e00d305e2eaf37dc79077ad9d1b444660f9d7ee2051364430c6c3043f19e56a984d7b3afe1591f983b83aff7706182b200e6b566ee96f3917c449c47ba2c4080e299c36dc6d985dc251a9c5a9321096205c131e50b8945355d9d666c22825dc6b224eee9b4de0c375b805762a483134c0e4de224acbde0b01e5a4f33a5648dd0984f737ae179ea14cc64f84ec3f59adaef418710e7e9f18de03ecc4ef6a59cb7aa7fcf36931013cd9b9bbf0015267a28', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137922, 1, 60.0, 60.0, 'mg', 'PO', NULL, 'Pediatric', X'789cb33334aab4523033c84d5708f0572834d135cb5008080200410f05c0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137923, 3326, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c2b482c4dce4c4a4cceccc9492caab452303430c84d5708f057087451a830cbcd0700bc610aa3', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137924, 3326, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789ccb2dcd29c94c4a4cceccc9492caab452303430c84d5708f057087451a83034cacd0700c9ae0ae9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137925, 3326, 50.0, 50.0, 'mg', 'PO', 1, 'Adult', X'789c3335c84d5708f057087401000ed702ae', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137926, 3326, 50.0, 50.0, 'mg', 'PO', 1, 'Adult', X'789c3335c84d5708f057087401000ed702ae', X'789ced59df73da3810fe5734bcdcdd0c69806bd21ef7949266f2d0365c4a1f6ece1dcf62af8d2eb2a44832c1e9e47fbf9521801d27d04c734d6678028bdd6f57dffe90d67c6bc5264f430919b6faac750cda2a89ad366be546f8958973daf6f7f7aff80566af9449fd37bebf266823031ae3109c97ef757a877b9dee5eb733eabce91f74fbbdc357bf77dffef1a657ca62e4b8929624bfb58ee28c4b6e9d01bf562e399c9528a342633f9047d2f131578e47813c5616526427ca64b6cf7a07ed6ea713c873953bb44c25ac8ad66767064469321faf5bbda125076381fee99faff424b8bc281f56e657763733b1267bf3d5a31fc5b97021b9cb655ad9548337ad539016e52f368cb945b018fe2a501b658bdf2aaa1af2888f21e2428029fa8cf69ea56c78c6fe3a66b3c34c05f28b4576c5dd84199e40a6b90c64467edcabd4ed356ab559245402d79cc82ca3bbc695dfdcbb5c0895db5063a6273c553caef879b0b4b086ed94e61108a60cb3857598f97046ca10658a1e0d81d80653c768328aa5e3369ca0d1e87842b1e7f61e830d08c3c1b0223c344a4f0a01336e176cecc75078f5984f798c31c1ec8d791cc8b3246102c628586e31902383e03294ae4662afcb08c006f29372ac6bdd1ee512324a53e9fef49ae5fe03e90ccfd04d94a6cf1a7683d71f81c2c521b4b9d606adadd7c6d283cbab8b15cb81d4c5dc0cf8d06d36335233a505d88c1295e2b9a2e6de803e88b8555d3504fde1e21ad414c8ca0a6d9dd6cd50a375e90a4e85b8cd40c38af8cd939745bd65ecea6257172fa52e1e91abf574df25eb334bd667945e2f2437ea29bd4b8eff23399e8ae57a347f06cd3f809e1fe0f6f6a35569f1b3c6888308874ae7025604aeaa175309322ad839fd2ad380a6b841203f40e44a691a52ec855fa4321f939d82e5d242d21894739464a96108fba418c4ffe6b6acf686a239454dc6a226d501e4a51b104f69588be7b7b8c95c9ef14c03371e34908377039f546cf6bacd2e3345135a9bb9094a7649a39aff46dd26a1a39bf67632b20c1c1bd3e8e75bcb424ea3e12af6b743513c2a3fea546e31d0fbd70073611b72192e11aa75590dc666d8a57ce8e5c3081ca6ca70727e9e85dbc7e9cee4fc8203f57c33ed3b4b7aa0e8ec032e3dc2dd823e12024d5ad0a4c322ea3476dfbf6ba21967b13b9e30e3c3ef27a0a6cdadc9cd978989084cccd5146c442dc4b02497a5b38f70fd289ea2b1189e2344775d6fcab8cf9eabbc2a0792e63608649b7690295194afaac0f755bf9bdb5f21352073a1a2c2f96e1b489c254a70daf11459bcbc23d3ba29282c19b0f2dd8dbf2bd309e4d48cb050f35252308991215304d4d0bf062acb6a075d82539f01590122f5de4c10628826846c685435643621fb694e0b040fdc5f88627e7d4d5962ef98d8aafdccf7bdcdbbb352aed2616ae46d01b25008a101ad81d0cd88ef174ae19a5275c27a30221bee3c5e375cea866bba151b65d436c39d946215cddbf86e563ebd95ace85762bfe1d4588acedbf9f32c917a21ef6a6457233faf469e22fb1ef327c78b246f3801ca8848099516150a4f4124349d27d867bdb76ce239fb88c401f5109bf5d9076a23a6cd067f0f5f1f7402f97e16199cff4ff4c52c46a8efb93fdcdcfc07a416588b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137927, 3326, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c0b28ca2fc8a8cc49acc82cb652303430c84dd74f49ac5408f05748c92ccb4c494d510874d14dca4c01001ffe0d99', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137928, 3326, 100.0, 100.0, 'mg', 'PO', 1, 'Adult', X'789c0b294a4d2cc94dcd2bb152303430c84d5708f057087451a83032544849ac2c0600a1aa09b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137929, 3326, 100.0, 100.0, 'mg', 'PO', NULL, 'Adult', X'789c333430c84d5708f057282ccf060014cc0398', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137930, 3326, 50.0, 50.0, 'mg', 'PO', 1, 'Adult', X'789c3335c84d5708f057087401000ed702ae', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137931, 443, 0.25, 0.5, 'mg', 'PO', 3, 'Adult', X'789cb35230d03332d535d033cd4d5708f05708f174d151f04dacb05230c94dd74f49ac040083c508b5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137932, 1190, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b65228494cca492db1523035d0513037d551303430c84db75628c82f4f492d5248cb2f52c8cccb4a4d2ec9cccfb38248ea976526e600007ce41804', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137933, 1190, 1.0, 3.0, 'mg/kg', 'PO', 1, 'Adult', X'789c33d435ce4dd7cf4e5708f057087401001cc003db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137934, 1190, 3.0, 5.0, 'mg/kg', 'PO', NULL, 'Adult', X'789c4dc8b10d80201005d055fe02c6186283135869e204a70285c091e334b2bdadaf7c9b92a885e9c614fa2b605df00eb80b94617052abd89d677150a15c4ba4ac13e6ecd9fe064558f9e05891a8e121691f37ee1f57', X'789ced5a6b6fdb3816fd2b1701069b00b623d9b19d38fbc54dfadca6934dd21683ba301889b638a148959492a883fef73d578a9ff5a4936276b69d2d1038167949dec7b92fcabf6dc5ae988e8d48e5d680b6861f459e289b3965e45683b60aa77938c9f3cc0f76776fd4954c5bd64df99bda5da7f69113998cc722e745eda0dd6b0661330c2e82fe606f7fd0eeb50e82b0dfdfaf6865942b6b3c287fdb1ac6a932cae74ef0583594cbdb6a978b32930352695a18eb8b2c73d27b61f29139b65e4c253db12ef503cac5a5967983327b134b4713eb48995feb3368fbf91b1e49a930e25a28cdb498a6d7e73bf37dce7327cd344fe67b0da81b34a8df6d501804e9f470e3d6837a72f75a093d3267b6c8a5273ba155810674fa7383c0c4f626068e6c9a82c90b276249af6008b000cd424aac490b274ca5afe27259659f3054f1c94fefdee3492b73553ff0dc302e743e866cca4c57f4b961afad7fa9d8c8720c6e8dcf34b43b76f24ec071e66c96945adc2abfb24fd8ec40eeab2944a37f1f8fcc792e1c74d66976e7c3b7211519e5963a148bd2d3a584ee242d8e39a4e76662074b2384e3721b59ed2915255d0b576ead4acac29d25b248456e15a0e6f2c4a95cf9c6d8cb6be9e41a93ed56cdcf2e38609e6275ad621983e5e6a58ae76c87f7101dd289b81dd0f24e33c6c52407227acdfd9bab8a5f6522278597142c1ffb61efe66a831447ce26c68f8f95e725ab7c0741b3dd05b0d6b4bb18ba87a91aa07151631f0f4ea6ca7b7e488532b934c244928489690288165a7d04482074c547833c64826a9b3e138e27e464022cf80d12bcd69164845fcb314cc656f8aba5f8c3dc7ec95fbe791758f7d91f3ef0c307fe641ff84e21b5ee193f30f50d61ea3b34c63a9efe46d6f8c64579608d7b2a632572a7a23fb9ce1db7bf994af745712d8dd272ac62f459dc6d45df556cfe2f9460ff4bebac03eaffc93cdfbbac0f0c2ee7998cd0d48f4f6d5668b130f94cb85327a71cd14a3ac3ac998eb8cb9f8f1d895c4ead2b09887c29a2bcda809cf2574c9759c4c54b5d5261bc98c88de53dc2a5de14d7aac67e4047ee48531834bbc180627927776cf1d1eefe74584fff33fc6cb21b60f2d9f180a6c801d053fbce4bf86645cb54b22f9c62dad81c2b27ca4858691e67bf702c07fd6adf0f9d5e722f0f0bcabdfd6489a17bd8d8101c9f49c07073f4bfd3d2d2fa438a44515941c4d7a80256e5ba8ff0018ef2fbf0f8f265da31dfc3d5c47eaccc78bec3160e5c6cbc8aa62f6f3ba71f33fd38aa81a9c0fca7bae8ff01b4cf81b6ee8ddf1ed2fe6a077860f43cb206c914e5a08a36c4cea1d6d24d4b4ec99116deeff21df4c864739fd93e1b52e1e5cec8cc585113d493402aa93413cab1e5562633a7606aa1af4a5db910892948bea6aa1cc648645e8ecfa4883e677d133ace250e2f56e9b42cae6c868429460639d2a697362af3d98830a88df13f2da59edf6a63bf9159bde8ae87cca43e0d063b7939324f9f535266cca3f1c8bdd72a2fa11b714792892a0be69c9547266184a092b95511c8ee9e554448e5b669a348179edde1ae2d1a195da6596253664d68555b03ec46452e69222f1df23f1959e45c8e298d8d62e9f8cac0ab4d7d6c7db3fd157a5912d908000143d73655759e1506d5db2d9301bdce253c3b7c79d1a0e1f905492daf11e2e24a00a158a6b4147acae4132e5146c6099f2ccbf750affb61ee99b93fbb79f95bdafbfb91eaa1fd7322604d3439765aae88f74ce84953ab8944eb4f892d1ca07522b195d5caa703d2009123103324afa52e1b245dc98a8016a44746fee574af1b8ccce35b80b37e0376092c35a8e05785b48dcee02714bf5122cc54c63b5fc1fb89e4c5e0666c27e361f4d96b430c7912f8e34e8ed34b753f914a17890c86aaf868a06348d4a5aaf38521693e96a984737d28944303c22bf204c54209234b609edfec1dbf1ab6e822293c56e7945a9f93877f9829ca79515f65f091ac3d5767a2486a0d6a5f440973c43b5ed483d5f5d4a3bbefd89ba7aa88c067fa5ca65fd3b748391e6a6f57b471b1686c239b667a9e951fb4ff1fdbeffe7274b172bcba72568d426dd24472ad60202c8be13ba84650322883651aed3a1ab48a81fa260931340624aca9effdc4d2db697ed90a0ff2d0305c94a64ea0b269d199f42893e6ba871e2c16f2659553293611baf44c77b258fab45a4a473326cef3222e316a8bac452fe8952c60fcfa9f2fdc944e7d19255c65952d0a0f0e3a87ddde7618ee0cc2b0db6f8661afd3a277a7c5e50904db6fb70f8276ef3d0201808add0d1d59944a53c90cce6ee7d95b6918d3331b11872695e7120466c1d2d302fd331e2450372ada41182d462a509f58a3725be98cbb0ec01958cdb881a6c53b001ace9bfb6a93a5819aaac1f2f41ad439d8eeee0cfaed4eb3132e09d3eb1c84bd7d16064806c76f1af4565c311774dea80c74264b6375ece9d58bdf61143d908f1c5c149c0ed7cc795ca72256c78cc1470e16988d37a81d047b60b21b6ef758dfcc607bc160d8ed05bd6e50a9dba5c5c78f8a860d7a82d32349470d3a1599e01199a3ac6c312bc8a2f5dde6843b780ef7f55d2a224654b80ab674a3f2641579d5b5e844ab5b958a4b669c5332d7a6356d7541fe0f3fcbc9030e449c489a5a5c4a4d99d296230c40c6f0aaafd319166c8716440c3b87fdedb0bd33903d08888f8316ba1fc53f4c688541d8dbfdb515558b5a4cdb0af65a413b5868a1ddd90f835ebfb293636bd0f149835e0968e37983cee1a7d6cfb530b312600793d45de8f3f55f66ccd154197026ebdb4a5664084014869f3814307c3ff2bc0e7717ab4934a2d3c221488bb965b5b5315b340c60d1b0bb0d0f6a1fac002e3cd83fe877ef24b1c64e26f4f4ac418fa43132cfe9ed097f7750de8bf3b93815fa9741c61e50b5194f84d2858339eade8ad68059b55775fc3e426514c3f80dea424419032a1811a046cd2480a3e18036f9f36982d8122984c343466abf41191de033ecf75b10a1fa01086d2f436987de652bbcf26f5a2a2bbc6f01fb2a9eca1b540d0ef67b3180ed8039bacbf1a8e1383478be4d73c84350e4417dcab24fcd7e2f73cf318fe15ac0c48da90f792b7dde7c2b5cfcf941c3625a2039e2a42e4e7a248a948eef4c904bf65fc02b178e35fa661d60f3c6949e49e1725a648d1a7422e7b5cc583c580ee2025eddfc054be8f12dbc53b14bce2034dfd357812b6cd0fefe36fca61d749ae1de128ef67b21221760f4482aef258e0760de4a37813ba23e7b826d352be6f5826924a8a33a0df93a3efcec8021944c49a9675949735e3a4505be1ac9381c9711ea6b94e8685d2582f30425939e571f175cde73bf5b8146a26057506c63b485780c4bae843b44e370af5de797bdbd7eb3bb2c571fd966bfd3856032b31142977c707bfce9d37f00d4b7ff82', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137935, 1190, 1.0, 2.5, 'mg/kg', 'PO', 1, 'Adult', X'789c33d435d233cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d14dca4c01009c2a09ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137936, 1190, 1.0, 1.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b2e492c2ab15230cc4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d14dca4cb156f04dacb05230d233852bb256f0cc4bcbb752484c2b492d5230d3b528cf56c805eacdcc4b2e4a4d2c4e55304052ac5068529e0d00dff021b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137937, 1190, 100.0, 250.0, 'mg', 'PO', 1, 'Adult', X'789c333430d0353235c84d5708f057087401001b0d039e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137938, 1190, 50.0, 50.0, 'mg', 'PO', 1, 'Adult', X'789c15c9410ac2301005d0abfc03a815a19b74ebc685a87882219984413391cc14d4d3b75d3eded3a97bc078ac05f71b1ee70957fa069c0e632dc3ab0c897e132e9a5b406e1da2698e2e4db1a27315b30d95449d9534324813b298cf6ff98b16243126e31dccb937497bfb50df8273e6e8b60052612e6a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137939, 1190, 100.0, 250.0, 'mg', 'PO', 1, 'Adult', X'789c333430d0353235c84d5708f057087401001b0d039e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137940, 1190, 50.0, 50.0, 'mg', 'PO', 1, 'Adult', X'789c15c7410a02310c05d0abfc03e88c08b3e96cddb810154f10dab404692a4904bdbdcedbbd479045c272e80db72beea71517fa241ca7a5b7f9d9e642df1567ad23a10e836879e790a1f8c7b88bfb964ea2c14a9a79070fb62165ef2f32d106ae9573f80f624d2541', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137941, 1190, 1.0, 3.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d435ce4dd7cf4e5708f057087401001cc003db', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137942, 1190, 3.0, 5.0, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c4dc8b10d80201005d055fe02c6186283135869e204a70285c091e334b2bdadaf7c9b92a885e9c614fa2b605df00eb80b94617052abd89d677150a15c4ba4ac13e6ecd9fe064558f9e05891a8e121691f37ee1f57', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137943, 1190, 1.0, 2.5, 'mg/kg', 'PO', 1, 'Pediatric', X'789c33d435d233cd4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d14dca4c01009c2a09ff', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137944, 1190, 1.0, 1.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab15230cc4dd7cf4ed74f49ac5408f05748c92ccb4c494d510874d14dca4cb156f04dacb05230d233852bb256f0cc4bcbb752484c2b492d5230d3b528cf56c805eacdcc4b2e4a4d2c4e55304052ac5068529e0d00dff021b4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137945, 1190, 0.25, 0.25, 'mg/kg', NULL, NULL, 'Adult', X'789c734c29cd29b152702e72ce513034d03535b05248494d2e4a4d2c4e5548c9071246a6aad610691b430c495303a0a4878b95427a6659aa82819e91696eba7e76ba42716941414e6a6e6a5e89b54200503a2fbf04a8332d332f3505008ba222fc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137946, 514, 55.0, 55.0, 'mcg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652f0cfcc2bc94dcd2bd1772e4a4dccb55230d033303255d501d2a6aa0a7a0a7e89c589390ac505458995560aa6a60ab9c9e9fa601e0013aa15d7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137947, 35, 10.0, 40.0, 'mg', 'PO', NULL, 'Adult', X'789ccba82c482d2a49cd2bcecccfb352303450d0553031c84d5708f057084c49acd451c84dac008be803790055790e4e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137948, 35, 0.1, 0.5, 'mg/kg', 'PO', NULL, 'Pediatric', X'789c3354c8cdcf2bc950d0353453a84c4d2c52c8cf49b15230d03354d00592a6b9e9fad9e9fa2989950a01fe0a2999659929a9290a858646405923930c1d85dcc40a0513835cb01200344c15c5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137949, 1426, 80.0, 160.0, 'mg', 'PO', NULL, 'Adult', X'789cb330d035343350c84d5708f057283434ca00002326043c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137950, 1426, 80.0, 80.0, 'mg', 'PO', NULL, 'Adult', X'789c0b2e492c2ab152b030c84d5708f05728543034ca0000426005e0', X'789ced59df73da3810fe5776784ae7e2020e4989af773324b45766da94162e2fe79e47d80b56634bae6427a19dfcefb7b2f96191a490dc3d5ceff2900062f793f4edb7abb5f8d68854310b044bb1e14163247396c8a4b10f8d42256624cef34c7bcde615bfc0f4b95433f38e376b863a542cc32860b9b1775bee91d36a3bedd6b8d5f55aaee7bacf3b47076efbb8b4c530e75268b2fcd6f80d052a9694ef73bc2eddc7f30c3d5f9c60ce6092c8f00295f6455f6a3643782d55aa3d18b309ec755b90cef6a1ed2e5e8faa57b7635e9ffd0c03f1b99acb17a7324da580b16211c219ed9430eaeb2f26f565ddd050ce26099a4f7f7ca24f091717e587f532adf56d67cb98072bf39b4f668e5e542479403be362665170c79a1ae72872c5c322612a604ac5f33c4e39db0f123e45278f15b21cc52650b7e554b4c0f03d7c69bbb12f463953b907ddd66210cad177ecda83a392b966c4e6be18534015c84bfad776dcab0bc825f49ba7be7871e8b40f4bc8c1b90df9e2d01aad205b5b211b36db37df61bf64ed3f4dc4ee4a2cb91862c49961e39f5651e05a502f5d98cb320911264c630426ab4e463d5f30110165a6a3330cf994873065612e952fdc9fc8679fa8f5c531b15f666b33fdd3351c18c2237ec923421a0ffa2be68e5b6b9b0571edae35b6401d9cfba2dba198766ba0c4f85da0ddce6dd0badf0304584bff516f87a427a39b0789f6ffc6fba32aefc3a81f198258120c6546f4af5361093754382336c3397ca46fc5cc171e9c52386652cde184de16c6075874c94d00f65067c005b8867ffa3b50115068e948c9513df3c55b0a43398b0743a9359f247328846653f4c547142c812a557d51967f3a9bd46902072de7f0d883dff825c217b7132f86db2dc75d0d1f1c399deef29b97ed9647275cc97bc112fe150d2ecd618241e739849214c7385984b49908ae781e43e5da69f96255397c7126738870ca0546be788319ad3edc5ce499845ef4b9d0794a42def0ae7df3d8906ec6607b7cfba667a98c75c045b04258447d506dfc56b447459629a4b85048e5142ed77909ebbcd4a070aaca7c9a9be22cf3986a758a1135221b00a3f3f13e3067ca278f28dfa7f518dd5a6a2f4950cdca058409d3ba69e24a0be0a2d030a156661e3245713043e105e8725ccf45a4644a42b86a4ac8588829a396831298b42a5529d73ece149245efbc6a606ed9d2ba66548ea83f322e2cfc527065c4f1610c9992097dcbaabeea846a126d09e1c338845fa163ce4322802a168632cd90749f1bc718a9225085e249a168e253b36e69a60841c7e50a2a65021dbc7ba4e04223a5d28992228ca5ce9836928cb8962a5a745b8f51d91d34edd0e69253503a052b279aad16a6058bdba17ae7550768fb6f90ba1de6c338b01c2c348be9ed586f8c79b034b7906e05693b5acd25a85c968d2ef53a1a838fc8c2db3abfab4f19a1e2b2b0eddecc3349a7a4ae9457d7ff50c975f2ae2ab4296494deba2c7da44172bf6009a6c6e3d942e4242c2aad1bf2a4880c2d998fa5d2f4e4a0a94c4226b9c8910ac1db222321a1a259296f72a90bbdd94994296e9e3cac7dbc26d45941f3f4f9d7af943c9ac0ce18499ed6d5f4c5b94c79750ef5b9d99519ee699a4498851309a8624e3ad49cfc862cc97875de6853bc59c4c2d89c0242cbb474e8cfa943c8b479fb2aa2853eaadba951bf83a66ac696a26a31dbe100af19db0a5fc771b7b52c8d6d75df13fd1d44bef20ce2fbb36743433b65f5f0deacbe4380db11974e4184c1d2c942bd47c1df472d9d02dbc9425dc87b3bd2d2d0f2ae1261bbf3c2cef25d66ce76ef95a5e5bfccb71dba8fa5a5e55f4fc6ed1896b585b34ce39dca776569ef6399f23b6c6465ba68967fd8babb79823c15dea7c2fb54789f0aef0f5278ff95e5ea310f594f2afc8155388c994a5948d57036b77b00964c1d7359e92daec991842013ae530fcea42025bdba0e1556f75ebf2b6e46de6118334126e69ea457cac8a3e3df5c65c060008e71d4981881d16130214467f103c9da6a00389d928586bdc533afb99bc96452debdad6e69caeca0dee23d01e666baea39137e01d7398809af5fa8926afbbb4eac1e716b33420c7a8996164127b5e5ebead7abe547c8e5350f793ea7fc14395f754ca1ae066293aae5b94d34a4b8be0cfa1bbf4c390ffb656a6d6ef70d77ede26188c1cacdbe34b189d8e1ee64c3e116daf758dc0e5df70eeade941737377f01ba3ff77b', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137951, 1426, 640.0, 640.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230333150c84dd74f49ac04002214047c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137952, 1426, 75.0, 150.0, 'mg', 'IV', NULL, 'Adult', X'789c3337d535343550c84d57f00c53283434ca00002351043f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137953, 1426, 75.0, 75.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e492c2ab152303755c84d57f00c53283434ca0000414405e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137954, 1426, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789cf34dacb05230333050c84dd74f49ac040021f00478', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137955, 1426, 90.0, 180.0, 'mg', 'PO', 3, 'Pediatric', X'789cb334d035b43050c84dd7cf8d33d24f49ac5408f05748c92ccb4c494d5108f174010091520976', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137956, 1426, 90.0, 90.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab152b034c84dd7cf8d33d24f49ac04003eee063f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137957, 1426, 180.0, 180.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb05230b430c84dd7cf8d33d24f49ac040032650587', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137958, 1426, 84.0, 168.0, 'mg', 'IV', 3, 'Pediatric', X'789cb330d13534b3c84dd7cf8d33d24f49ac54f00c5348c92ccb4c494d5108f17401008dce095f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137959, 1426, 84.0, 84.0, 'mg', NULL, NULL, 'Pediatric', X'789c0b2e492c2ab152b030c94dd7cf8d33d24f49ac04003f0e0642', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137960, 1426, 168.0, 168.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb0523034b3c84dd7cf8d33d24f49ac040032a5058d', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137961, 2822, 150.0, 300.0, 'mg', 'PO', 2, 'Adult', X'789c333435d0353630c84d5708f05770f27401001eec03d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137962, 2822, 12.5, 12.5, 'mg', 'PO', 1, 'Adult', X'789c458c410e82301045aff20f60b5051a13d9ba578e509c499d458b32d584db434dd4d54f5efe7b5ac25c4e70cddea788eb05c3d98c423b48becd1c94312e68bcf136c503850565c2a6442e68ad35dd8f4b06c95b880934296bf52a775d8f72e78cf439fda3af476d39fb0d3c5b73dc56fb15735b2f32', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137963, 2822, 900.0, 900.0, 'mg', NULL, NULL, 'Adult', X'789ccb4dac50b03430c84dd74f49ac04001d0f0441', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137964, 2822, 12.5, 12.5, 'mg', 'PO', 1, 'Adult', X'789c05c1b10d80300c04c0557e019088444b450f8c10e44fe4c20159cffedc25e5ca2aa2e51358cabc46c779e0daa7db0ddea0645570083ec4ccef150d1b0aec07a2491520', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137965, 2822, 150.0, 300.0, 'mg', 'PO', 2, 'Adult', X'789c333435d0353630c84d5708f05770f27401001eec03d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137966, 2822, 12.5, 12.5, 'mg', 'PO', 1, 'Pediatric', X'789c73cec8cc49294acd53b03353a84c4d2c2a5608f05730d3333255c82f523034d233cd4d57284c0100e96e0b5c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137967, 2822, 12.5, 12.5, 'mg', NULL, 1, 'Pediatric', X'789c734cc9cf492d4e4ecd2b29563034d233cd4d5730d435aa504849cccca9040092ff098b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137968, 26249, 5.0, 5.0, 'mg', 'IM', NULL, 'Adult', X'789c0bc848cd4fce28cacfcd4fae2cc9cf4d4d0612950a892959a579c925560aa6b9e90a9ebefa9e610a8546ba26190a01417e00e636115e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137969, 26249, 5.0, 10.0, 'mg', NULL, NULL, 'Adult', X'789c73ad28294a2c4b2c4e2cc9cccf53d0c8cb2f4a2dc8cc4b2dc8280292ba89c5c5f9c9998925a9299a560aa6ba8606b9e90a997959a9c9401120a3245f21312d0dc24b2c4a4d54a8300400bf811d13', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137970, 26249, 5.0, 5.0, 'mg', 'IM', NULL, 'Adult', X'789cb35230cd4d57f0f4d5f70c532834d235c9500808f203003b6b0584', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137971, 26249, 1.0, 1.0, 'mg', 'IM', NULL, 'Pediatric', X'789c0bc848cd4fce28cacfcd4fae2cc9cf4d4d0612950a892959a579c925560a86b9e90a9ebefa9e610a8546ba26190a01417e00e5ea115a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137972, 162, 6.0, 6.0, 'mg', 'IV', NULL, 'Adult', X'789c33cb4d57284a2cc84c51f00c5328282dce50c82f4b2d5230d4352a06007ea008d9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137973, 162, 12.0, 12.0, 'mg', NULL, NULL, 'Adult', X'789cf34c53c8cc4b4d4b4b4d2ec92c4b55484ecc532829aa543034ca4d5730cacdcc53c8492c492d020004d50d4e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137974, 162, 12.0, 12.0, 'mg', NULL, NULL, 'Adult', X'789cf34c53282ec9ccc951c8cc4b4d4b4b4d2ec92c4b55484ecc532829aa5448cccb2fc9482d523034ca4d07003be70ed9', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137975, 162, 3.0, 3.0, 'mg', 'IN', NULL, 'Adult', X'789c73cecf2bce4c492d52282dcecc4b57c8c92f07b253f28b5315340c8b4b148c73d375148cf252f48d8b5214cc72d3351532f3140a124b3253f34a144a12b3817a00fdcd169e', X'789ced58db6e1b3710fd95819f6c40b62e691344691f94b86d8c268e611bce435408d4eeec2e612eb925b9b2b781ffbd875c499614a5beb4685ac06f7b9919cee5cc21879f77525be7132d4ade19d2ce28656d9cd4bcd3a19ddaaaf0adf0be72c36ef74a5e7279606c1e9e64774dd42556549c4e840f1a83dee0f97eafbfdfef9df75e0cbf7b31ecf70f7a8397df0f5e44594ebc34da41f2f3ce91f6d6c427cfd751f98c79ac132bbd4c84a24458a6df6b995c92e58c2deb04bf336329f84da971ec68dad015cbbcf007631d57a8a7ab8bdce0931753c5e1edd36f7853525fb62fe1df2facd90ab5e6c57953f170ac47da4b616dd1f8a294891beb43e344cef4b3b1a51bd2d1c558bf316569349d5b91321d238ff81e7303d7d34efbe812f140c76e3dd970e11e85d950b889411ee91409bd4dfcc2fc1ba3676c1dbe93c99063464184f6747276714eded0f1d9e923523a4a6be52787011ff9da725b6ced9c454b1d80d05a7335494c5929be9e7891144d48a2146b269e9739016d3245faa9aa5d410611507f7f80fa1c6504486659b03f63c04793b70df507501a945293129e6d94735e2ab5555a68e38b60125a28b098b1f0638d9a53850c22438ebcb8446854b22f1a758d841530e4685706f00a58c4eb5877c6f8c1a6828c8a1ff680a9d7ca24978ec4a27f682a511b18131ef94fb8f258c8491fcc855cb097d13b2c2272a3a5f37b784ea3b78a451aaa34b5462785719570e52b5841c758e82b6173c411ba245477b96440ad7632c5bf3a948894b95ac8edf69da76765dea1814ebbcf6c4a48f81ef2b4087e1e7b88d34e4529fee02a9adc3de7dcb2376a0f61a368f82e4a7cbe104ad6e51e191b3e578d95a9288d0a1a27401ec282fade587f381deb2be90b1254b0b058074074958200fa3af4970c98114a359423219a6652a08aa64a90508aaab22c194b7ba64c0564006746a7023545928092865c6160ba102a2325333ea0630ea13b5fa7f1e75548872f508bc6d4548a86a6483df0192c94f2ba5d47a3ffc14e4e84b2c66ae4b1448e423a211c70d92198e380cdacb611503c43cec16024dd1c7e9a39e574ac3ff57f1beb839df5b6bab917412ce0763733bc5948c2eeadfe2a42efb671be2abd66670d0ef77166557ccdd2023c771b395c486ee8dfa2ec3e3656a45bb27c62a427467a62a405233de6d4f2444aff38299d441c59996c3b579d8cde9d515ea3982ab67d38214b9d01a9ae434921558aa37327e242a4b0e992401aa8f20055fe9b47eede41bfccbb97b71cd83dfad0d2e06e29ae43b37683d25ee43810192df9ad031f13cbc2452cf70e06d41a8a7a81eb5ac54783f0af42ba0718e6ea93a03e89ea935bf5f94e517122217262aa5a6d395e6f3bef9e58ceb5d049333985c64621dfa3bf6be423ad6de8fb6a210b0e95ee327066c61e2115c2966d32afe182e794a648634a38c72b59caf0a1a84b10722abcd83c57e0f59d487cf4777d1a889b5b42671e64ede89c5d707018592778750524617b0825f31988023f5fc18b95a548cc845471fb0469993a2f968eb7786c3d6f8118260f9ec3c105d74ba92e11b349eb98afaf04187108a98a2df8df0182231057bb43c24b0c60c7ddd1ab56acd60a5555916ec19b753031cfed5a18b7d6e57252da92b65306dd6f6bc038f18cf5311c4e39430fa6b41fddb7dc6e101ccaa2b111805b97ad7c3f852d7ebce5b0f76da582af7a52b43a0ff366bbd2030eaa2d777d13c86f36de13e69f30ffef61fe096df743db66973ec1ed5170fb6669dbacdfff2c6fff01771f78b98a491983a8fcca852e1a956d1ebb3151c2b96e68d2b1c6e8dca1303b8f2e681ae67d1cfbc3791841d718fd1a9d5a53e29c7fbabc013ebb3877d171a96746cd420743579b1453258ed3e18f67bb8cfdd8cc69267438f4d99a3cde897f3cf9f8a81be4485d935316c99741be6e6f17304abb90eec864bb20d40ab3b55bb97e484194de5887d9e3359c6996f7e262acdf3695f1acc3d537067f99cd47786f0c3965ae54f3e8b963c5f2dd53c6aaf07cd00bfc2d12a34cdeac45fd2bd00404817d3f68c73e5ea0b4b1ff4883defeb39ea3c3da464cacfd7bdedb7fd9c3b0f756a86c3fdc310ce9877e6f7e1581efef71bc9a1a255d39a499700926194bacd3c0f74a86f9899582dc4fd718d682cde1b6be7fcf4921348c4c4c3619255fec7cc79c8b786d24011d6c2d32e95000ddf2252950b4f9db62cb8ad72c484eb8e569d10777227e1fdae7dfc0bd8740fee6e64f56ffad03', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137976, 162, 0.1, 0.1, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d033cc4dd7cf4e57284a2cc84c51f00cd3f7f45728282dce50d0c84dac5030034aa6e417a76a0200fe550cb6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137977, 162, 0.2, 0.2, 'mg/kg', NULL, NULL, 'Pediatric', X'789cf34c53c8cb2f51484d4b4b4d2ec92c4bd551c8cc4b2e4a4d2c4e5528c95730d03352c84dd7cf4e57d0c84dac503034027252f28b5335010aca1218', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137978, 25288, 0.0, 0.0, 'units', 'IM', NULL, 'Adult', X'789c33d4313230d03130305028cdcb2c2956f0f45528343452c8c82f2d2a56a8503033504849ac2c56d0284e4d55484acdc92fd704005d930ed0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137979, 25288, 0.0, 0.0, 'units', 'IM', NULL, 'Adult', X'789c333330d0313030d035d43182b0144af3324b8af553122b153c7d01662c07a1', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137980, 25288, 500.0, 500.0, 'mg', 'IM', 4, 'Adult', X'789c33d23351c8cdccc9c9cccf5328cdcb2c29d64f49ac54f0f455d056303530c84d572828ca4f4acd4b4dce4c5108f05708f47451a8503034d0353451002a2c06007d8a1367', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137981, 25288, 0.0, 0.0, 'units/kg', NULL, NULL, 'Pediatric', X'789c3332d5313030d0353500510aa5799925c5fad9e9fa2989950a2999659929a9290a86ba460a2599b9a9c520510041fa0e8b', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137982, 25288, 0.0, 0.0, 'units/kg', NULL, NULL, 'Pediatric', X'789c73cb2c2a2e5170c92f4eb5523032d5313030d0353500510aa5799925c5fad9e90a150a8600d6470abc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137983, 25288, 0.0, 0.0, 'units/kg', 'IM', NULL, 'Pediatric', X'789c3332d53130305028cdcb2c29d6cf4e57f0f45528343452c8c82f2d2a060070350873', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137984, 25288, 0.0, 0.0, 'units', NULL, NULL, 'Pediatric', X'789cf34dacb05230d4313230d03130305028cdcb2c295628343452c8c82f2d2a06007b9408c4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137985, 25288, 0.0, 0.0, 'units/kg', 'IM', 1, 'Pediatric', X'789c3335d03130305028cdcb2c29d6cf4ed74f49ac54f0f4554849cccca954a850303400322b8b01da2c0bb6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137986, 3420, 20.0, 20.0, 'mg', 'PO', 3, 'Adult', X'789c333250c84d5708f05708f1745148cb2f5230574849ac2c0600491006a6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137987, 3420, 150.0, 150.0, 'mg', 'IM', 3, 'Adult', X'789c73cc29492dca4b2cc92c4bd551c8cb2f51c84f4bcb4cce4cccc9a95448cd4bc92f2a4e4d5148aa547074f677b752303435c84d57f0f455a850305428c948cd53303250008a04f82b8478ba00458d1552122b8b01e5851b2c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137988, 2107, NULL, NULL, NULL, NULL, NULL, NULL, X'789c0b4e4d5548492d49cccc494d51484e2c4a5148cb2f5248c92f4e4c4f55c8cc037272134b32f3f3f400381a0f22', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137989, 793, 500.0, 500.0, 'mg', 'PO', 2, 'Adult', X'789c333530c84d5708f05770f27451a85030564849ac2c06003b6e05d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137990, 793, 100.0, 100.0, 'mg', NULL, 2, 'Pediatric', X'789c33d435aeccb752303430c84d5770f27451a85030564849ac2c060053ec06e4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137991, 793, 200.0, 200.0, 'mg', NULL, 2, 'Pediatric', X'789c33d13534acccb752303230c84d5770f27451a85030564849ac2c060059150717', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137992, 793, 500.0, 500.0, 'mg', NULL, 2, 'Pediatric', X'789cb33334acccb752303530c84d5770f27451a85030564849ac2c060055ab06f7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137993, 1441, 50.0, 50.0, 'g', NULL, 1, 'Adult', X'789c0dc5c10980301004c056b6000515fc58870d2cc92ac10b396240d3bdce67f6e229d036d0dd3a5a018f43a1298255c43c2e6829eb4664b23e20f3c53a9d28f52f1b5c158f747da2d71890', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137994, 1441, 50.0, 50.0, 'g', NULL, 1, 'Pediatric', X'789c0dc7410a80201005d0abfc0318a4d0a6457719f41bd2888309e5ed6bf578870fb3398c66258aee10339d7f2139330e2648a7c02f01a354de4852743a5479b1ad275affa90a63c7435e1f39451a85', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137995, 1441, 0.02, 0.3, 'mg/kg', 'IN', NULL, 'Pediatric', X'789c0bae2c2a2db05230d033305228c907d2c60ab9e9fad9e9fa2989950a99790ac6ba260a2999659929a9290a29f9c5a9c5006a780f36', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (137996, 7516, 600.0, 600.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492dd151303330c84d070082b908e7', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170091, 1768170091, NULL, NULL, NULL, NULL, NULL, NULL, NULL);